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The genus Salmonella is a member of the Enterobacteriaceae, a family of 
microorganisms that reside within the gastrointestinal tracts of humans and higher animals. 
Already in the early 1980s Theobald Smith pointed out that not all members of the 
Enterobacteriaceae behaved the same. He noticed that the organisms that were 
pathogenic to humans and animals failed to ferment lactose, while the organisms that were 
thought to be normal inhabitants of the intestinal tracts of humans and higher animals did 
ferment lactose. This observation led to the early separation of two genera, later called 
Salmonella and Shigella, from the rest of the Enterobacteriaceae on the basis of their 
pathogenicity. The Salmonellae are named after Dr. Daniel E. Salmon (1850-1914), a 
veterinary medical scientist who pioneered research in bacterial diseases and in 
immunology. His efforts in research on Salmonella led to the development of killed typhoid 
vaccines and to the naming of the bacterial genus in his honor. In 1885 he discovered the 
first strain of Salmonella from the intestine of a pig with hog cholera, later called S. 
choleraesuis. It is argued that this pathogen should in fairness be called Smithella, since it 
was Theobald Smith who was the true discoverer of the first member of the Salmonellae 
(77). However, it was his supervisor Daniel E. Salmon who wrote the paper “The bacterium 
of swine plague” (141). Since 1885 a lot more Salmonella strains were discovered and 
















Originally, the Salmonellae were named according to the one serotype-one species 
concept proposed by Kaufmann (78) and nomenclature was based upon host specificity, 
the presence of specific surface antigens (i.e. lipopolysaccharide (LPS), O antigens, and 
flagellar H antigens), and sensitivity to phages. This resulted more than 2,100 different 
Salmonella “species” that were named after their favorite host or the place where they 
were originally isolated. However, with DNA-DNA hybridization techniques it became clear 
that all of the Salmonella strains, with the exception of the S. bongori strain, were related at 
the species level (28) and therefore, belonged to a single species, which was called 
Salmonella (S.) enterica (125). S. enterica has been divided into six subspecies (spp.) on 
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the basis of genetic similarity and host range: enterica (or choleraesuis, Group I), salamae 
(Group II), arizonae (Group IIIa), diarizonae (Group IIIb), houtenae (Group IV), and indica 
(Group VI). S. bongori was originally classified as ssp. V, but since it differed too much 
from the other Salmonella it is generally considered a separate species (136). Group I 
contains most of the serotypes that are pathogenic to humans, including S. typhi and S. 
typhimurium. The Salmonellae are nowadays classified as S. enterica with numerous 
subspecies and serovars (9). For example, S. typhimurium is now officially referred to as S. 
enterica spp. enterica serovar Typhimurium. Although this is the official classification, the 





The Salmonellae are rods that are approximately 2-3 × 0.4-0.6 µm in size with parallel 
sides and rounded ends. They are gram-negative, non-acid-fast bacteria that do not form 
spores and show no granules. The Salmonellae are motile because of the presence of 
flagellae, with the exception for the non-motile S. gallinarum and S. pullorum, the 
pathogens that cause fowl typhoid and pullorum disease in birds, respectively. Most of the 
Salmonella strains cannot survive in animals and humans and, as a result, do not cause 
disease. Only a few of the Salmonella enterica strains are pathogenic to humans and 
animals. Salmonella infections are one of the most common food-borne infections in the 
world. Annually, an estimated 1.41 million cases occur in the United States and are 
responsible for ±600 reported deaths (103). Salmonella infections have become a major 
food borne disease in the developed world, but are even a greater health problem in the 
developing countries where a lot of people, especially children, get infected and die due to 
infection with typhoidal as well as non-typhoidal Salmonella strains (reviewed in (56)). 
Severe Salmonella infections in the Western world are mainly a problem in the 
immunocompromized, the elderly, in people with AIDS and very young children. These 
groups of people can suffer from very severe infections and can die as a consequence. 
Recurrent infection with a Salmonella strain that persisted in the host after a previous 
episode has also been described for people with AIDS or other immune defects like 





The bacterial cell is composed of a nucleoid containing the chromosomal DNA, 
cytoplasm, and a cell envelope. All structural components have different functions and help 







As for most bacteria, the chromosomal DNA is a single, covalently linked, ring-shaped 
molecule. The S. enterica serovar Typhimurium strain LT2 chromosome (4,857 kilobases) 
and 94-kb virulence plasmid have been sequenced and revealed 4,597 suspected genes 
(100), encoding proteins involved in many processes and many of which were previously 
unknown. The chromosomal DNA is surrounded by the cytosol that is densely packed with 
ribosomes that often form polysomes, i.e. special structures that are formed when mRNA is 
translated by more than one ribosome at the same time.  
 
Cell envelope 
The cell envelope is composed of an inner cell membrane surrounded by a cell wall 
and an outer membrane. The cell envelope plays a very important role in the adaptation 
strategies of Salmonella since the structural components are adapted to take up nutrients, 
to exclude certain toxic compounds, and to adhere to surfaces or cells. The cell membrane 
is a lipid bilayer composed of phospholipids and is very much alike that of other biological 
membranes. The inner membrane is surrounded by a cell wall, which is a thin layer of 
peptidoglycan that confers structural strength and helps determine cellular shape. The 
region between the cell membrane and the outer membrane is called the periplasm. The 
periplasm has an osmotic strength that under most conditions is greater than the 
surroundings thereby maintaining the turgor necessary for growth of the bacterium. The 
periplasm is iso-osmotic to the cytosol (155) and contains catabolic enzymes, binding 
proteins involved in the uptake of nutrients, enzymes involved in inactivation of toxic 
compounds, and enzymes promoting the biogenesis of major envelope protein or polymers 
(reviewed in (122)).  
The outer membrane is built up outside the peptidoglycan layer and these two 
structures are connected by the outer membrane lipoproteins and porins. The outer 
membrane is also a bilayer, but the composition is rather different from that of the cell 
membrane and has the capacity to resist damaging chemicals. The inner leaflet of the 
outer membrane is similar to the cell membrane and is built up of phospholipids. The outer 
leaflet, however, does not contain phospholipids, but contains lipopolysaccharide (LPS) 
instead, which is involved in excluding hydrophobic compounds. Within the outer 
membrane special channels are formed by porins through which passive diffusion of 
hydrophilic compounds and certain ions takes place. Other structural components of the 
outer membrane are the pili and the flagellae. The pili are organelles of attachment to 
surfaces and minor proteins of pili, termed adhesins, play a role in Salmonella-host 
interaction. The flagellae are organelles of bacterial locomotion composed of basal body, 
hook, and flagellin forming the helical filament. Flagellae and LPS are antigenic and host 








LPS is the major constituent of the outer membrane of Salmonella that is involved in 
protection of the bacterial cell and is a potent inducer of host immune responses. LPS is 
composed of three major structural parts, the hydrophilic O-antigen polysaccharide, the 
hydrophobic lipid A, and the connecting core oligosaccharide (134) (Fig. 1A). The lipid A 
portion is also called endotoxin, as this the bioactive component that is responsible for 
some of the pathophysiology (septic shock) associated with severe Salmonella infection. 
Lipid A is the pathogen-associated molecular pattern (PAMP) that is recognized by Toll-like 
receptor (TLR) 4, leading to MyD88-mediated signal transduction and activation of the 
phagocytic cell. During infection, lipid A is bound by an acute phase serum protein (LBP, 
for LPS binding protein) and is delivered to CD14. CD14 is a cell surface protein expressed 
by macrophages (and other cell types) that delivers LPS to TLR4 that then induces 












Figure 1. LPS 
structure of S. enterica 
serovar Typhimurium (A) 
and organization of the rfb 
operon encoding genes 
involved in the formation of 
the O-antigen (B). 
 
 
The LPS core region is a short series of sugars and is composed of two 3-deoxy-D-
manno-octulosonic acid (KDO) residues and a heptose. The core is required for the outer 
membrane to function as a barrier to antibiotics (144, 176) and connects the lipid A to the 
O-antigen polysaccharide. The O-antigen is an immunogenic repeating oligosaccharide of 
1-40 units and each unit is composed of three sugars (mannose, rhamnose, and 
abequose). The components that are involved in the formation of the O-antigen are all 
encoded by genes of the rfb operon (73) (Fig. 1B). The presence of an intact O-antigen is 
important for Salmonella as it may enhance bacterial virulence and mediate resistance to 
complement-mediated killing, as the shorter the LPS chain, the more sensitive these 
mutants get to complement-mediated serum lysis and the less these S. enterica serovar 
Typhimurium mutants are able to colonize the intestines (89, 116, 146). 
 




























Clinical manifestations of Salmonella infection  
 
Human infection with Salmonella may occur in five different (clinical) forms including 
enteric fever and its asymptomatic chronic carrier state, gastroenteritis, bacteremia, and 
extra-intestinal localized complications, i.e. in the bones (osteomyelitis), joints (arthritis), or 
vasculature (endovasculitis). The strictly human serovars typhi and most of the paratyphi 
cause enteric fever. 
 
Asymptomatic chronic carrier state 
The most well known asymptomatic carrier of Salmonella is Typhoid Mary Mallon, a 
40-year-old Irish woman who emigrated to the United States to start working as a cook. 
She was shown to be a healthy carrier of S. typhi and spread the disease to at least 45 
people of whom three died (121). This illustrates the problem of chronic carriage of S. typhi 
since chronic carriers may show no signs of illness but shed the bacteria through their 
stools being the cause of spread of S. typhi to other individuals, especially by those 
working in the food industry. Both the typhoidal as well as the non-typhoidal Salmonella 
strains are able to persist within the host, although this is rare for the non-typhoidal strains. 
Chronic carriage, which is clinically defined as the situation in which the bacteria are shed 
in the stool for periods exceeding 1 year, occurs only in about 0.1% of non-typhoidal 
Salmonella cases and might even represent reinfection instead of true chronic carriage. 
Usually, the bacteria are shed during 6 weeks or 3 months depending on the serotype. In 
typhoidal infections, however, chronic carriage occurs more often as approximately 2-5% 
of untreated typhoidal infections results in a chronic carrier state. Better hygiene care can 
diminish the risk of spread of the bacteria.  
 
Gastroenteritis 
Gastroenteritis can be caused by several Salmonella strains, including S. enterica 
serovar Enteritidis and serovar Typhimurium. Infection occurs via ingestion of food or water 
that is contaminated with animal waste. Salmonella-induced enteritis leads to the 
development of an inflammatory reaction that is characterized by the infiltration of 
neutrophils. Patients show an acute onset of nausea and vomiting that is followed by 
diarrhea, abdominal pain, and fever after an incubation time that usually lies between 6 
and 72 h depending upon the host and the inoculum. Enteric infection with Salmonella is 
hardly distinguishable from that caused by other enteric pathogens like E. coli or Shigella 
as the symptoms are not very specific. The infection is usually cleared within 5 to 7 days 
without treatment, although Salmonella pathogens can be found in the stool four to five 
weeks after resolution of gastroenteritis (80, 107, 143). Salmonella gastroenteritis can be 
life-threatening in the elderly, children, and other immunocompromised individuals. The 
worldwide incidence of acute gastroenteritis has been estimated at 1.3 billion by the WHO, 
resulting in approximately 3 million deaths (124). S. enteritidis has surpassed S. 




Enteric (typhoid) fever 
Enteric fever is a severe disease caused by the human-specific strains S. typhi or S. 
paratyphi. Infection occurs through the ingestion of food or water that is contaminated with 
human waste and disease occurs within 5 to 21 days post-infection. Patients suffer from a 
systemic infection resulting in high fever, diarrhea, constipation, and sometimes a 
characteristic rash. Sometimes, very severe complications such as gut perforation, 
hemorrhage, and septic shock can occur (80, 107, 143). As for gastroenteritis, the severity 
of the disease depends on the type of strain and the immune status of the host. This type 
of Salmonella disease is a very serious threat since about 10-15% of the 
immunocompetent people will die due to the infection when no antibiotics are administered 
and even when proper antibiotic treatment is started mortality rates can be as high as 5-7% 
in some regions throughout the world. It was estimated that typhoid fever caused 
approximately 21 million illnesses and 200,000 deaths during 2000 and that paratyphoid 
fever caused an additional 5 million illnesses (29). Fortunately, most people clear the 
infection and due to better living conditions and hygiene care the number of cases has 
declined dramatically in the Western countries. In the developing countries, however, 
typhoid fever remains a significant problem of morbidity and mortality (38) since typhoid 
fever is endemic in many developing countries, particularly India, South and Central 
America, and Africa. These nations share several characteristics that form a risk for 
spreading typhoid fever; inadequate human waste treatment and limited water supply in 
combination with a rapid growth of the population, an increased urbanization, and an 
overloaded healthcare system (105).    
 
Bacteremia 
Approximately 5% of individuals with gastrointestinal illness caused by non-typhoidal 
Salmonella develop bacteremia, a serious and potentially fatal condition in which the 
bacteria pass the intestinal barrier and enter the bloodstream. Bacteremia is a serious 
complication of non-typhoidal Salmonella infections and can be lethal if not treated with 
antibiotics. Bacteremia has been most often described for the immunocompromised like 
HIV infected patients or patients with genetic defects in cellular immunity like Interleukin 12 
receptor β1 (IL12Rβ1) deficiency (2, 3, 33, 164) or Interferon γ receptor 1 (IFNγR1) 
deficiency (76, 117, 164). In these groups of patients also recurring infections with the 
same Salmonella isolate have been described (17, 52, 69, 152). 
 
 
Infection with Salmonella 
 
Infection with Salmonella occurs by the fecal-oral route, i.e. via ingestion of food or 
water that is contaminated with animal or human waste. A generally known risk factor is 
the consumption of raw eggs and non-pasteurized milk, but a risk factor that cannot be 
ruled out is the food-handler. Especially in places where there is no good hygiene care, the 




Natural infection with Salmonella occurs through the ingestion of contaminated food or 
water. The first natural barrier of the host is the low pH of the stomach. This pH usually is 
below 1.5 and most of the bacteria are killed. However, if for some reason the pH is slightly 
above 1.5, Salmonella can escape killing since it has evolved mechanisms to survive at 
low pH. Also when there are large numbers of bacteria present in the food or water, some 
of the bacteria will pass the stomach intact. Once Salmonella has passed, it enters the 
small intestines where it encounters several defense mechanisms like the thick mucus 
layer and competing naturally occurring intestinal flora. In the small intestine Salmonella 
will eventually encounter membranous epithelial (M) cells overlying the Peyer’s patches. 
The Peyer’s patches are organized mucosa-associated lymphoid tissues in the gut that are 
overlaid by specialized follicle-associated epithelium (FAE) in which the M cells reside. 
These M cells function as antigen-sampling cells transporting material across the FAE to 
the underlying lymphoid tissues where protective immune responses are initiated 
(reviewed in (115)). Some pathogens use these M cells to pass the intestinal lining and to 
invade the body (reviewed in (72)). Since reduced amounts of mucus are present at the 
FAE surface, Salmonella preferentially invades these M cells. In addition, M cells have an 
irregular brush border and a thinner glycocalyx than enterocytes, promoting invasion. 
Salmonella is then transported through the cytoplasm to the underlying lymphoid cells 
where it it preferentially infects phagocytes within the lamina propria. The phagocytes 
infected with Salmonella then enter the lymphatics and bloodstream, allowing for spread to 
the liver and the spleen (165). Depending on the type of Salmonella strain two major types 
of diseases occur in humans. When the gut is colonized by the typhoidal strains S. typhi or 
S. paratyphi, the bacteria spread to the lymph nodes, become systemic, reaching the liver 
and spleen and causing a chronic inflammatory response (typhoid fever). Non-typhoidal 
strains, on the other hand, reside within the Peyer’s patches and induce a local 




The most widely used in vivo model for Salmonella infection is the mouse model, 
although studies are also performed in chickens, cows, guinea pigs, and rats. The human-
specific Salmonella strains S. enterica serovar Typhi and Paratyphi cannot be used in 
these models due to their host-specificity. However, S. enterica serovar Typhimurium, the 
causative agent of gastroenteritis in humans, causes a disease in mice that is comparable 
to that of enteric fever in humans and therefore serves a good model for human infection 
with S. enterica serovar Typhi and is most widely used.   
The natural route of infection is the oral one, but in the experimental setting infections 
can also be initiated after injecting the bacteria intravenously, intraperitoneally, or 
subcutaneously. Once Salmonella has disseminated into the bloodstream and thus has 
become systemic, all these systems are equivalent to the natural infections. Within a few 
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days after local infection the bacteria spread to the spleen and liver where they reside and 
replicate within macrophages. The disease caused by S. enterica serovar Typhimurium is 
characterized by the influx of inflammatory cells (macrophages and neutrophils), which, 
together with the bacterial replication, result in hepatosplenomegaly, focal necrosis, and 
bacteremia. Depending on the dose and the type of mouse used in the infection model, the 
infection can either cause death within a few days, or an immune response is generated 
and the mice survive being protected against a second infection (96, 118). Vaccination is 
therefore an effective tool for the prevention of Salmonella infections (95). 
 
Four stages of infection 
Once S. enterica serovar Typhimurium has become systemic, the infection in mice is 
characterized by four different phases (Fig. 2). In the bloodstream, the bacteria are rapidly 
killed by resident macrophages and granulocytes (phase 1) (20, 160). In humans 
complement-mediated killing is also important in innate defense mechanisms. In mice, 
however, complement is not that potent and cannot kill virulent S. enterica serovar 
Typhimurium, although it might be involved in opsonisation of the bacteria to promote 
uptake and killing by macrophages and granulocytes (86-88, 142, 154, 172). Bacteria that 
survive reside within the liver and spleen where they survive and replicate within 
polymorphonuclear cells or macrophages or extracellularly (36, 37, 137). Bacteria that 
have adapted to the intracellular macrophage environment divide exponentially within 
these cells during the first week (phase 2). Survival and replication within macrophages is 
essential for immuno-pathogenesis as mutants unable tot do so are avirulent (43). 
Eventually, bacterial growth is halted by the macrophages resulting in a plateau-phase 
(phase 3). Then the adaptive immune response is initiated and mainly T cells mediate the 






Figure 2. Three of the four phases of 
primary S. enterica serovar Typhimurium 
infection in the livers of C3H/HeN mice. The 
first phase is characterized by rapid killing of 
the bacteria by resident macrophages and 
complement. During the second phase, when 
the bacteria have spread to the liver and 
spleen and reside within macrophages, they 
start dividing exponentially. Bacterial growth is 
halted during the third phase by the 
macrophages and the bacteria are eventually 
cleared during the fourth phase that is mainly 
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Salmonella: an intracellular pathogen 
 
S. enterica serovar Typhimurium is a facultative intracellular pathogen that 
preferentially invades mononuclear cells and is able to survive and replicate within these 
professional phagocytes. Like some other intracellular pathogens, S. enterica serovar 
Typhimurium has the capacity to adhere to host cells and to induce its own ingestion, even 
by nonprofessional phagocytes. These processes are induced by proteins that are 
expressed at the bacterial surface (adhesins and invasins) and can interact with host cell 
receptors (5, 6, 23, 24, 45, 51, 59, 74, 75, 133, 161). This leads to tha activation of 
intracellular signaling pathways resulting in cytoskeletal rearrangements and endocytosis 
(as in professional phagocytes). 
The interaction between bacteria and host cells also induces the synthesis of new 
proteins by the bacteria. This probably reflects an adaptive response to a new environment 
and illustrates the cross talk between bacteria and host cells. S. enterica serovar 
Typhimurium contains two very important gene clusters in localized regions of the 
chromosome that are involved in the invasion of and survival within phagocytes. These 
regions are called Salmonella pathogenicity islands (SPI-1 and SPI-2) and they contain 
several genes that are involved in the delivery of virulence proteins into the host cell. They 
encode type III secretion systems (TTSSs) that are needle-like structures through which 
proteins are injected into the host cell (46) (93). The action of the proteins encoded by 
these genes leads to the uptake of the bacteria and to intracellular survival and replication.  
 
Salmonella Pathogenicity Island 1 
SPI-1 contains genes that encode proteins involved in the uptake of Salmonella by 
intestinal epithelial cells and the induction of intestinal secretory and inflammatory 
responses (reviewed in (179)). Upon contact with the cells via invasins and adhesins, 
Salmonella starts producing the first TTSS, a needle-like structure that spans the inner and 
outer membrane of the bacterial envelope and secretes the translocon and at least 13 
effector proteins into the host cell cytosol to induce several cellular changes promoting the 
uptake of the Salmonella (reviewed in (179)). The effector proteins encoded by genes of 
the SPI-1 induce cytoskeleton rearrangements that lead to a process called membrane 
ruffling and leads to the phagocytosis of Salmonella, even by non-professional phagocytes. 
SPI-1 mutants are attenuated when administered orally, however, when given 
intraperitoneally, these mutants are as virulent as the wild type strain indicating that SPI-1 
does not play a role in survival and replication within the liver and spleen (47).  
One of the genes encoded by SPI-1 that is involved in Salmonella virulence is sipB, 
which is injected into the host cell cytosol upon entry. SipB binds to and activates caspase-
1 (64), an IL-1β converting enzyme capable of cleaving the pro-forms of the inflammatory 
cytokines IL-1β and IL-18 (65). Caspase-1 activation then leads to the secretion of IL-1β 
and IL-18 and results in macrophage death. This Salmonella-induced cell death is 
characterized by DNA fragmentation and membrane instability leading to lactate 
dehydrogenase (LDH) leakage and probably does not reflect a host response to infection, 
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but rather a bacterial strategy to promote disease by enabling cell-to-cell spread (8) since it 
has been shown that Salmonella mutants deficient in sipB are not cytotoxic and cannot 
induce apoptosis (64). In addition, Salmonella induces less cell death in cells deficient for 
caspase-1 and induces no acute inflammation in caspase-1-/- mice and is less virulent in 
these mice compared to wild-type mice (111). 
 
Salmonella-containing vacuole (SCV) 
Once inside the macrophage, Salmonella resides within a vacuole that is modulated 
by the bacterium. The SCV, as it is called, will undergo a few maturation steps during this 
intracellular lag period of 2-3 h to prevent bacterial killing and to promote bacterial survival 
and replication. The SCV is entirely Salmonella-specific (7, 14, 49, 67, 108) and its 
formation is an active process that is induced by Salmonella (1, 18, 50, 140) and includes 
the translocation of several bacterial proteins into the host cell cytosol and the cytoskeleton 
remodelling (10, 81, 104, 106). The SCV is different from the endosomes, although it does 
acquire the early endosome and recycling compartment markers such as EEA1 and 
transferrin receptor (reviewed in (54)), but these are recycled from the SCV once it 
matures. During maturation the SCV acquires the late endosome/lysosomal glycoproteins 
Lamp 1, Lamp 2 and CD63, but excludes the lysosomal enzymes and mannose 6-
phosphate receptors (reviewed in (54)). Once the SCV has completely matured and 
Salmonella has had the time to adapt to this intracellular environment (e.g. after ~3 h), a 
milieu has been created that enables bacterial growth. In non-phagocytic cells, at the same 
time, membrane tubules called Salmonella induced filaments (Sif) are formed that originate 
in the SCV and extend into the cell (10, 12, 60, 140). However, for reasons unknown, these 
Sifs are not formed in macrophages (7), although sifA encoding the SPI-2 effector protein 
SifA is required for intracellular survival and replication and for in vivo virulence (11, 153). It 
has been suggested that the SCV eventually acidifies and fuses with the lysosomes, while 
others have stated that fusion with the lysosomes is prevented by Salmonella (61, 112). 
After this ~3 h lag period of SCV maturation, Salmonella starts expressing the SPI-2 genes 
to enable intracellular maintenance and growth.  
 
Salmonella Pathogenicity Island 2 
The proteins encoded by genes of SPI-2 are effectors or structural proteins that form a 
second TTSS involved in intracellular survival and replication. SPI-2 encodes 31 genes 
that are organized in four operons involved in production of structural components and 
several effector proteins such as SseB, SseC, and SseD (reviewed in (173)). In addition to 
these structural and effector proteins SPI-2 encodes at least three chaperone proteins 
called SscA, SscB and SseA (173). The SPI-2 TTSS is involved in virulence of S. enterica 
serovar Typhimurium and is activated once the bacterium is inside the cell (21) (83, 
126)and facilitates intracellular bacterial replication and in vivo virulence (21, 63, 120). SPI-
2 has been shown to be involved in many processes including inhibition of fusion of the 
Salmonella-containing vacuole (SCV) and the lysosomes (SpiC) and evasion of NADPH 
General introduction 
21 
oxidase dependent superoxide production, all of which are involved in prolonged 
intracellular survival and replication (48, 163, 168). 
       
 
Host (mouse) immune response to Salmonella 
 
In the host’s defense against Salmonella several processes play a role. During the first 
three phases of Salmonella infection the innate immune system plays an important role in 
containing the extra- and intracellular growth. The fourth phase of infection, the elimination 
phase, is mediated by the adaptive immune response that leads to the T and B cell-
mediated killing and elimination of Salmonella.  
 
Innate immune response 
The innate immune response involves aspecific defense mechanisms that are not 
acquired upon exposure, but are constitutively present. Initial innate immune responses 
involved in defense against Salmonella include gastric acid, antimicrobial peptides 
(reviewed in (123)), complement (172), opsonins (25, 71), cytokines (reviewed in (174)) 
and lysozyme.  Upon adhesion and invasion of the macrophages or granulocytes, 
Salmonella encounters innate defense mechanisms used by these phagocytic cells to 
resist infection such as antimicrobial defense mechanisms inside the phagosomes 
(including low pH, nitrites, oxygen radicals, nitric oxide, and antimicrobial peptides such as 
defensins, cathelicidins, and thrombocidins), and the secretion of cytokines and 
chemokines such as IL-1β, IL-6, GM-CSF, MIP-1β, and melanocyte growth stimulating 
factor (175). Cellular innate immunity is initiated by the recognition of bacterial components 
called Pathogen-associated molecular patterns (PAMPs) that are recognized via pattern 
recognition receptors, leading to the induction of an innate response to kill and eliminate 
Salmonella (53). Cells expressing such pattern recognition receptors that are involved in 
innate defense against Salmonella include neutrophils, macrophages/monocytes, NK cells, 
and dendritic cells (DC’s) (53). These cells are involved in the engulfment and killing of 
Salmonella, antigen presentation, and production of cytokines and chemokines in response 
to the infection. These mechanisms act together to kill and eliminate Salmonella and to 
prevent systemic infection.    
 
Major cell types involved in innate immune response to Salmonella 
Neutrophilic granulocytes (neutrophils) are phagocytic cells that are necessary for the 
initial destruction of Salmonella and are also involved in the lysis of hepatocytes that are 
invaded by Salmonella during the first few days of infection (26, 27). Neutrophils are 
efficient in killing S. enterica serovar Typhimurium as these cells are capable of producing 
large amounts of damaging antimicrobial products like lysozyme and radicals such as 
superoxide. Especially when bacteria have been opsonized with serum components 
(complement, antibodies) bacteria are taken up at a high rate and are killed efficiently. 
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Macrophages/monocytes are phagocytic cells that play a crucial role in innate 
defense. Monocytes circulate in the blood while macrophages reside in the tissues. 
Macrophages are mainly activated by T cells, but may also be stimulated upon infection by 
live bacteria or upon contact with PAMPs (including LPS, porins and outer membrane 
proteins, fimbrial proteins, flagella, lipoproteins, glycoproteins, and peptidoglycan) (62). 
Macrophages have evolved mechanisms to respond to such PAMPs by expressing pattern 
recognition receptors that recognize the PAMPs and initiate the innate immune response to 
clear the infection (157). Macrophages that are of special interest in Salmonella infection 
are the Kupffer cells in the liver and macrophages in the spleen since these are in the 
target organs of S. enterica serovar Typhimurium. Macrophages play a special role in 
Salmonella infection, since they are crucial in innate defense against Salmonella but also 
act as a Trojan horse to mediate spread to the to the liver and spleen (84). The innate 
defense mechanisms of macrophages are mainly stimulated by IFNγ and TNFα that 
activate the macrophages in such a way that they should be able to kill and eliminate the 
intracellular Salmonella. However, despite the multitude of antimicrobial defense systems 
that are present in these phagocytic cells as part of the innate defense system, Salmonella 
has developed mechanisms to resist such killing and for some time is able to survive and 
even replicate within these cells.  
DC’s are antigen-presenting cells that have been shown to contain intracellular S. 
enterica serovar Typhimurium, especially those in the Peyer’s patches of the small 
intestine after oral infection (158). After phagocytosis of Salmonella, these cells are 
capable of presenting Salmonella antigen to T and B cells leading to the development of an 
adaptive immune response. 
 
Innate resistance/susceptibility 
Susceptibility to S. enterica serovar Typhimurium in mice is determined by several factors 
as many processes play a role in the defense against Salmonella. One major factor 
contributing to resistance is the Ity (for immunity to S. typhimurium) locus. Ity controls the 
growth rate of Salmonella in cells of the reticuloendotheial system and is present in two 
allelic forms, resistant alleles (Ityr) and susceptible alleles (Itys) and. Mice expressing the 
Ityr alleles are relatively resistant to Salmonella infection as they can control growth of the 
bacteria. Those expressing the Itys alleles show an increased growth rate of Salmonella 
and cannot control the infection and are therefore susceptible. Ity appeared to be identical 
to Bcg and Lsh, two loci that were discovered to be involved in resistance to 
Mycobacterium and Leishmania respectively (128, 150). This locus plays an important role 
in regulating innate resistance to these pathogens that is mediated by macrophages. By 
positional cloning it was revealed that Ity/Bcg/Lsh is homologous to the human Nramp1 
(natural resistance associated macrophage protein 1) (169). Nramp1 is a gene locus on 
chromosome 1 that is only expressed in macrophages in the reticuloedothelial organs 
(spleen and liver) and by the macrophage cell lines J774A and RAW264.7 (55, 170) and 
encodes a divalent metal (Fe2+, Zn2+, Mn2+) pump phosphoglycoprotein (90–100 kDa) that 
is rapidly recruited to the bacteria-containing phagosome (170, 171) and  is involved in 
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resistance against Salmonella (127, 169). Expression of Nramp1 is greatly increased by 
activation of macrophages with IFNγ and LPS (55). Mice expressing the resistant allele of 
Nramp1 (Nramp1G169) can control the growth rate of S. enterica serovar Typhimurium in 
vivo, allowing the development of an acquired, predominantly, T cell-mediated immune 
response, which is essential for the eventual clearance of S. enterica serovar Typhimurium 
(66, 98, 99). However, mice expressing the sensitive allele Nramp1D169 cannot control the 
growth rate of S. enterica serovar Typhimurium and will die due to the infection.  
Another locus involved in resistance against Salmonella is lps. Two alleles of the lps 
gene have been assigned; lpsn (responsive) lpsd (hyporesponsive). Mice expressing the 
lpsd allele do not mount an immune response upon injection with LPS and are 
hypersusceptible to infection with S. enterica serovar Typhimurium while those expressing 
the lpsn allele do mount an immune response and are resistant to infection. The lps gene 
appeared to be identical to the Toll-like receptor 4 (tlr4) gene (129). This tlr4 gene encodes 
an important part of the LPS receptor complex and is part of the TLR family of pattern 
recognition receptors involved in innate immunity. TLR4 is expressed by all cells of the 
immune system as well as by several non-immune cells and activation of TLR4 by LPS has 
been shown to lead to the production of cytokines, chemokines, and NO (85, 114) (167). 
Null mutations in tlr4, as seen in C3H/HeJ mice, lead to hyporesponsiveness to LPS and 
cause these mice to be hypersusceptible to S. enterica serovar Typhimurium and other 
Gram-negative bacteria (68, 118, 119, 129).  
 
Adaptive immune response 
Eventually, in immunocompetent (ityr) mice an adaptive immune response is 
generated that is mediated by T and B cells to completely eliminate Salmonella from the 
body (99, 102, 109). B cells that recognize a certain antigen presented by DC’s or 
macrophages will mature and respond to the S. enterica serovar Typhimurium infection by 
the production of antibodies (109). Mice with reduced B cell function are susceptible to 
infection with virulent S. enterica serovar Typhimurium infection, but are able to resist 
infection with an attenuated ∆aroA mutant suggesting that other defense mechanisms play 
a more important role (109). It is of no doubt that antibodies produced by B cells do play an 
important role in clearing the infection, but despite the presence of these antibodies, 
reactivation of the infection can occur when IFNγ is neutralized (110), suggesting that the 
production of antibodies by B cells is not enough to completely eliminate the bacteria from 
the body. For complete elimination of primary infection and protection against secondary 
infection with S. enterica serovar Typhimurium, T cells, especially CD4+ T cells, are 
absolutely necessary since depletion of T cells early in infection leads to a very severe and 
life-threatening infection (113) and infection of nude mice or MHCII deficient mice cannot 
even clear the attenuated ∆aroA mutant (66, 149). CD8+ T cells also play a role in defense 






Reactive oxygen intermediates (ROI) 
  
One of the major early defense mechanisms against microorganisms is the production 
of toxic superoxide by the phagocyte NADPH oxidase and the subsequent generation of 
superoxide derivatives, both in vitro (97) and in vivo (147, 148, 166). Reactive oxygen 
intermediates (ROI) play an important role by targeting vulnerable lipid proteins, certain 
enzymes, and DNA (70, 82), thereby damaging the bacteria. ROI play a crucial role in 
Salmonella infection since mice deficient in a functional NADPH oxidase system are highly 
susceptible to infection (97).   
 
Sources of ROI 
Every aerobically growing organism is exposed to ROI formed as a by-product of 
respiration. Therefore part of the mechanisms that Salmonella has evolved o cope with 
superoxide stress is aimed at fighting endogenously formed ROI. Under experimental 
conditions, superoxide stress can be generated by addition of redox-cycling agents such 
as menadione and paraquat, which raise the intracellular levels of ROI.  
Upon invasion of macrophages, Salmonella is exposed to large amounts of 
superoxide in its direct environment, generated by the anti-microbial defense mechanism 
of the eukaryotic cell. ROI formed by the NADPH-oxidase upon contact with or uptake of 
Salmonella  may cause microbial damage, and will ultimately lead to bacterial death, 
unless appropriate microbial defenses are activated. The phagocyte NADPH oxidase is 
composed of two membrane-bound components gp91phox and p22phox, and four cytosolic 
factors, p47phox, p67phox, p40phox, and RacGTPase (phox for phagocyte oxidase). The active 
NADPH-oxidase is formed after recruitment and assembly of these components, resulting 
in the formation of cytochrome b558 that accepts electrons from NADPH and donates them 
to molecular oxygen (reviewed in (4)). Thus, upon stimulation of the phagocyte with 
opsonized microorganisms or any other activating agent, the oxygen consumption 
increases dramatically (“respiratory burst”) and a large amount of superoxide is produced. 
Superoxide is believed not to pass over membranes, but it can diffuse through anion 
selective pores and will in this manner reach the periplasmic space of Gram-negative 
bacteria like Salmonella. Spontaneous or enzymatic dismutation of superoxide results in 
the generation of hydrogen peroxide, which is more reactive than superoxide and unlike 
this compound, can diffuse readily across cell membranes. Together with Fe(II), hydrogen 
peroxide can form hydroxyl radicals, which are an even more potent oxidant species.  
Phagocytes also generate nitric oxide (NO) using the inducible nitric oxide synthase. 
Together with superoxide, the highly reactive and toxic peroxynitrite is formed. In murine 
models, the role of NO in anti-microbial defense is well established, but its importance in 
human defense is to date less clear, although NO can be produced by human 
macrophages (40). It also appears that production of superoxide and NO are separated in 
time. Superoxide is produced early, i.e., immediately after uptake of Salmonella, whereas 




Chronic Granulomatous Disease 
The importance of the superoxide-mediated defense system is made evident by a rare 
inherited syndrome, chronic granulomatous disease (CGD), in which the patient’s 
phagocytes fail to produce any superoxide. This leads to susceptibility to life-threatening 
microbial infections in these patients, mainly by Staphylococcus aureus, Aspergillus 
species, Candida species, Pseudomonas species, and Salmonella species (90). These 
infections can cause lymphadenitis, pyodermia, pneumonia, skin abscesses, and hepatic 
abscesses. CGD can be caused by mutations in either one of the genes encoding p47phox, 
p67phox, p22phox, and gp91phox of the NADPH oxidase complex (31, 139, 162). CGD affects 
about 1 in 500,000 individuals and 60% of these cases show an X-linked deficiency in 
gp91phox resulting either in absence, inactivity, or reduced activity of the protein. 
Approximately 40% of the patients have autosomal recessive deficiencies and lack p47phox 
(±30%), p67phox (±5%), or p22phox (±5%) (19, 22, 30, 34, 138, 151). 
 
Oxidative damage 
Superoxide radicals inactivate iron-sulfur clusters present in bacterial enzymes, for 
instance, enzymes involved in branched amine acid synthesis (82). Therefore, superoxide 
dismutase mutant strains are auxotrophic for branched amino acids. As a result of iron-
sulfur cluster damage, iron is released into the cytosol (Fig. 3). Hydrogen peroxide can 
cause damage to membranes, enzymes and DNA directly, however, in conjunction with 
iron, hydroxyl radicals are formed in the Fenton reaction. Hydroxyl radicals are highly 
reactive and will not diffuse over log distances but cause damage at the site of production. 
Fe(II) is present in the backbone of DNA and it is likely that most of the cell death that 
occurs secondary to hydrogen peroxide exposure is caused by DNA damage via hydroxyl 
radicals (reviewed in (70)). DNA repair mechanisms are therefore crucial for Salmonella in 
order to cope with ROI. Their relative importance is exemplified by the fact that RecA 
mutants are attenuated in vivo whereas catalase mutants are not (15). The amount of 
available iron in host cells is limited and bound to a range of host proteins including 
transferring, lactoferrin, hemoglobin, ferritin and cytochromes. Bacteria have evolved 
elaborate, high-affinity mechanisms to ensure uptake of sufficient iron even in this 
environment. Therefore, intracellular iron levels must be tightly controlled. Genes involved 
in the uptake of iron are regulated by fur, the ferric iron uptake repressor. When complexed 
to Fe(II) Fur generally represses the iron uptake genes. The fur regulon will only be 
expressed when the amount of iron is limiting and Fe(III) needs to be taken up from the 
environment. Just how toxic a role iron can play in oxidative damage mediated by 
hydrogen peroxide, is illustrated by the fact that chelation of intracellular Fe(II) protects the 
bacteria from killing by hydrogen peroxide. In addition, superoxide dismutase mutants are 
more sensitive to hydrogen peroxide-mediated killing, presumable due to increased 
complexed intracellular iron levels in these mutants (101). Interestingly, catalase does not 
have an effect on this process, indicating that not the actual hydrogen peroxide 
concentration but the intracellular level of Fe(II) is rate limiting in this process (101). 
Recently, it was also shown that Fur complexed to Fe(II) can enhance the expression of 
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several proteins including the cytoplasmic iron superoxide dismutase (SodB) (35, 94). This 
positive regulation by Fur is mediated by a small anti-sense RNA encoded by ryhB, which 
is regulated by fur. This small anti-sense RNA is expressed under iron limitation and 




Figure 3. Schematic overview of superoxide-mediated 
damage. Superoxide produced by the NADPH-oxidase 
passes the outer membrane and may cause damage to 
periplasmic targets or can be converted into hydrogen 
peroxide, which will pass the cytoplasmic membrane. In 
conjunction with Fe(II), hydroxyl radicals are formed that 
cause DNA and protein damage. Superoxide and NO will 
form peroxynitrite, which can pass over membranes and 
cause damage. Superoxide produced as a by-product of 
respiration or generated by redox-cycling agents may cause 
damage to [Fe-S] clusters, resulting in the release of Fe(II) 
which, in conjunction with hydrogen peroxide, will form 






The genes regulated by this anti-sense RNA include two genes encoding enzymes in the 
tricarboxylic acid cycle, acnA and fumA, two ferritin genes, ftnA and bfr, and sodB (94). 
Therefore, under high-iron conditions, fur repression not only leads to decreased 
expression of proteins involved in iron uptake, but also to increased expression of proteins 
involved in binding iron in the cytoplasm of bacteria. Taken together, these data show that 
there is a complex interplay between genes involved in defense against oxidative stress 
and genes involved in controlling intracellular iron levels.   
 
 
Defense mechanisms of Salmonella against ROI 
 
Exposure of Salmonella to ROI results in extensive alterations in protein expression 
patterns. Although genome-wide transcriptional profiling of the response of Salmonella has 
not been evaluated, exposure of Escherichia coli (E. coli) to superoxide stress has shown 
that the expression of a total of 112 genes was modulated by exposure to the redox-cycling 
agent paraquat (130). Approximately 60% of the genes were upregulated and 40% down-
regulated under these conditions (130). Similar experiments performed with hydrogen 
peroxide have shown that under these conditions, 140 genes are induced by E. coli (178). 
These data indicate that the defense against ROI involves complex mechanisms and, 
although insight into ROI defense mechanisms has increased extensively over the past 
decade, the exact function of many of the genes whose expression is modulated under 




Exposure of E. coli or Salmonella to elevated levels of intracellular superoxide results 
in activation of the SoxR/S regulon (58, 131). This regulon is composed of at least ten 
genes with diverse functions (reviewed in (41, 156)). For instance, the cytoplasmic 
superoxide dismutase, which can neutralize superoxide, is regulated by the SoxR/S 
system. Other genes regulated by this system include those involved in uptake of 
superoxide or oxidizing compounds (e.g. micF which regulates the expression of pore 
protein OmpF), those involved in maintenance of the cellular redox state (e.g., the zwf-
encoded glucose-6-phosphate dehydrogenase) and those involved in protection against 
superoxide-induced damage. The latter group includes genes involved in the repair of DNA 
damage, e.g. nfo, encoding an endonuclease, and genes involved in repairing damaged 
iron-sulfur-cluster-containing proteins. In addition, fur, the ferric uptake repressor is 
regulated by the SoxR/S system (177). SoxR is a constitutively expressed transcription 
factor whose activity is regulated by reduction or oxidation of its iron-sulfur cluster 
(reviewed in (156)). When this cluster is in a reduced state, the transcription of factor SoxR 
is inactive. Oxidation of the iron-sulfur cluster in conditions of oxidative stress result is in a 
conformational change of the protein, leading to its activation. Activated SoxR is a 
transcription factor whose only known target gene is soxS which in turn will activate the 
whole regulon.  
 
OxyR system 
The OxyR system is activated upon exposure to hydrogen peroxide, and the activation 
of this transcription factor also involves oxidation of the tetrameric protein (reviewed in (41, 
156)). In this case, oxidation of the cysteine residues in this complex results in the 
formation of di-sulfide bridges. Only this oxidized form of OxyR is mediated by glutathione. 
The genes activated by OxyR include that of a cytosolic catalase, KatG, that can inactivate 
hydrogen peroxide, the glutathione reductase, glutaredoxin, and genes involved in 
protection of DNA and RNA against oxidative damage (reviewed in (156)). Fur, the ferric 
uptake repressor is regulated by both the SoxR/S and the OxyR system (177). This is not 
surprising given the role in intracellular iron in damage caused by ROI. 
 
Other regulators of superoxide sensitivity 
Several genes involved in resistance against superoxide or hydrogen peroxide are not 
regulated by the SoxR/S or OxyR system. For instance katE, encoding another cytosolic 
catalase is regulated by rpoS, the sigma factor involved in stationary-phase survival. RpoS 
is not only involved in responses of Salmonella to oxidative stress but also in responses to 
carbon starvation and acid stress (145). The transcriptional regulator, SlyA, positively and 
negatively regulates the expression of a set of unknown genes. Mutants in slyA are highly 
sensitive to superoxide-generating agents, indicating that some of the genes regulated by 
SlyA are involved in the oxidative stress response (13). The same holds true for the global 





Recently, Gralnick et al. (57) identified the YggX protein and proposed that this protein 
is involved in blocking superoxide damage to [Fe-S] clusters, since an overexpression 
mutant is more resistant to redox-cycling agents. This protein is not controlled by the 
SoxR/S system, indicating that genes involved in prevention of damage to proteins can 
also be found outside this regulon. 
In addition to cytoplasmic superoxide dismutases, Salmonella and E. coli also contain 
periplasmic superoxide dismutases, S. enterica serovar typhimurium and several other 
Salmonella strains express even two of these copper-zinc superoxide dismutases, 
designated SodCI and SodCII (39). In addition, a putative SodCIII protein has been 
identified in Salmonella (44). E. coli, on the other hand, only contains the sodCII gene. 
These periplasmic superoxide dismutases protect against extracellular superoxide, for 
instance, that were produced by the macrophages’ NADPH-oxidase (32, 42). To date, no 
clear role of SodCIII in the defense against oxidative stress has been established.  
Recently, the mntH gene, the E. coli and Salmonella homologue of NRAMP, was 
identified as being important for resistance against ROI. In E. coli and Salmonella, NRAMP 
homologue is a divalent metal (Fe2+, Zn2+, Mn2+) pump phosphoglycoprotein able to 
transport manganese, and intracellular manganese is thought to be able to neutralize 
hydrogen peroxide (79). As a result, mntH mutants are more sensitive to hydrogen 
peroxide. However, an important role for this gene in virulence has not been established 
(79). This indicates that metals other than iron are involved in the ROI defense.  
 
Protection against oxidative damage 
The genes involved in defense of S. enterica serovar Typhimurium against oxidative 
stress do not all act the same. Some proteins may directly scavenge the oxygen species 
while others act by producing antioxidants. The cytoplasmic SOD’s encoded by sodA and 
sodB and the periplasmic SOD’s encoded by sodCI and sodCII are enzymes that catalyze 
the reaction in which superoxide radicals are converted to oxygen and hydrogen peroxide 
as follows:  
SODoxidized + ·O2-                          SODreduced + O2  
SODreduced + ·O2- + 2H+                  SODoxidized + H2O2                
 
The hydrogen peroxide produced in this reaction might be damaging to the cells, but S. 
enterica serovar Typhimurium has catalases encoded by katE and katG to neutralize it. In 
addition, peroxidases might also play a role in destroying hydrogen peroxide in a NADH- or 
NADPH-dependent manner. 
Glutathione (GSH) is an antioxidant that is synthesized by glutathione synthetase that 
is very important in the defense against hydrogen peroxide, superoxide radicals, and 
hydroxyl radicals. GSH reacts with these radicals to form a stable glutathione radical GS· 
which will dimerize to form oxidized glutathione (GSSG). Glutathione reductase then 
transfers an electron from NAPDH to the GSSG leading to the re-formation of the reduced 
GSH NADP+.  
General introduction 
29 
  GSH + ·HOO-             GS· + H2O2 
  GS· + GS·           GSSG 
  GSSG + 2NADPH         2GSH + 2NADP+ 
 
Another type of defense against oxidative stress is repair of induced damage. Oxygen 
radicals can cause cell, protein or DNA damage. Therefore, S. enterica serovar 
Typhimurium has mechanisms to repair the damage (reviewed in (41)). Examples include 
RecA, a protein encoded by recA that is involved in the recombinational DNA repair 
pathway important for cell survival upon exposure to hydrogen peroxide (15, 16), as well as 
endonuclease IV encoded by nfo and exonuclease III encoded by xth involved in excision 
repair (159). In conclusion, defense mechanisms of S. enterica serovar Typhimurium 
against oxidative stress are diverse and complex since many genes are involved and 
compensatory systems as well as systems overlapping with other types of stress defense 
systems have been described. Further research on S. enterica serovar Typhimurium genes 
that are involved in superoxide stress is necessary for better knowledge on the response to 
one of the most powerful defense mechanisms of the host: oxidative stress.  
 
 
Scope of this thesis 
 
One goal of this thesis was to gain more insight into the mechanisms by which S. 
enterica serovar Typhimurium is able to persist and reactivate at a later timepoint. This was 
done by investigating the possibility of reactivation in a mouse model of latent S. enterica 
serovar Typhimurium infection and determining which mechanisms are involved in 
prevention of growth during the phase of persistence. The other goal was to get more 
insight into the strategies that are used by S. enterica serovar Typhimurium to survive 
within macrophages and mice and to resist superoxide produced by the macrophages in 
response to infection with the pathogen. Chapter 1 gives an overview of what is currently 
known about Salmonella, the interaction with the host, and systems that play a role in the 
defense against superoxide and in survival within macrophages.     
Chapter 2 describes a novel in vivo mouse model for reactivating S. enterica serovar 
Typhimurium infection to elucidate which mechanisms are involved in persistency and 
reactivation at a later time point. Since depletion of CD4+ T cells and neutralization of IFNγ, 
as shown by others, resulted in reactivation of the S. enterica serovar typhimurium 
infection we investigated in Chapter 3 whether neutralization of TNFα, another very potent 
activator of macrophages and a cytokine shown to be involved in suppression of growth 
early in infection, was able to cause reactivation of the S. enterica serovar typhimurium 
infection as well.    
In the research on persistency and survival of S. enterica serovar Typhimurium within 
host cells, we have created and selected for mutants that were less able to induce cell 
damage and were able to survive for a longer period of time within RAW264.7 
macrophages. Chapter 4 deals with these LPS mutants and shows that mutants with the 
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rough phenotype are attenuated, although able to survive within macrophages in vitro and 
to cause a local infection in the lymph nodes. 
To analyze the systems used by S. enterica serovar Typhimurium to resist superoxide 
stress we have created many mutants by random MudJ transposon insertion and selected 
for increased susceptibility to superoxide as described in Appendix 1. One of the mutants 
obtained in this way was studied in further detail and has been described in Chapter 5. 
This mutant AVD101 is a mutant in which the MudJ transposon had inserted into the 
promotor region of pnp, the gene encoding PNPase which is involved in the degradation of 
mRNA and in the growth adaptation at low temperatures and is considered a regulator of 
virulence and persistence of S. enterica serovar Typhimurium. We have described an 
additional role for PNPase in the resistance to superoxide and for intracellular survival 
within macrophages. 
In Chapter 6 we describe the isolation and characterization of DLG294, an S. enterica 
serovar typhimurium mutant that has a MudJ transposon insertion in a gene designated 
sspJ that has rendered this mutant hypersusceptible to superoxide and to be attenuated in 
vitro. The phenotype of this sspJ mutant was further studied in Chapter 7. We have 
determined the in vivo phenotype of this mutant in C3H/HeN and C57BL/6 mice and in 
p47phox-/- mice that were unable produce any superoxide. To find out whether the in vitro 
attenuation of DLG294 was due to differences in the state of activation of the macrophages 
we compared the gene expression profiles of RAW264.7 macrophages that had been 
infected with the wild-type strain or DLG294 using Affymetrix gene chips and is described 
in Chapter 8. Since we did not observe many differences in gene expression profiles of the 
wild-type and DLG294-infected cells, we concluded that the difference in outgrowth in 
RAW264.7 cells must have been due to the lack of expression of sspJ. Because it was still 
unclear why DLG294 was attenuated in RAW264.7 macrophages we have studied the 
phenotype DLG294 in Chapter 9 using a phenotypical array and have studied the 
intracellular behavior of DLG294 by looking at the intracellular gene expression profile of 
the intracellular bacteria and have compared that to that of the wild-type strain using a 
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Salmonella is a gram-negative pathogen that can cause a range of diseases in both 
animals and man varying from mild diarrhea to severe disseminated infections like typhoid 
fever. Upon infection, a host develops an immune response to limit bacterial growth and kill 
and eliminate the pathogen. Salmonella has evolved mechanisms to evade the host 
immune system and remain dormant within the body, only to reappear (reactivate) at a 
later time point when the immune system is abated. The exact mechanism by which 
Salmonella is able to persist is unknown, but evading the immune response likely plays an 
important role. We have developed an in vivo model for studying reactivation of Salmonella 
enterica serovar Typhimurium infection in mice. Upon subcutaneous infection, C3H/HeN 
(Ityr) mice showed an increase in bacterial numbers in livers and spleens reaching a peak 
on day 19. After full recovery of the infection, these mice were irradiated or depleted for 
CD4+ T cells. The mice showed a decrease in numbers of leukocytes and CD4+ T cells, 
respectively, and displayed a secondary infection peak in livers and spleens with a course 
similar to the primary infection. From this we concluded that CD4+ T cells are involved in 
active suppression of S. enterica serovar Typhimurium during persistency.  
The role of CD4+ T cells during primary infection with S. enterica serovar Typhimurium 
is well established. This is the first study to describe a role of CD4+ T cells during the 
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Introduction 
 
Salmonellae are Gram-negative, facultative intracellular pathogens that can cause a 
range of diseases in both animals and man varying from mild diarrhea to severe 
disseminated infections such as typhoid fever. Like other intracellular bacteria, Salmonella 
has the capacity to adhere to host cells and induce its own uptake, even by 
nonprofessional phagocytes. Natural infection with Salmonella occurs through the intestinal 
tract. Once Salmonella has survived the antimicrobial mechanisms of the gastrointestinal 
tract, e.g. low pH, normal intestinal flora, intestinal mucus layer, and has reached the lining 
of the intestine, Salmonella preferentially penetrates the M cells that transport the bacteria 
from the lumen to the underlying Peyer's patches, or alternatively, Salmonella passes the 
epithelial cells (14, 30). After passing the epithelial barrier Salmonella is taken up by 
phagocytic cells, especially macrophages. These cells are important components of the 
host innate defense and are equipped with a multitude of antimicrobial mechanisms. 
Following ingestion by macrophages, bacteria reside within phagosomes that fuse with 
lysosomes to form phagolysosomes in which the bacteria can be rapidly killed due to 
acidification and bacteriolysis (reviewed in (10)). However, despite this multitude of 
antimicrobial mechanisms present as part of the innate defense of phagocytic cells, 
Salmonella is able to enter, survive and even replicate within these cells and can cause 
chronic or persistent infections by evasion or disturbance of the host defense (15). This 
ability of Salmonella to enter and replicate within phagocytic cells is essential for its 
survival, as mutants unable to do so are avirulent (5). Although the exact mechanisms for 
intracellular survival of Salmonella after phagocytosis are still unknown, it has become 
clear that Salmonella responds to the specific host environment by expressing factors 
crucial for intracellular survival and for circumvention of the host defense systems (3, 6, 7, 
15, 23).  
Upon infection, the host will try to develop an immune response to limit bacterial 
growth and to eventually kill and eliminate the pathogen. B cells, T cells and macrophages 
are important for host resistance and their protective effects are mediated by several 
cytokines such as IFNγ, IL-12, and TNFα (4, 16, 19-21, 26).  This integrated response 
results in activation of macrophages that in turn kill Salmonella. Although the macrophages 
are the main host cells, necessary for survival and replication of Salmonella within the host, 
and mediate the Salmonella-induced pathology, these same macrophages also play a 
crucial role in host defense against Salmonella (31). They are necessary for the early local 
control of infection, and, subsequently, for the induction of acquired immunity (11, 18) as 
well as for restriction of bacterial growth in immune mice (31). During a Salmonella 
infection, macrophages are mainly activated via TLR4 signaling and via several cytokines 
produced by NK cells and T lymphocytes.  
Following full activation of the macrophages and the acquired immune system, the 
host should be able to eliminate and clear Salmonella from the body. However, Salmonella 
has evolved mechanisms to evade the host immune system, to persist reside within the 
body, and to reappear (reactivate) at a later time point. Several studies and case reports 
Chapter 2 
42 
have shown that patients who underwent total body irradiation or received an organ 
transplant and were treated with glucocorticoids or other immunosuppressive therapy, as 
well as patients suffering from HIV infection (1, 9, 12) or Interleukin 12 receptor β1 
deficiency (27) can suffer from recurrent (systemic) infections with a Salmonella strain that 
persisted within the host. 
By investigating the possibility of S. enterica serovar Typhimurium to persist and 
reactivate after immune intervention in a mouse model of latent S. enterica serovar 
Typhimurium infection, we aim to gain insight into the mechanisms by which S. enterica 
serovar Typhimurium is able to persist and to reactivate at a later time point. This study 
shows that total body irradiation or selective CD4+ T cell depletion in C3H/HeN (Ityr) mice 
that were infected with S. enterica serovar Typhimurium and had apparently cleared the 
bacteria form the organs, leads to reactivation of the S. enterica serovar Typhimurium 
infection. In addition, this is the first study that describes the role of CD4+ T cells during 
persistent S. enterica serovar Typhimurium infection in mice.  
 
 
Materials and Methods 
 
Mice. Six- to eight-week old female Salmonella-resistant (Ityr) C3H/HeN mice were 
obtained from Harlan (Horst, The Netherlands). Mice were maintained according to the 
institutional guidelines. Water and food were given ad libitum. All studies involving animals 
were carried out in accordance with, and after approval of, the animal research ethics 
committee of the Leiden University Medical Center. 
 
Bacteria. For in vivo infection experiments, single colonies of S. enterica serovar 
Typhimurium strain 14028s were grown overnight in Luria-Bertani (LB) medium (10 mg of 
tryptone, 5 mg of yeast extract, and 10 mg of NaCl/ml) at 37°C while being shaken (225 
rpm). The overnight cultures were diluted in fresh LB medium and grown to the end of log 
phase and were then washed and diluted in sterile PBS. The CFU in the inoculum were 
determined by plating serial dilutions.  
 
Antibodies.  Monoclonal antibodies (mAbs) directed to mouse T cell surface antigen 
CD4 were obtained from the supernatant of cultured hybridoma GK1.5 (rat anti-mouse 
CD4, American Type Culture Collection (ATCC)). The hybridoma was cultured in protein-
free hybridoma medium (Gibco). The supernatant was isolated and concentrated using a 
capillary dialyzer. The concentrated supernatant was filter-sterilized and, after 
determination of the protein concentration, stored at –20°C until use. FITC-conjugated rat 
anti-mouse CD4 (L3T4) and PE-conjugated rat anti-mouse CD8 (Ly-2) monoclonal 
antibodies were obtained from BD Biosciences. 
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S. enterica serovar Typhimurium infection. Mice were inoculated subcutaneously in 
the flanks with 0.1 ml bacterial suspension containing 3 × 104 CFU S. enterica serovar 
Typhimurium 14028s. For each group on each time point 3-6 mice were used. Mice were 
sacrificed by carbon dioxide inhalation and blood was taken immediately by cardiac 
puncture. Part of the blood was prevented from coagulation by adding 40 U heparin/ml and 
another part was used to obtain serum. To determine the bacterial load within spleens, 
livers, and inguinal lymph nodes, these organs were aseptically removed and single cell 
suspensions were prepared by using sterile 70-µm-mesh-size cell strainers (Falcon). Cells 
were pelleted by centrifugation for 10 min and were lysed in distilled water. The bacterial 
number per organ was determined bacteriologically by plating serial dilutions. The lowest 
number of bacteria that can be detected in this way is 30 CFU for the spleens and lymph 
nodes and 50 CFU for the livers. 
 
Leukocyte count and blood cell differentiation. Blood was obtained by cardiac 
puncture and 40 U heparin/ml was added to prevent coagulation. The number of 
leukocytes was determined by counting the number of nucleated cells in the blood and we 
used 5 µl blood to make blood smears for the differentiation of the blood cells. Blood 
smears were fixed in methanol and stained with Giemsa and were used to determine the 
relative percentages of the different types of cells in the blood. This, together with the total 
leukocyte numbers was used to calculate the number of lymphocytes, monocytes, and 
PMN present in the blood on the different time points. The number of lymphocytes was 
used together with the FACS analysis data, to calculate the number of CD4+ and CD8+ T 
cells in the blood on the different time points after infection. 
 
Gamma irradiation and in vivo T cell depletion. Immune intervention was carried 
out either by sublethal total body gamma irradiation or in vivo depletion of CD4+ T cells on 
a time point when bacteria could no longer be detected bacteriologically within livers, 
spleens, and inguinal lymph nodes. For total body gamma irradiation, mice were put in a 
small perspex box and were irradiated until a dose of 6 Gy was reached. CD4+ T cells were 
depleted using 200 µg rat anti-CD4 GK1.5 antibody injected intraperitoneally. Mice 
received a second and a third injection with 100 µg of this antibody on day two and four 
after the first injection. 
 
Flow Cytometry. To determine CD4+ and CD8+ T cell counts in blood, 100 µl 
heparinized blood was used. Before staining, erythrocytes were lysed on ice for 10 minutes 
using lysisbuffer (155 mM NH4Cl, 100 mM KHCO3, 10 mM EDTA). After washing with PBS, 
the cells were stained during 30 minutes with FITC-conjugated rat anti-mouse CD4 mAb 
and PE-conjugated rat anti-mouse CD8 mAb, respectively. Flow cytometry was performed 





Detection of S. enterica serovar Typhimurium-specific antibodies. Induction of S. 
enterica serovar Typhimurium -specific antibodies was determined in a whole cell ELISA in 
which Maxisorp plates (Nunc) were coated with whole S. enterica serovar Typhimurium 
14028s. Briefly, S. enterica serovar Typhimurium 14028s was grown ON in LB medium 
and after washing with PBS was resuspended in 0,5 mM Na2HPO4, pH 9.6. Maxisorp 
plates were filled with 100 µl of this suspension and were dried ON at 37°C. Non-specific 
binding was blocked by incubating the plates with 3% FCS in PBS for 2 h at 37°C. Serial 
dilutions of the sera were added to the wells. Sera from naïve mice were included as a 
control. The plates were incubated at 37°C for 2 h. After washing the plates four times with 
PBS-Tween (0.05%) per well 100 µl 1:10,000 diluted peroxidase-labeled goat-anti-mouse 
IgG antibodies (SouthernBiotech, Birmingham, AL35260, USA) were added and the plates 
were incubated at 37°C for another 2 h. Plates were washed again with PBS-Tween 
(0.05%) and substrate solution (0.11 M NaAc, 1 mg/ml TMB, 0.01% H2O2) was added to 
the wells. The coloring reaction was stopped by addition of H2SO4 and the wavelength 
absorbance was measured at 490 nm using an ELISA plate reader (VICTOR2 1420 
multilabel counter, PerkinElmer Life and Analytical Sciences). Titers are defined as the 
dilution for which: 
 
OD450 (sample) > OD450 (naïve serum) + 2 × standard deviation. 
 
Calculation of bacterial growth. The growth rate was determined according to the 
equation: k = [ln N(t peak) – ln N(day 1)] / t, in which N(t peak) is the number of viable 
bacteria per organ on the peak of infection after time t (min) has elapsed, and N (day 1) 
represents the bacterial number on day 1 after infection.  
 
Statistical analysis. For comparison between treatments we used Student's t tests 
and for correlation analysis a Pearson correlation analysis was performed. For both 





 Replication of S. enterica serovar Typhimurium 14028s during a primary 
infection in C3H/HeN mice. Mice were inoculated subcutaneously in the flanks with 3 × 
104 CFU S. enterica serovar Typhimurium 14028s. During the first 5 days after the 
infection, the body weight of the infected mice was comparable to that of the age-matched 
weight controls (Fig. 1A). The infected mice showed a decrease in body weight between 
days 12 and 19. During this period, some of the mice also showed signs of illness like 
ruffled fur and malaise. During the next week, the mice fully recovered and showed an 
increase in body weight. The infection with S. enterica serovar Typhimurium 14028s 
induced severe hepatosplenomegaly reaching a peak on day 19 (Fig. 1C and 1E). The 
isolated livers and spleens were weighed and were used to determine the pathology 
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induced by the S. enterica serovar Typhimurium infection. Pathology was calculated as the 
percentage organ weight of the total body weight as described before (28). The induction 
of pathology during the first 19 days after infection was similar for the spleens and livers as 
is shown by a statistically significant correlation between the induced liver and spleen 
pathology (R=0.763; P<0.001). The pathology induced by S. enterica serovar Typhimurium 
became less severe during the next week and eventually stabilized at 7.5% for the livers 
and 1-1.25% for the spleens.  
Fig. 1B shows that S. enterica serovar Typhimurium 14028s was detectable in the 
lymph nodes already on day 1 after infection and was able to replicate reaching a peak on 
day 5 after infection. From there, the infection spread to the spleens and livers and within 
these organs bacterial loads up to 3 × 107 CFU per organ were reached (Fig. 1D and F). 
The bacterial loads were highest on day 19, which correlated with the induced pathology in 
the livers (R=0.590; p=0.001) and spleens (R=0.577; P=0.002). The bacterial loads 
eventually declined, which coincided with the increase in body weight and a reduction in 
spleen and liver pathology (Fig. 1A, 1C and 1E).   
 
Reactivation of the S. enterica serovar Typhimurium infection by gamma 
irradiation. On day 41, when the bacterial loads in the organs were reduced below the 
detection limit, the mice received a sublethal total body irradiation (6 Gy). The infection 
control group was not treated. The irradiated mice showed signs of illness, like ruffled fur 
and malaise between day 54 and 61. Due to the irradiation, the spleenweight on average 
decreased by ~40% compared to the infection controls (0.18 g vs 0.33 g) and the 
liverweight showed ~8% reduction (1.86 g vs 2.03 g). The effects of the irradiation on the 
bacterial numbers in the organs are shown in Fig. 2. In the infection control group, 60% of 
the mice showed detectable amounts of bacteria in the livers (Fig. 2B), but the averages 
were around or below the detection limit and no increase in bacterial numbers could be 
observed. The bacterial numbers in the lymph nodes and spleens stayed below or around 
the detection limits (Fig. 2A and 2C). 
In the irradiated mice population, on the other hand, we observed an increase in 
bacterial numbers of S. enterica serovar Typhimurium in the livers and spleens (Fig. 2B 
and 2C) upon immune intervention and in all the mice the infection peaked on day 54. This 
secondary infection (i.e. reactivation) was milder than the primary infection as is shown by 
lower maximal bacterial numbers in the organs reached, but otherwise followed a course 
that was similar to that of the primary infection peak (Table 2, Fig. 2). In the lymph nodes 
we also observed a slight increase in bacterial numbers on day 54 (Fig. 2A), although the 










































Figure 1. Total body weight (A), liver and spleen pathology (C and E) and bacterial numbers within the lymph 
nodes (B), livers (D), and spleens (F) of C3H/HeN (Ityr) mice during a primary infection with S. enterica serovar 
Typhimurium 14028s (open circles). The crosses in A represent the total body weights of mice that were not infected 
with S. enterica serovar Typhimurium and that served as weight controls. Averages from 2 independently performed 
experiments are shown. On day 0, C3H/HeN (Ityr) mice were infected subcutaneously in the flanks with ~3 × 104 CFU 
S. enterica serovar Typhimurium 14028s. The actual dose was confirmed by plating serial dilutions of the inoculum. 
At the indicated time point, the livers, spleens, and lymph nodes were aseptically removed and weighed. The 
pathology in the livers and spleens was calculated as the percentage organ weight of the total body weight. The 
viable count within the organs was determined by making lysates and plating serial dilutions of the lysates (n=6-8 per 
group). The results are expressed as log10 viable counts (means ± standard errors of the means). Asterisks indicate 
statistically significant differences (P<0.05) compared to the infection controls (Students t test) and the gray dashed 












































CFU in the lymph nodes
liver
days after infection




































































































































































































































Reactivation of latent S. typhimurium infection in mice 
47                       
Leukocyte counts in the blood. On each time point we determined the leukocyte 
counts in the blood for each mouse and differentiated the types of blood cells present at 
the different time points after infection (Table 1). During the growth phase in the primary 
infection, there was a statistically significant correlation between time and the total number 
of leukocytes (R=0.544; p<0.001), meaning that the number of leukocytes increased during 
the primary infection peak. The number of leukocytes did not change further, but stabilized 
up to the day of treatment on day 41 (Table 1). Giemsa stained blood smears were used to 
determine the percentages of the different types of cells in the blood on the different time 
points after infection. The observed increase in the number of leukocytes was mainly due 
to the increase in the number of granulocytes (Table 1) whereas the number of 
lymphocytes and monocytes did not change during the primary infection as well as in the 
infection control group on the later time points. FACS analysis on the lymphocyte 
population revealed no change in the number and ratio of CD4+ and CD8+ T cells during 






































































































































































Figure 2. Bacterial loads within the lymph
nodes (A), livers (B), and spleens (C) of mice
infected with S. enterica serovar Typhimurium
14028s and that were irradiated on day 41 (closed
squares) or untreated infection controls (open
circles). The viable count within the organs was
determined by making lysates and plating serial
dilutions (n=6-8 per group). The results are
expressed as log10 viable counts (means
±standard errors of the means). Asterisks indicate
statistically significant differences (P<0.05)
compared to the infection controls (Students t test)
and the gray dashed lines represent the detection
limit of the microbiological method. 
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Table 1. Number of leukocytes, lymphocytes, monocytes, 
and granulocytes in the blooda 
day treatment 
  
  leukocytes 
  (n × 105) 
  lymphocytes 
  (n × 105) 
monocytes 
(n × 105) 
  granulocytes 
  (n × 105) 
1 ---   54.7 ±   8.3   38.7 ± 12.9 1.1 ± 0.5 14.3 ±   8.9 
5 ---   85.1 ± 13.5   48.3 ±   9.4 1.8 ± 1.4 29.9 ±   7.3 
12 ---   77.3 ± 24.4   30.4 ± 12.7 0.8 ± 0.7 42.3 ± 13.6 
19 --- 100.7 ± 28.5   33.8 ± 13.8 2.8 ± 2.2 52.2 ± 13.1 
26 ---   78.0 ± 13.4   39.3 ±   5.6 1.2 ± 1.0 33.8 ± 11.7 
33 --- 110.8 ± 37.6   52.2 ± 10.3 1.8 ± 1.9 53.3 ± 29.2 
              
42 ---   86.2 ± 29.7   53.7 ± 18.0 0.7 ± 0.7 27.9 ± 14.2 
42 irrb   23.5 ±   9.4     7.4 ±   3.8 0.0 ± 0.0 15.5 ±   6.3 
43 deplc   50.2 ± 11.3   26.3 ±   6.9 1.1 ± 0.9 21.6 ± 13.0 
              
47 ---   87.8 ± 23.9   58.5 ± 20.6 1.0 ± 0.5 24.7 ±   7.6 
47 irr     9.1 ±   4.4     5.1 ±   2.6 0.2 ± 0.2        3.1 ±   2.3 
47 depl   61.1 ± 21.2   31.4 ± 11.8 1.5 ± 1.6 26.2 ± 17.1 
              
54 ---   50.8 ± 29.0   29.0 ± 22.4 0.6 ± 0.7 19.3 ± 10.2 
54 irr   10.6 ±   5.1     5.8 ±   3.0 0.1 ± 0.1   2.8 ±   3.4 
54 depl   89.6 ± 21.1   39.0 ± 16.2 2.1 ± 1.4 39.0 ± 16.2 
              
61 ---   94.6 ± 24.1   45.6 ± 14.3 1.0 ± 1.1 41.9 ± 27.4 
61 irr   29.5 ±   7.6     8.7 ±   2.2 0.2 ± 0.2 15.8 ±   4.5 
61 depl   55.0 ± 14.2   29.2 ±   8.5 0.7 ± 0.4 23.2 ± 11.9 
a values are mean numbers/ml ± stdev 
b mice that received a total body irradiation (6 Gy) 




The irradiated mice, however, showed reduced leukocyte counts in the blood already 
on day 1 after the irradiation (day 42) when compared to the untreated infection controls 
and the numbers remained lower up to day 61 after infection (Table 1). Table 1 also shows 
that the numbers of granulocytes declined in the irradiated mice and were lowest on day 47 
and 54. On day 61 the number of granulocytes had not recovered fully yet, but showed an 
increase compared to day 54. The number of monocytes seemed to be decreased by the 
irradiation, but the numbers are too low to reach statistical significance. The number of 
lymphocytes, on the other hand, was reduced dramatically already on day 1 after the 
irradiation compared to the infection controls and remained significantly lower up until day 
61. We used these lymphocyte numbers together with the FACS analysis data to calculate 
the number of CD4+ and CD8+ T cells and, as expected, observed that both the CD4+ and 
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the CD8+ T cells were reduced to the same extent in the irradiated mice compared to the 
infection controls (Fig. 3A and 3B). These data suggest that the observed reactivation of 
the S. enterica serovar Typhimurium infection upon irradiation could have been due to the 
reduction in the numbers of either granulocytes, CD4+ T lymphocytes, CD8+ T 























Figure 3. Number of CD4+ T cells (A and C), and CD8+ T cells (B and D) per ml blood of C3H/HeN mice 
infected with S. enterica serovar Typhimurium that received no further treatment (white bars), mice that received a 
total body irradiation (checkered bars), or mice that were depleted for T cells (black bars). The number of CD4+ and 
CD8+ T cells was calculated by combining data from leukocyte counts, cell differentiation, and FACS analysis. 
 
 
Reactivation following T cell depletion. Reactivation of a latent S. enterica serovar 
Typhimurium infection in people has been described for patients suffering from AIDS. 
These patients showed reduced CD4+ T cells counts and suffered from recurring infections 
with the same S. enterica serovar Typhimurium strain. This strongly suggests a role for the 
CD4+ T cells in the suppression of S. enterica serovar Typhimurium during the persistence 
phase. Since the irradiated mice also showed a reduction in the numbers of CD4+ T cells 
as well as the numbers of granulocytes and CD8+ T cells, we wondered whether only 
reducing the number of CD4+ T cells by in vivo depletion could also result in the 
reactivation of a latent S. enterica serovar Typhimurium infection in C3H/HeN mice. The 
primary infection and change in the number of leukocytes followed a course similar to that 
shown in Fig. 1 and Table 1, respectively (data not shown). In the infection control group 
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we observed no reactivation of the infection as the bacterial numbers stayed around or 
below the detection limits in all the organs up to day 61. In the lymph nodes of the mice 
that were depleted for CD4+ T cells, we observed no detectable outgrowth of S. enterica 
serovar Typhimurium (Fig. 4A). In the livers and spleens, on the other hand, we observed 
an increase in bacterial numbers that was significantly different from those in the infection 
controls and this reactivation reached a peak on day 47 (Fig. 4B and 4C). As for the 
irradiated mice, this reactivation peak was lower than the peak observed for the primary 
infection, but followed a course that was similar to that of the primary infection peak, 
although the growth rate was slightly lower (Table 2). Of note, neither spleenweight nor 
liverweight significantly changed upon CD4+ T cell depletion as the average spleen- and 
liverweights were 0.39 g and 2.03 g, respectively for the CD4+ T cell depleted mice 
compared to 0.35 g and 2.10 g  for the infection controls. Table 1 shows that the total 
number of leukocytes and lymphocytes slightly, though significantly, changed upon 
injection with the rat anti-CD4 antibody compared to the infection controls with an 
exception for day 54. FACS analysis on the lymphocyte population revealed a strong 
decrease in the number of CD4+ T cells in the depleted mice indicating that the injection of 
the rat-anti CD4 antibody resulted in a successful depletion (~95% reduction on days 42 
and 47) of the CD4+ T cell population (Fig. 3C) and, as expected, had no effect on the 
number of CD8+ T cells (Fig. 3D). From this we concluded that CD4+ T cells are involved in 
the suppression of S. enterica serovar Typhimurium during persistency. 
 
 
Table 2. Growth rates of S. enterica serovar Typhimurium 
in the spleen, liver, and inguinal lymph nodesa 
 
liver (hr-1) spleen (hr-1) lymph nodes (hr-1) 
primary 0.030 ± 0.003 0.038 ± 0.006 0.048 ± 0.004 
irradiation 0.026 ± 0.005 0.030 ± 0.005 0.012 ± 0.004 
T cell depletion 0.017 ± 0.018 0.013 ± 0.007 ND 
a values are growth rates ± stdev 
ND, not done 
Growth rate = k 




Anti-Salmonella IgG antibodies in the serum of S. enterica serovar Typhimurium 
infected mice. To determine whether the mice had antibodies to the pathogen, serum was 
collected from the mice that were sacrificed on each time point and anti-Salmonella IgG 
antibodies were detected using a whole cell ELISA. The infected mice showed no 
antibodies to S. enterica serovar Typhimurium on days 1 and 5, but started producing 
antibodies between day 5 and 12, when the infection reached its peak in the lymph nodes 
and spleens. 
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Figure 4. Bacterial loads within the lymph nodes (A), livers (B) , and spleens (C) of mice infected with S. 
enterica serovar Typhimurium 14028s and that were depleted for CD4+ T cells (closed triangles) or untreated 
infection controls (open circles). On day 39 after infection, the mice were treated with 200 µg rat anti-CD4 GK1.5 
and/or anti-CD8 2.43 antibodies injected intraperitoneally. Mice received a second and a third injection with 100 µg of 
these antibodies on day two and four after the first injection. The infection controls were injected intraperitoneally with 
an equal volume of PBS. At the indicated time points, livers, spleens, and lymph nodes were aseptically removed 
and weighed. The viable counts within the organs were determined by making lysates and plating serial dilutions of 
the lysates (n=6-8 per group) and are expressed as log10 viable counts (means ± standard errors of the means). 
Asterisks indicate statistically significant differences compared to the infection controls (Students t test). 
 
 
The titers increased further until day 43 after infection and then remained around a log3 
dilution factor of 8.5 (Fig. 5). The mice that were irradiated or depleted for CD4+ T cells and 
that showed a reactivation of the S. enterica serovar Typhimurium infection had serum 
antibody levels that were similar to those of the infection controls. So despite the fact that 
these mice have serum antibodies to S. enterica serovar Typhimurium they still showed 
reactivation of the S. enterica serovar Typhimurium infection. To exclude the possibility that 
mice displaying the strongest reactivation of the S. enterica serovar Typhimurium infection 
showed lower serum levels of anti-Salmonella IgG, the serum antibody titers were plotted 
against the number of bacteria in the organs and showed no statistically significant 
correlation (data not shown). From this, we concluded that the observed reactivation of the 
S. enterica serovar Typhimurium infection was not due to a reduction in the serum antibody 
levels, but was due to the effects of the irradiation and depletion on the blood cells. The 
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observed reactivation of the S. enterica serovar Typhimurium infection in the irradiated 
mice might have been due to the reduction in the numbers of either granulocytes, CD4+ T 
lymphocytes, CD8+ T lymphocytes, or a combination of cells, while in the depleted mice, 




Figure 5. Anti-Salmonella IgG 
antibodies in the serum of S. enterica 
serovar Typhimurium infected mice 
that received no further treatment 
(open circles), received a total body 
irradiation (closed squares), or were 
depleted for CD4+ T cells (closed 
triangles). Titers are defined as the 
OD450(serum sample) > OD450(naïve 









The main findings of the present study on reactivation of Salmonella after clearance of 
a primary systemic infection in C3H/HeN (Ityr) mice are that after total body irradiation or 
selective CD4+ T cell depletion, the number of bacteria in the livers and spleens increased 
at a rate identical to that in the primary infection. The main difference between the two 
outgrowth curves was that upon reactivation, the S. enterica serovar Typhimurium infection 
appeared to be controlled more rapidly than in the primary infection, i.e. by about two 
instead of three weeks. The presence of high levels of Salmonella-specific antibodies did 
not prevent the reactivation, but could play a role in the differences in outgrowth rate 
between the irradiated and CD4+ T cell depleted mice, since antibodies might act as 
opsonins for granulocytes which were not affected by CD4+ T cell depletion. 
We have used subcutaneous S. enterica serovar Typhimurium infection of C3H/HeN 
(Ityr) mice in the inguinal region to set up a model for reactivation of S. enterica serovar 
Typhimurium infection. By infecting subcutaneously, a reservoir is established near the 
draining lymph nodes from where Salmonella readily spreads via the lymph stream and 
becomes systemic, finally reaching the liver and spleen (2). This model gives rise to a 
more subtle infection than the intraperitoneal, intravenous, or oral models that result in 
peracute and overwhelming infections. Another advantage over oral infection is that the 
subcutaneously injected bacteria can be dosed precisely, while in an oral infection, the 
actual dose depends on the amount of bacteria that pass the stomach. Using this 
subcutaneous infection model, we have been able to set up a new in vivo model for 
reactivation of latent S. enterica serovar Typhimurium infection in which total body 
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irradiation or in vivo depletion of CD4+ T cells in C3H/HeN (Ityr) mice that fully recovered 
from a primary infection with S. enterica serovar Typhimurium resulted in the outgrowth of 
bacteria that resided within the body. In our reactivation model we have accepted that 
some of the control mice showed bacterial numbers in the organs that were slightly above 
the detection limits. Otherwise, we would have needed many more animals to find only a 
few in which S. enterica serovar Typhimurium persisted and reactivated upon irradiation or 
T cell depletion.   
Upon total body irradiation, the mice showed a reduction in both granulocyte and CD4+ 
and CD8+ T cell numbers and, as a result, they showed a strong reactivation of the S. 
enterica serovar Typhimurium infection. Reactivation of a latent S. enterica serovar 
Typhimurium infection in humans has been mainly described for patients suffering from 
AIDS (1, 8, 9, 13). These patients all showed strongly reduced CD4+ T cells counts and 
suffered from recurring infections with the same S. enterica serovar Typhimurium strain. 
This strongly suggests a role for the CD4+ T cells in the suppression of S. enterica serovar 
Typhimurium during the persistence phase. The studies describing reactivation of 
Salmonella infections in HIV infected individuals are all studies that were done before the 
introduction of the highly active antiretroviral therapy (HAART) (1, 8, 13) or were done in 
developing countries where patients receive no such effective therapies (9). HAART 
therapy has been shown to be very effective in restoring the CD4+ T cell population in 
patients with AIDS, thereby reconstituting immunity. Hung et al have shown that the risk of 
recurrent non-typhoidal Salmonella bacteremia has decreased significantly by the 
introduction of HAART therapy in Taiwan (12). In our in vivo reactivation model by 
irradiation, the mice showed reduced numbers of both granulocytes and CD4+ and CD8+ T 
lymphocytes. We investigated whether reducing the number of CD4+ T cells, as occurs in 
HIV infected individuals, could also result in a reactivation of (a latent) S. enterica serovar 
Typhimurium infection C3H/HeN mice. Therefore, we performed another set of reactivation 
experiments in which we depleted the mice for CD4+ T cells. Like for the irradiated mice, 
these CD4+ T cell depleted mice showed a reactivation of the S. enterica serovar 
Typhimurium infection in both the livers and spleens. Strikingly, this reactivation took place 
despite the presence of high anti- S. enterica serovar Typhimurium antibody titers (Fig. 5). 
This is consistent with the observation that protection against Salmonella requires both 
immune serum and T cells (22). The reactivation peak followed a course similar to that of 
the primary infection, although slightly less severe. This could be due to the presence of S. 
enterica serovar Typhimurium -specific antibodies that might suppress extracellular 
bacterial growth, but cannot prevent the bacteria from reactivating. A more likely 
explanation could be that these antibodies act as opsonins for granulocytes thus promoting 
granulocyte-mediated uptake and killing of S. enterica serovar Typhimurium (29). This is 
also consistent with the observation that the growth rate upon irradiation was similar to that 
of the primary infection peak while after T cell depletion it was lower, especially in the 
spleen (Table 2). If the antibodies, which are highly abundant (Fig. 5), favor granulocyte-
mediated uptake and killing of S. enterica serovar Typhimurium, this would indeed reduce 
the growth rate in CD4+ T cell depleted mice as compared to the irradiated mice since the 
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granulocytes disappeared upon irradiation, but were still present in the CD4 depleted mice 
(Table 1). Furthermore, the pool of phagocytic cells in the spleens would be lower in the 
spleens of the irradiated mice as was evident from a reduction in spleenweight (~40% 
reduction compared to the infection controls), while in the CD4+ T cell depleted mice no 
significant reduction in spleen weight was observed. Since CD4+ T cell depletion still 
resulted in reactivation, apparently, granulocytes cannot completely compensate 
completely for the absence of CD4+ T cells. 
Very recently, Monack et al. have described a model for chronic carriage of S. enterica 
serovar Typhimurium in Ityr mice (24). In contrast to our latent infection model in which 
bacteria could no longer be detected in the lymph nodes after 43 days, these mice show 
high numbers of bacteria in the mesenteric lymph nodes up until 268 days after oral 
infection and periodical fecal shedding as observed for chronic carriers of S. enterica 
serovar Typhi and S. enterica serovar Paratyphi in man and serves a good model for 
chronic carriage. They have shown that in their chronic carriers S. enterica serovar 
Typhimurium persisted within macrophages in the mesenteric lymph nodes. Apparently, 
these macrophages were not able to eliminate the pathogen. When IFNγ  the most potent 
activator of macrophages produced by T cells, was neutralized in this in vivo chronic 
carriage model, these mice showed reactivation of the S. enterica serovar Typhimurium 
infection (24). This indicates that IFNγ plays an essential role in the control of chronically 
persistent S. enterica serovar Typhimurium infection, but is not able to activate the 
macrophages in such a way that they can completely eliminate the pathogen as the 
bacteria persisted in the macrophages of the mesenteric lymph nodes from which they 
could spread to the environment. IFNγ is produced by NK cells and by activated CD4+ and 
CD8+ T cells in response to cytokines like IL-12 and IL-18 that are produced by infected 
macrophages (19, 20). IFNγ then acts together with bacterial components like LPS to 
activate the macrophages to display maximal capacity to kill the pathogen. In the 
reactivation model described by Monack et al. they have neutralized IFNγ and thereby 
have prevented the activation of the infected macrophages by all these types of IFNγ 
producing cells, resulting in the reactivation of the S. enterica serovar Typhimurium 
infection. In our reactivation model of latent infection, however, we have depleted the mice 
for the CD4+ T cells and, as a result, have prevented the production of IFNγ by this type of 
cell. In our reactivation model upon CD4+ T cell depletion, the IFNγ producing NK and 
CD8+ T cells were still present (Fig. 3D). Apparently, the amounts of IFNγ produced by the 
CD8+ T cells and by the NK cells are not sufficient to appropriately activate macrophages 
and prevent reactivation. Our data, together with those described by Monack et al., indicate 
that IFNγ produced by CD4+ T cells is necessary to suppress bacterial growth during the 
persistence phase and suggests that IFNγ produced by NK cells and CD8+ T cells do not 
play an important role in this process.  
It has been known for several years that CD4+ T cells play a very important role in the 
clearance of the bacteria during a primary infection with S. enterica serovar Typhimurium. 
Previous studies have shown that mice depleted for CD4+ T cells on the day of infection 
are highly susceptible to S. enterica serovar Typhimurium and die due to the lack of CD4+ 
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T cell-mediated defense against Salmonella (25). This is the first study, however, that 
describes the role of CD4+ T cells in preventing reactivation of the S. enterica serovar 
Typhimurium infection in Ityr mice during the persistence phase. We have set up an in vivo 
reactivation mouse model that is very suitable for further studies on reactivating S. enterica 
serovar Typhimurium infections and might give further insights into the strategies that are 
used by S. enterica serovar Typhimurium to persist without being noticed by the host's 
immune system. Such knowledge might eventually lead to the development of new 
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TNFα is a tightly regulated non-specific effector molecule that has pro-inflammatory 
and immuno-regulatory effects. The action of TNFα appears to be unopposed and results 
in damage to tissue, e.g. cartilage or bowel mucosa. In some inflammatory disorders, 
TNFα is induced, but fails to decrease leading to high amounts of this potent and 
damaging pro-inflammatory cytokine. Nowadays, patients suffering from these disorders 
can be successfully treated with the TNFα blocking agents Infliximab or Ethanercept. 
However, this treatment carries an increased risk of manifest infection with Mycobacteria 
and might lead to reactivation of latent infections, as has been described for intracellular 
pathogens such as Mycobacteria. 
Reactivation of latent Salmonella infection has been described for patients with an 
impaired immune system due to medication or underlying disease, and a role for IFNγ and 
CD4+ T cells during the phase of persistency of Salmonella has been described. Since 
TNFα plays an important role in defense to primary Salmonella infections, we tested 
whether treatment with TNFα neutralizing agents may lead to reactivation of a latent 
Salmonella infection. In the C3H/HeN mouse model of latent S. enterica serovar 
Typhimurium infection, in contrast to previous findings on reactivation after CD4+ T cell 
depletion or anti-IFNγ treatment, neutralization of TNFα did not lead to reactivation and 



























TNFα is a non-specific effector molecule that is mainly produced by phagocytes 
(neutrophils and macrophages) and that has pro-inflammatory and immuno-regulatory 
effects. TNFα can act both as a membrane-associated protein and as a soluble cytokine 
after cleavage from the cell surface by the TNFα converting enzyme (2, 16, 20). Both 
soluble and membrane-bound TNFα are able to bind to the TNF receptor (TNFR) 1 as well 
as to TNFR2. Soluble TNFα preferentially binds to and activates the TNFR1, while TNFR2 
is mainly engaged and activated by the membrane-bound form of TNFα. Activation of 
TNFR1 leads to a whole range of cellular and tissue responses such as induction of 
cytokine and chemokines production, MHC class I and II expression, cell adhesion 
molecule expression, inhibition of cell growth, apoptosis, tissue repair and damage, 
neurotoxicity and neuroprotection. TNFR2 activation leads to thymocyte proliferation, skin 
necrosis, and T-cell proliferation and apoptosis. TNF receptors are expressed on the 
surface of most cell types (30), so TNFα exerts its effects on almost every cell and organ 
within the body. Therefore, the production of TNFα is strictly regulated during infection. 
TNFα production is induced rapidly, but also degraded at a high rate. 
In some inflammatory diseases such as rheumatoid arthritis and inflammatory bowel 
disease, TNFα is induced, but fails to decrease. In these patients, the regulation of TNFα 
appears to be disturbed leading to the production of high amounts of this potent but 
damaging pro-inflammatory cytokine. Recently, new therapeutics have been developed to 
lessen the damage induced by TNFα , i.e. Infliximab (Remicade, Centocor Inc) and 
Ethanercept (Enbrel, Wyeth/Immunex), which are TNFα-blocking agents that are 
presently applied in the treatment of patients with rheumatoid arthritis and Crohn's disease. 
This treatment is highly beneficial for these patients. However, an important disadvantage 
of treatment with neutralizing antibodies to TNFα is the increased susceptibility to infection 
with intracellular bacteria. By its ability to activate macrophages to enhanced microbicidal 
activity and role in the formation of granulomas, TNFα has been shown to play a central 
role in immunity to bacterial infections with Mycobacteria (reviewed in (1, 9)), Listeria 
moncytogenes (4), Salmonella (22) and some other bacterial pathogens (6-8, 11, 12, 15, 
21, 23, 25). 
Besides the increased susceptibility to primary infection with intracellular bacteria, 
another complication of treatment with anti-TNFα is reactivation of latent infection with 
such bacteria, as has been described for Mycobacteria. Keane et al. reported 70 cases of 
tuberculosis (TB) among ~147,000 patients treated with TNFα blocking agents world-wide 
(14). The early onset after start of anti-TNFα treatment and low background incidences of 
TB is suggestive of reactivation rather than primary infection (14) and shows a role for 
TNFα in controlling latent infection with Mycobacteria. In line with these observations, it 
has been speculated that treatment with neutralizing antibodies to TNFα could lead to 
reactivation of latent Salmonella infection as well.  
Reactivation of infection of non-typhoidal Salmonella strains that had persisted within 
the host have been described for patients with an impaired functioning immune system 
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such as HIV-infected individuals (5, 10, 13), with Interleukin 12 receptor β1 deficiency (26), 
or patients with hematologic malignancies who underwent total body irradiation or who 
received a solid organ transplant and were treated with glucocorticoids or other 
immunosuppressive therapy.  
Recently, we have shown that CD4+ T cells play an important role during the phase of 
latency in C3H/HeN (Ityr) mice and that depletion of the CD4+ T cells resulted in 
reactivation of latent infection (29). Monack et al. have shown that neutralization of IFNγ 
resulted in reactivation of latent S. enterica serovar Typhimurium as well (19). CD4+ T cells 
and IFNγ are important for activation of macrophages by inducing the release of TNFα, 
which via an autocrine loop acts on the macrophages’ TNF receptor and leads to the 
formation of an angry macrophage expressing enhanced bacterial killing. Thus, given the 
pivotal role that TNFα plays in the cellular immune response, some problems with 
reactivation of persistent infections were to be expected in those receiving treatment with 
anti- TNFα. 
The role of TNFα in mice during a primary infection with Salmonella enterica serovar 
Typhimurium has been known for years (18), however, its role in controlling latent infection 
is unclear. Therein, we used the mouse model for latent S. enterica serovar Typhimurium 
infection as described in detail recently (29) to address the question whether reactivation of 
the persistent S. enterica serovar Typhimurium infection is induced upon neutralization of 
TNFα by treating the mice with Ethanercept after full recovery from a primary infection with 
S. enterica serovar Typhimurium.  
 
 
Materials and Methods 
 
Mice. Six- to 8-week-old female Salmonella-resistant (Ityr) C3H/HeN mice were 
purchased from Harlan (Horst, The Netherlands). Mice were maintained under standard 
conditions according to institutional guidelines. Water and food were given ad libitum. 
Experiments were approved by the local Animal Ethical Committee. 
 
Bacterial strains and growth conditions. For the infection experiments wild-type S. 
enterica serovar Typhimurium 14028s was used. Single colonies of the different strains 
were grown in Luria-Bertani (LB) medium (10 mg of tryptone, 5 mg of yeast extract, and 10 
mg of NaCl/ml) at 37°C while being shaken (225 rpm). For the in vivo experiments, the 
overnight cultures were diluted in fresh LB medium and grown to the end of log phase and 
were then washed and diluted in sterile PBS. The CFU in the inoculum were determined by 
plating serial dilutions. 
 
In vitro infection experiment. RAW264.7 cells were seeded in a 24-wells plate at a 
density of 1 × 105 cells per well and allowed to adhere at 37°C in RPMI medium 
supplemented with 10% fetal calf serum. The cells were left unaffected or were incubated 
with 100 U recombinant IFNγ (Pharmingen International) and/or 0.5 mg anti-TNFα 
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antibodies (Enbrel) for 18 h prior to infection. Bacteria were washed in PBS and were 
added to the cells at a 10:1 multiplicity of infection. The bacteria were spun onto the cell by 
centrifugation for 30 min at 270 × g. Cells were incubated for 30 min at 37°C and 5% CO2 
to allow bacterial endocytosis. After washing the cells with PBS, medium containing 100 
µg/ml gentamicin was added and incubated at 37°C for another 30 min to kill the 
extracellular bacteria. The cells were then washed again. This point was designated time 
point zero. Next, medium containing 10 µg/ml gentamicin was added to the cells to kill any 
remaining extracellular bacteria and prevent reinfection. At 0, 24, and 48 hours the cells 
were lysed in 1 ml H2O and serial dilutions were made to determine the number of 
bacteria. 
 
In vivo S. enterica serovar Typhimurium infection. Mice were inoculated 
subcutaneously in the flanks with 3 × 104 CFU S. typhimurium 14028s. For each group on 
each time point 3-4 mice were used. Fecal samples were taken and mice were sacrificed 
by carbon dioxide inhalation. Blood was obtained immediately by cardiac puncture. Part of 
the blood was prevented to coagulate by adding 40 U heparin/ml and another part was 
used to obtain serum. To determine the bacterial load within spleens, livers, mesenteric 
and inguinal lymph nodes, these organs were aseptically removed and single cell 
suspensions were prepared by using sterile 70-µm-mesh-size cell strainers (Falcon). Cells 
were pelleted by centrifugation for 10 min and were lysed in distilled water. The bacterial 
number per organ was determined bacteriologically by plating serial dilutions. The lowest 
number of bacteria that can be detected in this way is 30 CFU for the spleens and lymph 
nodes and 100 CFU for the livers. The feces was weighed and suspended in PBS and was 
plated on selective (SS) agar to determine the number of S. enterica serovar Typhimurium. 
 
Leukocyte count and blood cell differentiation. The number of peripheral blood 
leukocytes was determined by counting the number of nucleated cells in the heparinized 
blood. In addition, we used 5 µl blood to make blood smears for the differentiation of the 
blood cells. Blood smears were fixed in methanol for 15 min and were stained with Giemsa 
for 30 min. In the blood smears the relative percentages of the different types of cells were 
determined. Next, the number of lymphocytes, monocytes, and PMN present in the blood 
on the different time points was calculated. 
 
Treatment with neutralizing TNFα antibodies and dexamethasone. Immune 
intervention was carried out either by intraperitoneal injection of the mice with with 300 µg 
Ethanercept (a concentration known to have an effect in mice, personal communication 
with R. Flierman, Dpt. of Rheumatology, LUMC, The Netherlands) or 6 mg/kg 
dexamethasone on a time point when bacteria could no longer be detected 
bacteriologically within livers, spleens, and inguinal lymph nodes. Mice received a second 
and a third injection with 300 µg of Ethanercept or 6 mg/kg dexamethasone on day two 











































Figure 1. Total body weight (A), liver and spleen pathology (B and C) and bacterial numbers within the lymph 
nodes (D), livers (E), and spleens (F) of C3H/HeN (Ityr) mice. On day 0, C3H/HeN (Ityr) mice were injected 
subcutaneously in the flanks with ~3 × 104 CFU S. enterica serovar Typhimurium 14028s. The dose was confirmed 
by plating serial dilutions of the inoculum. Four age-matched mice were not infected and served as weight controls 
(white triangles). After full recovery from the primary infection, the mice were injected i.p. with PBS (white dots and 
bars), anti-TNFα antibodies (black dots and bars), or dexamethasone (grey dots and bars).  
A.
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Figure 1 continued. At the indicated time points, the livers, spleens, and lymph nodes were aseptically 
removed and weighed. The pathology in the livers and spleens was calculated as the percentage organ weight of the 
total body weight. The viable count within the organs was determined by making lysates and plating serial dilutions of 
the lysates (n=3-4 per group). The results are expressed as log10 viable counts (means ± standard deviations). The 
gray dashed lines represent the detection limit of the microbiological method. 
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Detection of antibodies raised against S. enterica serovar Typhimurium. 
Induction of S. enterica serovar Typhimurium-specific antibodies was determined in a 
whole cell ELISA as described in (28). Maxisorp plates (Nunc) were coated with whole S. 
enterica serovar Typhimurium 14028s and after blocking, serial dilutions of the sera were 
added to the wells. Sera from naïve mice were included as a control. The wavelength 
absorbance was measured at 490 nm using an ELISA plate reader (VICTOR2 1420 
multilabel counter, PerkinElmer Life and Analytical Sciences). Titers are defined as the 
dilution for which: 
OD450 (sample) > OD450 (naïve serum) + 2 × standard deviation. 
 
Statistical analysis. For comparison between treatments we used Student's t tests 
and a P value <0.05 was considered significant.  
 
 
Results and Discussion 
  
No reactivation following neutralization of TNFα. Mice were inoculated 
subcutaneously in the flanks with 3 × 104 CFU S. enterica serovar Typhimurium 14028s. 
After full recovery from the primary infection, the mice were injected with neutralizing 
antibodies to TNFα. The mice lost weight during the primary infection reaching a nadir 
between day 6 and 12 and gained weight during the next few weeks following a course 
comparable to that of the weight controls (Fig. 1A). The mice showed a primary infection 
reaching bacterial loads up to 1 × 106 and 2.5 × 104 CFU for the spleen and lymph nodes 
respectively on day 6 and 1.5 × 107 for the liver on day 12. 
On day 48, 50, and 54, when the bacterial numbers in the organs were reduced to 
below the detection limit, the mice were treated with anti-TNFα antibodies. Infection 
controls were injected with equal volumes of PBS. None of the mice showed signs of 
illness and they all gained weight (Fig. 1A) and showed no consistent change in liver and 
spleen weight (Fig. 1B and 1C).  Anti-TNFα treatment had no effect on the bacterial 
numbers in the organs (Fig. 1D-F), although treatment with anti-TNFα antibodies did 
induce a transient increase in bacterial numbers in the livers (Fig. 1E).  In both groups, the 
mice showed detectable amounts of bacteria in the livers and spleens (Fig. 1B and 1C), 
but the averages were around or below the detection limit and no increase in bacterial 
numbers could be observed. In the feces on the other hand, we were able to detect 
bacteria on the later timepoints in these groups of mice. In our reactivation model we 
accepted that some of the control mice still showed some low number of bacteria in the 
organs, just above the limit of detection. Otherwise, we would have needed many more 
animals to find only a few in which S. typhimurium persisted and reactivated upon 
treatment.   
 
Leukocyte counts in the blood. On each time point after infection and immune 
intervention, the number of leukocytes in the blood was determined and the types of blood 
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cells were differentiated using Giemsa stained blood smears (Table 1). During the growth 
phase of the primary infection, the number of leukocytes increased which was mainly 
attributable to the increase in the number of granulocytes (Table 1). During recovery from 
the infection, the leukocyte counts declined and eventually stabilized. Treatment of the 
mice with neutralizing antibodies to TNFα did not result in a change in the number of 
leukocytes, nor in the numbers of lymphocytes, granulocytes, and monocytes (Table 1).  
 
Anti-Salmonella IgG antibodies in the serum of S. enterica serovar Typhimurium 
infected mice. From each mouse on each timepoint, serum was collected to determine the 
anti-Salmonella IgG antibody titer to the pathogen using a whole cell ELISA. Between days 
6 and 12, when the primary infection peaked in the organs, the mice started producing 
antibodies to S. enterica serovar Typhimurium 14028s (Fig. 2). The antibody titers 
increased further to a log3 dilution factor of around 8 (Fig. 2). The mice that were treated 
with anti-TNFα antibodies had serum antibody levels that were similar, or slightly lower on 
days 50 and 5 to those of the infection controls so lack of reactivation could not be 
explained by altered antibody production in these mice.  
 
In vitro infection of IFNγ stimulated RAW264.7 macrophages. To examine the role 
of TNFα in vitro in RAW264.7 macrophages, we performed in vitro infection experiments in 
which we stimulated the cells overnight with 100 U IFNγ and infected the cells as described 
in Materials & Methods.  Just prior to infection, cells were treated with 10 µg/ml Anti-TNFα 
antibodies or were left untreated. At timepoint zero and after 24 h the number of 
intracellular bacteria was determined. In the untreated cells, the bacteria were able to grow 
out within 24 h to 1.5 × 106 CFU. Pre-treatment of the cells with 100 U IFNγ resulted in no 
outgrowth after 24 h, while treatment with anti-TNFα antibodies had no effect. When cells 
were activated with IFNγ and anti-TNFα treatment had no effect on the number of bacteria 














Figure 2. Anti-Salmonella IgG antibodies in the serum of S. enterica serovar Typhimurium infected mice that 
received no further treatment (white bars), were treated with anti-TNFα antibodies (black bars), or were treated with 
dexamethasone (grey bars). Titers are defined as the OD450(serum sample) > OD450(naïve serum). 
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Table 1. Number of leukocytes, lymphocytes, monocytes, 
and granulocytes in the blooda 
day treatment 
  
  leukocytes 
  (n × 105) 
  lymphocytes 
  (n × 105) 
monocytes 
(n × 105) 
  granulocytes 
  (n × 105) 
1 ---   64.3 ±   9.1   42.3 ±   5.6 4.8 ± 0.8 17.2 ±   8.9 
5 ---   73.8 ± 54.0   28.0 ± 17.9 9.8 ± 6.8 35.9 ±   7.3 
12 ---   77.2 ± 15.2   27.2 ± 10.9 9.9 ± 5.4 40.1 ± 13.6 
19 ---   95.3 ± 23.8   38.2 ±   8.7 10.6 ± 6.3 46.5 ± 13.1 
26 ---   80.8 ± 34.7   44.9 ± 16.1 5.1 ± 3.1 30.8 ± 11.7 
33 ---   46.5 ±   4.2   32.0 ±   3.2 2.5 ± 1.8 12.0 ± 29.2 
40 --- 120.0 ± 14.1   90.8 ±   4.0 6.2 ± 3.3 23.1 ±   6.9 
47 --- 104.3 ± 23.8   76.4 ± 20.0 5.3 ± 1.6 22.6 ±   5.4 
              
50 --- 117.7 ± 38.7   80.1 ± 22.4 5.4 ± 2.6 32.1 ± 17.1 
50 αTNFb 155.0 ± 28.9   89.5 ± 36.8 12.0 ± 6.8 53.5 ± 23.1 
50 dexc 172.5 ± 38.6 100.5 ± 17.6 10.3 ± 3.5 61.7 ± 19.3 
              
54 ---   72.3 ± 16.3   48.5 ± 13.5 5.1 ± 2.4 18.7 ±  8.4 
54 αTNF   62.0 ± 16.7          37.4 ±   6.1 6.3 ± 2.8 18.4 ±  8.6 
54 dex  50.3 ±   7.3          15.8 ±   5.5 7.1 ± 2.6 27.4 ±  6.4 
              
68 ---   57.0 ± 13.0          30.8 ±   6.4 4.4 ± 2.0 21.8 ±  8.0 
68 αTNF   66.5 ± 26.6          38.6 ± 15.8 4.0 ± 2.0 23.9 ±  9.7 
68 dex   38.3 ± 12.8          18.4 ±   4.1 3.3 ± 1.4 16.5 ±  8.4 
              
72 ---   58.3 ± 15.5          37.1 ±   9.3 4.0 ± 1.3 17.1 ±  6.1 
72 αTNF   66.5 ±   7.3          38.7 ±   6.7 4.0 ± 1.1 23.8 ±  6.0 
72 dex   48.5 ± 17.7          22.7 ±   6.0 2.2 ± 0.3      23.6 ± 12.6 
      
75 --- 135.0 ± 30.0          94.2 ±   9.3 5.6 ± 3.0 35.2 ± 19.7 
75 αTNF 187.5 ± 42.7        106.8 ±   6.7 10.9 ± 8.1 69.8 ± 30.8 
75 dex 142.5 ± 41.1          92.1 ±   6.0 5.9 ± 0.9 44.5 ± 11.8 
      
82 ---   79.0 ±   8.5   52.4 ± 11.3 1.8 ± 0.5 24.8 ± 12.1 
82 αTNF   87.0 ± 15.0          62.3 ± 19.9 1.6 ± 0.3 23.1 ±  5.1 
82 dex   57.5 ± 14.0          37.6 ± 29.1 1.6 ± 0.5 18.2 ±  6.8 
a values are mean numbers/ml ± stdev 
b mice that were treated with anti-TNFα  
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Dexamethasone treatment of mice during latency. In the experiment shown in 
Figure 1 we have also treated mice with the glucocorticoid dexamethasone. 
Glucocorticoids have immunosuppressive effects through the inhibition of several immune 
functions, including chemotaxis, phagocytosis, and cytotoxicity, and by the down-regulation 
of cytokine gene expression, including IL-I, IL-2, IL-6, IFN-γ, and TNF-α (3). 
Glucocorticoids are known to inhibit neutrophil infiltration at inflammatory sites, thereby 
inhibiting neutrophil-mediated killing via mechanisms that are no completely understood 
yet. Glucocorticoids exert an anti-inflammatory effect and downregulate the expression of 
ICAM-1, which is constitutively expressed on neutrophils and vascular endothelial cells and 
is upregulated by inflammatory cytokines (17, 24, 27) such as TNFα. Treatment with 
dexamethasone (and other glucocorticoids) might promote reactivation of latent S. 
typhimurium infection by inhibiting the neutrophil-mediated killing. Treatment with 
dexamethasone resulted in a slight increase in the number of granulocytes and moderate 
decrease in lymphocyte number (Table 1). Dexamethasone treatment did not have an 
effect on body weight and hepatosplenomegaly (Fig. 1A, B, and C), nor did it induce 
reactivation of the latent S. enterica serovar Typhimurium infection in the organs (Fig. 1D, 
E, and F). Also in these mice, antibody production was induced to a similar extent as in the 
infection controls (Fig. 2). 
 
Figure 3. Intracellular S. 
enterica serovar Typhimurium 14028s 
in RAW264.7 macrophages. The cells 
were left untreated (white bars), 
stimulated with IFNγ (white bars with 
black dots), not stimulated but treated 
with anti-TNFα antibodies (black bars) 
or stimulated with IFNγ and treated 
with anti-TNFα antibodies (black bars 
with white dots). All cells were 
challenged with S. enterica serovar 
Typhimurium 14028s as described in 
Materials and Methods and the 
numbers of intracellular bacteria were 
determined at 24 h after challenge. 
Asterisks indicate that the number of 
intracellular bacteria is significantly 
different from that of wild-type S. 
enterica serovar Typhimurium 14028s. 




Concluding remarks. The main finding of this study is that neutralization of TNFα did 
not result in reactivation of latent S. enterica serovar typhimurium infection in C3H/HeN 
mice. This is in sharp contrast to the many reports of reactivating Mycobacterial infections 
after neutralization of TNFα. Both species are intracellular pathogens that preferentially 
invade mononuclear cells and have developed mechanisms to reside within a host without 
being noticed by the host immune system and are much alike. For both Salmonella and 
Mycobacteria an important role has been ascribed to TNFα in preventing or dealing with a 





































































































Mycobacteria, recurrence of latent infections due to anti-TNFα have been described 
several times now, while this is not the case for Salmonella. Recurrent infections with the 
same Salmonella strain have been described for patients with immune disorders such as 
HIV and recently a role for CD4+ T cells and IFNγ in preventing recurrence of a latent 
infection has been described. This strongly suggests that TNFα plays only a modest role in 
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Salmonella is a facultative intracellular pathogen that can invade and replicate within 
several cells, including epithelial cells and macrophages. To be able to spread from the 
intestines into the body and to the liver and spleen, S. enterica serovar Typhimurium has to 
go from cell to cell and it can do so by inducing cell death, although it is currently unknown 
what the in vivo relevance of Salmonella-induced cell death is. To gain more insight into 
the strategy that is used by Salmonella to survive within macrophages and to induce 
apoptosis, we have created and selected S. enterica serovar Typhimurium mutants with 
increased ability to survive within macrophages without causing enhanced cell-death and 
analyzed the in vitro cytotoxicity and its in vivo virulence.  
In this way, we have selected for an rmlC mutant that has truncated LPS chains. This 
mutant as well as a rough (Ra chemotype) variant displayed increased bacterial 
intracellular numbers in RAW264.7 macrophages and persisted even after 48 h, while 
inducing cell death to a similar extent as the wild-type strain. However, despite the 
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Introduction 
 
Salmonella is a facultative intracellular pathogen that can invade and replicate within 
several cells, including epithelial cells and macrophages. Salmonella is able to infect both 
humans and animals and depending on the type of Salmonella strain and host it can cause 
a range of diseases. S. enterica serovar Typhimurium causes gastroenteritis in humans, 
but causes typhoid fever-like disease in mice. S. enterica serovar Typhimurium is most 
widely studied in vitro and in vivo and serves a good model for human typhoid fever 
caused by S. enterica serovar Typhi.  
Natural infection with S. enterica serovar Typhimurium occurs through the ingestion of 
contaminated food or water. Those bacteria that have survived the acidic environment of 
the stomach and have reached the intestine will eventually encounter membranous 
epithelial (M) cells overlying the Peyer’s patches. S. enterica serovar Typhimurium uses 
these M cells to pass the intestinal lining and to invade the body by inducing its own uptake 
through a mechanisms known as Salmonella-induced membrane ruffling mediated by type 
three secretion system proteins that are encoded by genes of Salmonella-pathogenicity 
island 1 (SPI-1) (reviewed in (16)). S. enterica serovar typhimurium is transported through 
the cytoplasm to the underlying lymphoid cells where it predominantly infects the 
macrophages. S. enterica serovar Typhimurium then becomes systemic and spreads to 
the liver and spleen and causes the chronic inflammatory response that is typical for 
typhoid fever. 
To be able to spread from the intestines into the body and to the organs, S. enterica 
serovar Typhimurium has to go from cell to cell. S. enterica serovar Typhimurium can do 
so by inducing cell death. Two types of Salmonella-induced cell death have been 
described. The first one involves a rapid, caspase-1-dependent, induction and the second 
one a slower, caspase-1-independent, induction of cell death.  The rapid Salmonella-
induced cell death leads to a strong pro-inflammatory response that is mediated by IL-1β 
and IL-18 and therefore differs from the classical apoptotic mechanisms. It has therefore 
been stated that Salmonella induces programmed necrosis in a caspase 1-dependent 
manner (2). This type of Salmonella-induced necrosis is dependent upon the production 
and secretion of the SPI1 encoded protein SipB and requires the presence and activation 
of caspase-1 (5, 10). The second type of Salmonella-induced cell death is slower than the 
rapid caspase-1 induced cell death (at 12-13 h post infection) and is not dependent upon 
SipB and caspase-1 as Salmonella can still induce cell death in the absence of these 
proteins (8, 15). This type of induced cell death is reminiscent of apoptosis and occurs 
even in the absence of bacterial replication, is SPI-1 independent and requires a functional 
SPI-2 and ompR (15). It is currently unknown which other mechanisms, besides SPI-2-
encoded genes and ompR might play a role in this second type of Salmonella-induced cell 
death.  
Van der Velden et al. have proposed a model in which the rapid and delayed 
Salmonella-induced apoptosis in infected macrophages is induced under different 
physiological conditions at distinct time and location during a natural infection. The rapid 
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SPI-1-dependent induction of cell death resulting in inflammation may be required for the 
recruitment of phagocytes and for systemic dissemination, while the delayed, caspase-1 
independent, apoptosis is required during the systemic phase of infection and is used to 
spread intercellularly within apoptotic bodies (15). In this model, Salmonella-induced cell 
death is generally thought to reflect a bacterial strategy to promote disease (1) and seen as 
a virulence mechanism. 
Alternatively, cell death upon S. enterica serovar Typhimurium infection might also 
been seen as a host response to infection that is beneficial to the host as cell death 
exposes S. enterica serovar Typhimurium to immune defense mechanisms of the host 
such as antibodies, complement, and neutrophils. By inducing cell death of infected 
macrophages, the bacteria are released into the host tissues and blood and can be rapidly 
killed by complement or can be opsonized and then killed by granulocytes. 
Further research on the relevance of Salmonella-induced cell death is necessary 
since it is currently unknown what the in vivo relevance of Salmonella-induced cell death is. 
Although it has been shown that several Salmonella mutants are less cytotoxic and cannot 
induce apoptosis in vitro (11, 13), it is not known whether such mutants are attenuated or 
not. Therefore, we have selected for S. enterica serovar Typhimurium mutants that reside 
in macrophages and that are still viable after prolonged times of infection when most of the 
cells have undergone cell death. Analysis of in vitro cytotoxicity and in vivo virulence of 
such mutants might give more insights into the role of Salmonella induced cell-death in in 
vivo virulence.  
 
 
Materials and Methods 
 
Mice. Six- to 8-week-old female Salmonella-resistant (Ityr) C3H/HeN mice were 
purchased from Harlan (Horst, The Netherlands). Mice were maintained under standard 
conditions according to the institutional guidelines. Water and food were given ad libitum. 
All experiments were approved by the local Animal Ethical Committee. 
 
Bacterial strains and growth conditions. The bacterial strains used in this study are 
enlisted in Table 1. Single colonies of the different strains were grown in Luria-Bertani (LB) 
medium (10 mg of tryptone, 5 mg of yeast extract, and 10 mg of NaCl/ml) at 37°C while 
being shaken (225 rpm). For the in vivo experiments, the overnight cultures were diluted in 
fresh LB medium and grown to the end of log phase and were then washed and diluted in 
sterile PBS. The CFU in the inoculum were determined by plating serial dilutions. 
 
Generation of S. enterica serovar Typhimurium mutants. Wild type S. enterica 
serovar Typhimurium  14028s was used as the parental strain to isolate mutants that 
displayed reduced ability to induce cell death in RAW264.7 cells. Mutants were made by 
random MudJ transposon insertion. Phage lysate containing the MudJ was made using 
TT10289 (7). Briefly, P22 phages were added to a 1:10 diluted ON culture of TT10289 and 
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incubated at 37°C ON while being shaken. After adding 10% chloroform and another 
incubation at 37°C for 30 minutes, the lysate was centrifuged for 2 minutes to remove the 
cell debris. This cell lysate containing phages with the MudJ transposon (10 µl) was added 
to100 µl ON culture of the recipient strain 14028s. After incubation at 37°C for 5 hours, the 
bacteria were plated on LB agar containing 50 µg/ml kanamycin (Sigma) and 0.1% sodium 
citrate (Merck) to select for bacteria in which the MudJ transposon had been inserted. 
 
 
Table 1. Salmonella strains and plasmids used in this study 
Salmonella Strain  Characteristics Origin or reference 
S. enterica serovar Typhimurium   
14028s Wild type ATCC 
14028r Ra chemotype (rough) This study 
SF1398Re Re chemotype (deep rough) This study 
TT10289 LT2 hisD9953::MudJ hisA9949::Mud1 {370} 
AVD16703 14028s rmlC::MudJ This study 
 
 
Selection of S. enterica serovar Typhimurium mutants. To select for S. enterica 
serovar Typhimurium mutants we pooled the random MudJ transposon insertion mutants 
by scraping the plates. The pooled bacteria were washed with PBS and were used for in 
vitro infection of RAW264.7 cells as described. Only now the cells were seeded in 150 cm2 
flasks at a density of 1 × 107 cells per flask and were allowed to adhere ON at 37°C and 
5% CO2 and the pooled bacteria were used to infect the cells at a 10:1 multiplicity of 
infection. Endocytosis was allowed to proceed for 30 minutes and gentamicin treatment 
was performed as described for the in vitro infection experiment. At 72 hours after 
infection, the cells were washed and lysed in milliQ and the lysate was plated on agar 
plates. The bacteria were again scraped off the plates, washed with PBS and again used 
for infection of RAW264.7 cells. After this second passage, single colonies were made 
phage-free by repetetive plating on EBU agar and were tested in a regular in vitro infection 
experiment.  
 
Inverse PCR. To identify the gene in which the MudJ transposon had inserted, the 
DNA flanking the left end of the transposon was amplified and sequenced using inverse 
PCR. Genomic DNA of strain AVD16703 was isolated and digested with HaeIII (Gibco-
BRL) for 4 hours. After inactivating the HaeIII enzyme, the sample was treated with T4 
DNA ligase (Invitrogen). The digested and ligated DNA was amplified using the following 
primers: 5'-CCGGGAGGACATTGGATTAT-3' (sense) and 5'-
CGTACTTCAAGTGAATCAATAC-3'. The PCR product was purified using the QIAquick 




In vitro infection experiment. RAW264.7 cells were seeded in a 24-wells plate at a 
density of 1 × 105 cells per well and allowed to adhere ON at 37°C in RPMI medium 
supplemented with 10% fetal calf serum. Bacteria were washed in PBS and were added to 
the cells at a 10:1 multiplicity of infection. The bacteria were spun onto the cell by 
centrifugation for 10 min at 270 × g. Cells were incubated for 10 min at 37°C and 5% CO2 
to allow bacterial endocytosis. After washing the cells with PBS, medium containing 100 
µg/ml gentamicin was added and the cells were incubated at 37°C  for another 10 min to 
kill the extracellular bacteria. The cells were then washed again. This was designated time 
point zero. Medium containing 10 µg/ml gentamicin was added to the cells to kill the 
extracellular bacteria and to prevent reinfection. At 0, 24, and 48 hours the cells were lysed 
in 1 ml milliQ and serial dilutions were made to determine the number of bacteria. 
 
Cytotoxicity test. Salmonella-induced cytotoxicity was determined using the Cytotox 
96 Non-Radioactive Cytotoxicity Assay (Promega) that is based upon the release of 
lactate dehydrogenase (LDH). From each well, 50 µl supernatant was taken and 
transferred to a 96 wells plate. As a control for spontaneous release of LDH 50 µl 
supernatant was taken from non-infected cells on each timepoint. The maximum LDH 
release was determined by adding 0.9% Triton X-100 to the cells and thereby lysing them 
and transferring 50 µl to the 96-wells plate. Then 50 µl substrate mix was added to each 
well and the plate was incubated at room temperature in the dark for 30 min. The coloring 
reaction was stopped by adding 50 µl stop solution provided with the kit and the OD490 
was determined using an ELISA plate reader (VICTOR2 1420 multilabel counter, 
PerkinElmer Life and Analytical Sciences). The induced cytotoxicity (%) was calculated as 
follows: 
OD490(Salmonella-induced release) – OD490(spontaneous release)         
                                                                                                                    × 100% 
OD490(maximum release) – OD490(spontaneous release)  
 
In vivo infection experiment. Mice were inoculated subcutaneously in the flanks with 
0.1 ml bacterial suspension containing 3 × 104 CFU S. enterica serovar Typhimurium 
14028s, 14028r, or AVD16703. For each group on each time point 4 mice were used. Mice 
were sacrificed by carbon dioxide inhalation and blood was taken immediately by cardiac 
puncture. Part of the blood was used to obtain serum and the other part was prevented 
from coagulation by adding 40 U heparin/ml to count the number of leukocytes and to test 
the blood for the presence of Salmonella by culture in LB medium. To determine the 
bacterial load within spleens, livers, and inguinal lymph nodes, these organs were 
aseptically removed and single cell suspensions were prepared by using sterile 70-µm-
mesh-size cell strainers (Falcon). Cells were pelleted by centrifugation for 10 min and were 
lysed in distilled water. The bacterial number per organ was determined bacteriologically by 
plating serial dilutions.  
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Preparation of cell envelopes followed by Proteinase K digestion. Single colonies 
were grown ON in 10 ml LB medium at 37°C while being shaken. The ON culture was 
pelleted for 10 min at 3,000 rpm and cell envelopes were isolated as described in (3). 
Briefly, the pellets were washed once in ice-cold sonicationbuffer (50 mM Tris-HCl, 2 mM 
EDTA, pH 8.5) and were then resuspended in 4 ml of this buffer. The suspension was then 
sonicated with 8 pulses of 20 sec with an amplitude of 20-24 µm and with cooling. The 
sonicates were pelleted and the pellets containing cell debris and the cell envelopes were 
resuspended in 100 µl of 2 mM Tris-HCl pH7.8. Protein concentrations in the samples were 
measured using a BCA (Pierce) protein assay according to the manufacturers 
recommendations to standardize the samples at 1 mg/ml. The samples were then treated 
with Proteinase K (250 µg/ml) for 2 hours at 60°C to degrade the proteins present in the 
cell envelopes and equal volumes of sample buffer were added. 
 
Electrophoretic separation. For the separation of the LPS fragments was done by 
SDS-PAGE by loading 35 µl of the samples on a 16% acryl amide separation gel and a 5% 
acryl amide stackinggel.  
 
Silver-staining. To visualize the LPS fragments, the acryl amide gel was stained 
using a silver staining method according to Heukeshoven and Dernick (6) with a few 
modifications. Briefly, the acryl amide gel was incubated in fixing solution (40% ethanol, 
10% acetic acid) for 30 min. The gel was then placed ON in incubation solution (30% 
ethanol, 0.5 M sodium acetate, 0.13% glutardialdehyde, 0.2% sodium thiosulphate). After 
washing with distilled water, the gel was stained in silver solution (0.1% silver nitrate, 
containing 0.007% formaldehyde) for 40 min and developed in 0.24 M sodium carbonate 
containing 0.0035% formaldehyde for 15 min until the bands become intensively dark. The 
coloring reaction was stopped by placing the gel in 0.04 M EDTA-NA2·2 H2O and was 
washed with distilled water. The gel was then preserved in 10% glycerol. 
 
Statistics. Statistical analysis was performed using Student’s t tests and a P value 





Isolation of S. enterica serovar Typhimurium mutants with reduced ability to 
induce cell damage. In a typical in vitro infection experiment of RAW264.7 macrophages 
with the wild-type strain 14028s, the bacteria start to replicate until they reach a maximum 
after 24 h. At later timepoints after infection, the bacterial numbers decline due to death of 
the macrophages and subsequent exposure of the bacteria to gentamicin that is present in 
the medium or due to eventual killing of the bacteria by the macrophages. To select for 
mutants with reduced capacity to induce death of the host cell, we have generated S. 
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type strain 14028s and pooled them for use in in vitro infection of RAW264.7 cells. As a 
control we infected cells with wild-type S. enterica serovar Typhimurium. At 72 h after 
infection, the cells were lysed and the lysate was plated onto agar in order to enrich for 
mutants with a reduced capacity to cause death of the macrophages. The bacteria were 
again scraped off the plates and were again used for infection of RAW264.7 cells. During 
this second passage we observed that many cells were no longer attached to the bottom of 
the tissue culture flask when wild-type bacteria were used for infection, while in the flasks 
used for infection with the pooled mutants cells remained attached. This suggested that 
this pool contained mutants with a reduced ability to induce cell damage. After the second 
passage, several single colonies were isolated and used in an in vitro infection experiment. 
Mutants H and J displayed increased survival compared to the wild-type strain 14028s at 


















Figure 1. Relative number of random MudJ transposon insertion S. enterica serovar Typhimurium 14028s 
mutants in RAW264.7 macrophage-like cells. On t=0, 3, and 24 h the number of intracellular bacteria was determined 
bacteriologically and the relative number compared to the wild-type strain on each timepoint was calculated. Each 
first bar represents t=0 h, the second bar t=3 h, and the third bar t=24 h.  
 
 
Identification of the gene inactivated by MudJ insertion. The gene that was 
inactivated by the MudJ insertion and rendered mutants H and J to be able to survive 
within RAW264.7 cells even after 48 was identified by inverse PCR. Part of the gene in 
which the MudJ had inserted (left flanking region) was sequenced and NCBI nucleotide 
BLAST search revealed homology of the MudJ flanking region to rmlC, a gene encoding 
dTDP-4-deoxyrhamnose 3,5-epimerase (complement 2175118-2175669, accession 
number NC_003197.1). Sequence analysis also revealed that mutants H and J were 
identical. The MudJ had been inserted at exactly the same position in the rmlC gene. 
Therefore, we continued our experiments with mutant J only and have named this strain 
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AVD16703. RmlC is part of the rfb gene cluster that encodes the enzymes for O-antigen 
biosynthesis. RmlC acts together with rmlB, rmlD, and rmlA to encode L-rhamnose, which 
is part of the repeating unit of the O-antigen polysaccharide of LPS.  
 
LPS fragment analysis. The MudJ insertion in rmlC should in theory result in the lack 
of production of L-rhamnose and result in a lack of the O-antigen. To confirm that the 
isolated mutant AVD16703 was indeed an LPS mutant we isolated cell envelopes and 
analyzed the LPS fragments by gel electrophoresis and silver staining. As a control we 
used the LPS rough mutant 14028r (Ra chemotype) and the deep rough LPS mutant 
SF1398Re (Re chemotype). LPS of 14208r consists of the lipid A portion and the core 
region and lacks the O-antigen. The LPS chain of SF1398Re is even shorter as it consists 
only of lipid A glycosylated with two 3-deoxy-D-manno-octulosonic acid (Kdo) residues and 
thus lacks both the O-antigen and the core region. Figure 2 shows the LPS fragments of 
the wild-type strain 14028s show the typical ladder pattern. LPS from mutant SF1398Re is 
very small and gives only a smear at the bottom of the gel. LPS from our mutant 
AVD16703 appeared to be very much alike that of the 14028r strain. This 14082r strain is 
an LPS mutant that is known to lack the O-antigen and consists only of lipid A and the core 
region.  
One striking feature was that mutant AVD16703, although very much alike 14028r in 
the LPS fragment analysis, showed different colony morphology on LB agar plates. 
Colony morphology of the Ra chemotype mutant 14028r was rough, while that of mutant 
AVD16703 was not. On blood agar plates, on the other hand, the colony morphology of 










Figure 2. SDS-PAGE fractionation of LPS fragments from wild-type S. 
enterica serovar Typhimurium 14028s (lane 1), the rmlC mutant AVD16703 (lane 
2), the Ra chemotype rough mutant 14028r (lane 3), and the Re chemotype 
mutant SF1398Re (lane 4). The gel was silver stained. 
 
 
In vitro intracellular growth of S. enterica serovar Typhimurium mutant strains. 
Since LPS fragment analysis revealed that LPS from 14028r and mutant AVD16703 was 
very much alike, we tested both mutants in an in vitro infection experiment. Since mutant 
AVD16703 was originally isolated as a strain that was able to survive for a longer period of 
time and is thought to induce less cell death, we also assessed the intracellular 
1 2 3 4
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survival/outgrowth after 48 h. The wild-type strain grows out after 24 h, but after 48 h the 
number of viable bacteria is reduced (Fig. 3A). In contrast, mutant AVD16703 is able to 
survive after 48 h. The bacterial numbers are somewhat reduced compared to 24 h, but 
are still significantly higher than those of the wild-type strain. Remarkebly, the 14028r 
mutant showed even higher numbers of intracellular bacteria both at 24 and 48 h after 
infection.  
 
Salmonella-induced cytotoxicity. The reduction in the number of wild-type bacteria 
at 48 h after infection and the higher numbers of the LPS mutants could be explained in 
two ways. The intracellular replication of the mutants could have been faster than that of 
the wild-type, or the infection with the wild-type strain could have caused more cell death 
than the LPS mutants, resulting in a reduction in the number of viable bacteria. Therefore, 
we analyzed the induced cytotoxicity by measuring the LDH release in the infected wells. 




















Figure 3. Intracellular S. enterica serovar Typhimurium in RAW264.7 mouse macrophage-like cells (A), 
percentage cytotoxicity induced by the infection (B), relative induced cytotoxicity per 104 intracellular CFU (C), and 
number of intracellular bacteria in the absence or presence of different concentrations of extracellular E. coli LPS (D). 
The cells were challenged with S. enterica serovar Typhimurium 14028s (white bars), AVD16703 (checkered bars), 
14028s (black bars) as described in Materials and Methods. The numbers of intracellular bacteria were determined at 
0, 24, and 48 h after infection and the percentage cytotoxicity 24 and 48 h after infection. Asterisks indicate that the 
number of intracellular bacteria is significantly different from that of wild-type S. enterica serovar Typhimurium 
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Figure 4. Total body weight (A), induced pathology in the spleen (B) and liver (C), and number of bacteria in 
the inguinal lymph nodes (D), liver (E), and spleen (F). Mice were infected subcutaneously in the flanks with 3 × 104 
CFU of 14028s (white dots and white bars), AVD16703 (black squares and checkered bars), and 14208r (black dots 
and black bars). At the indicated time points, livers, spleens, and lymph nodes were aseptically removed and 
weighed. The viable counts within the organs were determined by making lysates and plating serial dilutions of the 
lysates and are expressed as log10 viable counts (means ± standard errors of the means). Averages from 4 mice per 
time point and per group are shown. Asterisks indicate statistically significant differences compared to the wild-type-
infected mice (Student's t test) and the gray dashed lines represent the detection limit of the microbiological method 
(50 CFU for the livers and 30 CFU for the spleens and lymph nodes 
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~50% after 48 h (Fig. 3B). The induced cytotoxicity seemed slightly higher for the 14028r 
strain at 48 h, but this was not statistically significant. When the relative cytotoxicity was 
calculated as LDH release per 104 intracellular bacteria, it appeared that this was reduced 
for both mutant AVD16703  and the 14028r strain (Fig. 3C). This indicates that with similar 
cytotoxicity more mutant S. enterica serovar Typhimurium was present in the macrophages 
as reflected by the relative cytotoxicity (Fig. 3C). Since the mutants have truncated LPS 
that might have influenced the activation status of the macrophage, we added different 
concentrations of LPS during the in vitro infection. However, no effect of extracellular LPS 
was observed (Fig. 3D).   
 
In vivo infection with AVD16703 and 14028r. To determine whether the mutant 
strains are capable of surviving for a longer period of time in mice, we performed an in vivo 
infection experiment in which C3H/HeN mice were infected subcutaneously in the flanks 
with ~3 × 104 CFU of wild-type 14028s, 14028r, or AVD16703.  All the mice showed an 
increase in total body weight during the 19 days after infection. Only in the wild-type 
infected mice showed growth was halted between days 2 and 5 after infection (Fig. 4A) but 
the mice showed no reduction in body weight. The mice that were infected with the wild-
type strain showed an increase in spleen and liver pathology (Fig. 4B and 4C) while the 
14028r-infected mice showed no signs of hepatosplenomegaly. The AVD16703 infected 
mice showed no increase in liverweight, but did show a slight increase in spleenweight 
reaching intermediate spleenweights (Fig. 4B and 4C). All the strains tested showed 
detectable numbers of bacteria in the inguinal lymph nodes already on day 1 after infection 
and in all groups the numbers increased reaching a peak between days 5 and 12 (Fig. 4D). 
For the livers and spleen the strains behaved differently. The wild-type infected mice 
showed high bacterial numbers in the liver and spleen peaking on day 12 after infection, 
while in the 14028r and AVD16703-infected mice hardly any bacteria could be detected 











Figure 5. Sensitivity to rat 
complement of 14028s (white dots), 
AVD16703 (black squares), and 
14028r (black dots). Bacteria were 
incubated at 37°C in PBS containing 
no serum (straight lines), 10% rat 
serum (dashed lines), or 10% C3-
deficient rat serum (dotted lines). 
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In vitro sensitivity to complement. The in vivo attenuation could have been 
explained by increased sensitivity to complement-mediated killing as has been described 
for other LPS mutants (14). Therefore, we determined the rate of killing by complement of 
the wild-type strain and the two LPS mutant strains AVD16703 and 14028r. First, we 
determined the in vitro killing of rat serum that had not been heat inactivated. The wild-type 
strain is not killed when incubated in the presence of 10% rat serum and bacterial numbers 
are comparable to those bacteria that were incubated in the absence of serum (Fig. 5A). 
The LPS mutant strains, on the other hand, appeared to be more sensitive to rat 
complement since bacterial numbers declined already after 30 minutes (Fig. 5B and 5C). 
AVD16703 then stabilized, while the numbers of 14028r declined even further during the 
next 90 min (Fig. 5C). Comparable results were obtained when human serum was used 
(data not shown). When rat serum was used that was deficient for the C3 component of the 
complement system, the bacteria were not killed (Fig. 5A, B, and C), indicating that the C3-
mediated complement is involved in the increased sensitivity to complement-mediated 
killing of the LPS mutants. However, when mouse serum was used in this experiment, no 
killing was observed even when the bacteria were incubated in 100% serum. Even when 
much lower numbers of bacteria were used, these mutants were not killed (data not 
shown). However, the outgrowth within 4 h of the LPS mutants was less than that of the 
wild-type strain, indicating that complement-mediated killing could play a role in vivo, when 





To gain insight into the role of Salmonella-induced cell death in virulence, we have 
selected for mutants that survived for prolonged periods after infection in macrophages, 
when most of the cells infected with wild-type S. enterica serovar Typhimurium 14028s 
have undergone cell death. We reasoned that such mutants would be less cytotoxic. The 
relative cytotoxicity of the selected mutants was lower compared to the wild-type strain. 
These mutants reached higher intracellular numbers in the in vitro macrophage infection 
assay while inducing a similar cytotoxicity as the wild-type strain did at a much lower 
number of intracellular bacteria. Also, the LPS mutants were highly attenuated in vivo 
indicating that Salmonella-induced cell death should be regarded as a virulence 
determinant.  
We have selected two mutants from the in vitro infection assay and sequence analysis 
revealed that these mutants were identical and the MudJ transposon had inserted in the 
rmlC gene encoding dTDP-4-deoxyrhamnose 3,5-epimerase (RmlC). RmlC is involved in 
the pathway of biosynthesis of dTDP-L-rhamnose from glucose 1-phosphate and thymidine 
triphosphate. The rmlC gene is part of the rfb gene cluster that is involved in the LPS O-
antigen biosynthesis of S. enterica serovar Typhimurium (9). RmlC catalyzes the third step 
in the biosynthesis of dTDP-L-rhamnose, which requires three additional enzymes RmlA, B, 
and D. These enzymes act together to synthesize dTDP-L-rhamnose from D-glucose-1-
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phosphate and dTTP. The sugar dTDP-L-rhamnose is the precursor of L-rhamnose, a major 
residue in the O-antigen of LPS. An intact LPS chain is essential for colonization and 
resistance to complement-mediated serum killing as the shorter the LPS chain, the more 
sensitive these mutants get to complement-mediated serum lysis and the lesser these S. 
enterica serovar Typhimurium mutants are able to colonize the intestines (12, 14). The 
biosynthesis of dTDP-L-rhamnose by the four enzymes RmlABCD is a very important 
process for Salmonella since humans do not synthesize dTDP-L-rhamnose and therefore 
cannot be taken up and has to be produced by Salmonella itself. It has therefore been 
stated by others that these four enzymes including RmlC might be very good targets 
against which new drugs might be designed (4). When looking at the data presented here, 
this might indeed be a good target for defense against Salmonella colonization since our 
mutant lacked the O-antigen of LPS and as a result showed an attenuated in vivo 
phenotype in mice and increased sensitivity to human complement, so targeting of the 
genes involved in L-rhamnose biosynthesis might indeed be a good way of designing a 
potent drug against human Salmonella infection. 
Since infection with the RmlC mutant and the 14028r strain resulted in decreased 
relative cytotoxicity in RAW264.7 macrophages and since SPI-1-inducing conditions had 
no effect on the early induction of cell death (data not shown), this would suggest that 
these LPS mutants induce cell death in a SPI-1-independent manner and that SipB and 
caspase-1 are not required. Therefore, it is most likely that the second, delayed type of 
Salmonella-induced cell death is induced at a higher rate for these mutants. In the model 
proposed by Van der Velden et al. (15) Salmonella-induced cell death is generally thought 
to reflect a bacterial strategy to promote disease (1) and seen as a virulence mechanism 
allowing the bacteria to spread from cell to cell within the host. The delayed, caspase-1 
independent, type of Salmonella-induced cell death is proposed to be required during the 
systemic phase of infection and is used to spread intercellularly within apoptotic bodies 
(15). The LPS mutants displayed similar cytotoxicity to infected macrophages as the wild-
type strain while showing increased intracellular numbers. This could be due to increased 
intracellular replication that could continue for a longer period because of the relatively 
lower induction of cytotoxicity. However, despite the increased numbers of intracellular 
bacteria, these mutants were highly attenuated in vivo. This suggests that these LPS 
mutants were killed at a higher rate or were not able spread from the inguinal lymph nodes. 
Increased killing could have been due to increased complement-mediated killing as the 
LPS mutants are highly susceptible to rat complement (Fig. 5). However, the LPS mutants 
were not killed when mouse serum was used and therefore we could not confirm the in 
vivo attenuation to be due to increased complement-mediated killing. Still, complement-
mediated killing is a likely explanation for the in vivo attenuation since mouse complement 
should be able to kill, eliminate, or at least reduce bacterial loads when bacterial numbers 
are low and local concentrations of complement are high. Another explanation could be the 
increased opsonisation of the LPS mutants with mouse complement that does not result in 
killing by complement itself, but to increased uptake and killing of the bacteria by 
granulocytes, thereby preventing the bacteria form reaching the liver and spleen.  
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We have shown that LPS mutants display increased bacterial intracellular numbers in 
RAW264.7 macrophages that persist even after 48 h while inducing more cell death. This 
would suggest that the infected cells that were still intact contained more intracellular 
bacteria without being lysed. This could mean that the LPS mutants are able to grow very 
fast intracellularly and are able to reach high bacterial numbers inside macrophages. 
However, despite the increased ability to survive within cells, these LPS mutants are 
strongly attenuated in vivo due to mechanisms that need to be studied in more detail. 
Based on the data presented here, one would suggest that the relatively reduced induction 
of cell death of the LPS mutants is not beneficial to the in vivo virulence of S. enterica 
serovar Typhimurium, despite the increased ability to survive within macrophages. 
Apparently, Salmonella-induced cell death is a process that needs to be regulated and 
further research on the relevance of Salmonella-induced cell death is necessary before it is 
clear what the in vivo relevance of Salmonella-induced cell death is.  
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Salmonella enterica serovar Typhimurium is a Gram-negative, facultative intracellular 
pathogen that predominantly invades mononuclear phagocytes. Upon contact with host 
cells, the intracellular pathogen Salmonella promotes its uptake, targeting and survival in 
its intracellular niche, thereby evading the macrophages' microbicidal effector mechanisms 
such as oxygen intermediates. Many genes involved in bacterial resistance to superoxide 
stress have been characterized, but the exact contribution of many of these genes to 
bacterial survival within macrophages and in vivo virulence in mice is still poorly 
understood. 
By generating S. enterica serovar Typhimurium mutants with increased susceptibility 
to superoxide and investigating the intracellular fate of the strains within macrophages we 
hope to gain insight into the mechanisms that are essential to Salmonella to resist 
superoxide stress and to survive and replicate within host cells and in mice. Here we 
describe the isolation of an S. enterica serovar Typhimurium mutant lacking the expression 
of polynucleotide phosphorylase (PNPase). This mutant is hypersusceptible to superoxide 
and is attenuated in macrophages, yet was more virulent in C3H/HeN mice than the wild-
type strain. This diverse fate of a superoxide-hypersusceptible strain underscores the 
complexity of virulence determinants and demonstrates that care must be taken when 
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Introduction 
 
The Gram-negative, facultative intracellular pathogen Salmonella enterica serovar 
Typhimurium has evolved many mechanisms that allow the bacterium to survive, persist, 
and even replicate within a host. It predominantly invades mononuclear phagocytes and is 
able to establish persistent infections by evasion or disturbance of the host defense (13). 
S. enterica serovar Typhimurium can respond to a specific host environment by selectively 
expressing appropriate factors to prevent the induction or to neutralize the action of 
antimicrobial effector mechanisms within the macrophage which favor intracellular survival 
and replication and are necessary for resistance against the defense systems of the host 
(5, 7, 8, 13, 17). This ability of S. enterica serovar Typhimurium to enter and replicate 
within phagocytic cells is essential for its survival, as mutants unable to do so are avirulent 
(6). One of the major early defense mechanisms of macrophages against microorganisms 
is the production of toxic superoxide by the phagocyte NADPH oxidase and the 
subsequent generation of superoxide derivatives, both in vitro (16) and in vivo (18, 19, 21). 
Since superoxide is a by-product of normal aerobic metabolism, both eukaryotic and 
prokaryotic cells have evolved ways to respond to superoxide stress by the activation of 
genes involved in a protective response (10). In bacteria, these mechanisms include 
neutralization of phagocyte derived oxidants, repair of damage resulting from such 
oxidants or prevention of their production all together (17) and are (10) of huge importance 
for the ability of S. enterica serovar Typhimurium to survive within the phagosome. The 
essential role of the periplasmic Cu,Zn-SOD and the type III secretion system encoded by 
Salmonella pathogenicity island 2 (SPI2) in this defense has been demonstrated, as 
mutants deficient in one of these systems show reduced survival within macrophages (4, 
10, 22). 
Research on mutant strains of E. coli as well as Salmonella has led to the 
identification of a range of genes that are necessary for survival during oxidative stress 
generated in vitro. A range of mutants have been isolated and described that are either 
sensitive to endogenously or to exogenously produced superoxide, or to exogenously as 
well as endogenously produced superoxide, or to hydrogen peroxide (reviewed in (12)).  
However, the exact contribution of many of these genes to bacterial survival within 
macrophages and in vivo virulence in mice is still poorly understood since for a lot of 
mutants the in vitro sensitivity to superoxide does not translate into attenuated intracellular 
or in vivo behavior (reviewed in (12)). 
By generating S. enterica serovar Typhimurium mutants with increased susceptibility 
to superoxide and investigating the intracellular fate we hope to gain more insight into the 
mechanisms that are used by Salmonella to resist superoxide and to survive and replicate 
within host cells and in mice. Here we describe the isolation of an S. enterica serovar 
Typhimurium mutant lacking the expression of polynucleotide phosphorylase (PNPase) 
that is hypersusceptible to superoxide, is severely attenuated in macrophages, but was 




Materials and Methods 
 
Mice. Six- to 8-week-old female Salmonella-resistant (Ityr) C3H/HeN mice were 
purchased from Harlan (Horst, The Netherlands). Mice were maintained under standard 
conditions according to the institutional guidelines in filter top cages. Water and food were 
given ad libitum. All experiments were approved by the local Animal Ethical Committee. 
 
Cells and culture conditions. RAW264.7 were grown in RPMI 1640 medium 
supplemented with 2 mM glutamine, 10% fetal bovine serum, penicillin (100 units/ml), and 
streptomycin (50 µg/ml) at 37ºC and 5% CO2.  
 
Bacterial strains. The bacterial strains used in this study are enlisted in Table 1. 
Strain MC1 and MC71 were a kind gift from Dr. Mikael Rhen (Microbiology and Tumor 
Biology Center, Karolinska Institute, Stockholm, Sweden). Single colonies of the different 
strains were grown in Luria-Bertani (LB) medium (10 mg of tryptone, 5 mg of yeast extract, 
and 10 mg of NaCl/ml) at 37°C while being shaken (225 rpm). For the in vivo experiments, 
the overnight cultures were diluted in fresh LB medium and grown to the end of log phase 
and were then washed and diluted in sterile PBS. The CFU in the inoculum were 
determined by plating serial dilutions. 
 
 
Table 1. Salmonella strains and plasmids used in this study 
Salmonella Strain Characteristics Origin or reference 
S. enterica serovar Typhimurium  
   14028s Wild type This study 
   AVD101 14028s pnp::MudJ This study 
   AVD102 MudJ transposon insertion in 14028s This study 
   AVD103 MudJ transposon insertion in 14028s This study 
   AVD104 MudJ transposon insertion in 14028s This study 
   TT10289 LT2 hisD9953::MudJ hisA9949::Mud1 (11) 
 
 
Generation of S. enterica serovar Typhimurium mutants. Wild type S. enterica 
serovar Typhimurium was used as the parental strain to isolate mutants that displayed 
increased susceptibility to the superoxide generating agent menadione. Mutants were 
generated by random P22 MudJ transposon insertion and were selected for superoxide 
sensitivity by streaking single colonies onto series of M9 agar plates containing 0.5 mg/ml, 
0.25 mg/ml, or no menadione (Sigma). A single tip was used to streak on all three plates 
starting with the plate containing the highest concentration of menadione and ending on 
the plate containing no menadione. Colonies that did not grow on the plates containing 
menadione, but that did grow well on the control plate, were selected for further research. 
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Disk diffusion assay. To determine superoxide susceptibility, disk diffusion assays 
were performed as described by Bauer et al. (1). Briefly, overnight cultures of salmonellae 
were spread onto M9 plates. A cotton disk containing 30 mmol menadione was placed in 
the center. After overnight incubation at 37oC the diameter of the bacterium-free zone was 
determined (mm) as a measure of susceptibility. 
 
Inverse PCR. To identify the gene in which the MudJ transposon had inserted, the 
DNA flanking the left end of the transposon was amplified and sequenced using inverse 
PCR. Genomic DNA of strain AVD16703 was isolated and digested with HaeIII (Gibco-
BRL) for 4 hours. After inactivating the HaeIII enzyme, the sample was treated with T4 
DNA ligase (Invitrogen). The digested and ligated DNA was amplified using the following 
primers: 5'-CCGGGAGGACATTGGATTAT-3' (sense) and 5'-
CGTACTTCAAGTGAATCAATAC-3'. The PCR product was purified using the QIAquick 
PCR purification kit (Qiagen) and was sequenced.  
 
Replication within macrophages. RAW264.7 cells (2 × 105) were challenged with S. 
enterica serovar Typhimurium at a 10:1 multiplicity of infection (MOI). The bacteria were 
spun onto the cell by centrifugation for 10 min at 270 × g to promote bacterial uptake. Cells 
were allowed to internalize the bacteria for 30 min at 37°C and 5% CO2. After washing the 
cells with PBS, medium containing 100 µg/ml gentamicin was added to kill the extracellular 
bacteria and cells were incubated at 37°C for 1 h. The cells were then washed again. This 
was designated time point zero. Medium containing 10 µg/ml gentamicin was added to the 
cells to kill any remaining extracellular bacteria and to prevent reinfection. At 0, 24, and 48 
hours the cells were lysed in 1 ml H2O and serial dilutions were made to determine the 
number of intracellular CFU.  
 
In vivo infection experiment. Mice were inoculated subcutaneously in the flanks with 
0.1 ml bacterial suspension containing 3 × 104 CFU S. enterica serovar Typhimurium 
14028s or 14028s pnp::MudJ. For each group on each time point 4-6 mice were used. 
Mice were sacrificed by carbon dioxide inhalation and blood was taken immediately by 
cardiac puncture. Spleens, livers, and inguinal lymph nodes were aseptically removed and 
single cell suspensions were prepared by using sterile 70-µm-mesh-size cell strainers 
(Falcon). Cells were pelleted by centrifugation for 10 min and were lysed in distilled water. 
The bacterial number per organ was determined bacteriologically by plating serial dilutions.  
 
Western Blot analysis. To analyze the expression of PNPase in wild-type S. enterica 
serovar Typhimurium strains and PNPase mutants total bacterial extracts were prepared 
by lysing the bacteria in Laemmli's sample buffer (62.5 mM Tris/HCl (pH 6.8), 2% SDS, 
10% glycerol, 5% b-mercaptoethanol). The proteins were separated by SDS PAGE on an 
11% Lugtenberg polyacrylamide gel (14) and were blotted onto nitrocellulose. Western 
blots were assayed using 1:5,000 polyclonal rabbit serum to PNPase (a kind gift from Dr. 
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Mikael Rhen, Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, 
Sweden). 
 
Statistics. Statistical analysis was performed using Mann-Whitney rank order tests or 





Isolation and selection of S. enterica serovar Typhimurium mutants that are 
hypersusceptible to superoxide. A total of 165 independently isolated mutants were 
selected from the series of M9 plates supplemented with 0, 0.25, or 0.5 mg/ml menadione. 
The superoxide sensitivity of the mutants was confirmed by disc diffusion assay. Diameters 
of bacterial-free zones were determined and four mutants were shown to be extremely 
sensitive to superoxide (Table 2) (bacteria free zone ≥35 mm). These four strains were 
selected for further research. First, the number of bacteria in RAW264.7 macrophages 
after 24 h was determined as described in Materials and Methods. Only one of the four 
mutants was able to reach bacterial numbers comparable to those of the wild-type (Figure 
1), whereas the other three were attenuated. One strain, AVD101, did not show any net 
replication over 24 h and was selected for further analysis. By sequence analysis of the 
inverse PCR product, it was shown that the MudJ transposon had inserted in the promotor 
region of pnp, the gene encoding polynucleotide phosphorylase (PNPase) (Fig. 2).   
 
 
Table 2. Analysis of susceptibility to menadione by disk diffusion assay 







(100 µg)  
14028s 27 26 26 
AVD101 35 32 36 
AVD102 40 34 38 
AVD103 35 28 30 
AVD104 37 nd
a nd 
a nd, not determined 
 
 
In vitro growth of 14028s pnp::MudJ in RAW264.7 macrophages. AVD101 was 
taken up by the macrophages to the same extent as the wild-type strain (i.e. ±2.5 × 104 
CFU) and bacterial numbers remained as high as those of the wild-type strain at 3 h after 
infection. However, after 24 h, the wild-type strain had grown out reaching bacterial 
numbers up to 3.6 × 105 CFU, whereas AVD101 only reached 1.5 × 105 CFU (Fig. 3A). We 
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compared our wild-type and pnp::MudJ mutant with the MC1 (wild-type strain) and MC71 
(a known PNPase-/-  derivative) strains described by Clements et al. (3). The wild-type 
strain MC1 was able to grow out within 24 h reaching higher numbers that 14028s. The 
number of intracellular bacteria  was lower for the PNPase mutant MC71 compared to the 








Figure 1. Number of intracellular bacteria in 
RAW264.7 murine macrophage-like cells infected with 
wild-type S. enterica serovar Typhimurium 14028s 
(white bar) and the superoxide hypersusceptible 
mutants AVD101 (black bar), AVD102 (dashed bar), 
AVD103 (checkered bar), and AVD104 (dotted bar). At 
24 h after infection of the cells the numbers of 





Western Blot analysis to determine PNP expression. Expression of PNPase in our 
mutant AVD101 was analyzed by Western Blot analysis on total cell lysates of overnight 
LB broth cultures of wild-type and AVD101 and polyclonal rabbit serum raised to PNPase. 
As control we included strain MC1 expressing wild-type PNPase and MC71 a strain that 
expresses a truncated and non-functional PNPase. MC1 and 14028s express wild-type 
PNPase and MC71 the truncated PNPase as described  (3) (Fig. 3B). AVD101, however, 










Figure 2. Position of the MudJ transposon in the genome of S. enterica serovar Typhimurium. The MudJ 





















































Figure 3. Intracellular S. enterica serovar Typhimurium in RAW264.7 mouse macrophage-like cells at 0, 3, 
and 24 h after infection (A) and expression of PNPase in a total extract (B) of S. enterica serovar Typhimurium 
14028s (white bars, wild-type), AVD101 (black bars, 14028s pnp::MudJ), MC1 (white bars with black dots, wild-
type), MC71 (black bars with white dots, truncated PNPase). Asterisks indicate that the number of intracellular 
bacteria is significantly different from that of the parental wild-type S. enterica serovar Typhimurium strains. Two 
asterisks indicate P<0.005 and one asterisk P<0.05.  
 
 
In vivo virulence of 14028s and AVD101 in Salmonella-resistant C3H/HeN mice.  
Because the superoxide hypersusceptible mutant AVD101 appeared to be avirulent in 
RAW64.7 macrophages, we next assayed the in vivo virulence in Salmonella-resistant 
C3H/HeN mice (Ityr). Mice were infected subcutaneously in the flanks as described (20). 
AVD101-infected mice showed a strong reduction in body weight after day 6 (Fig. 4A) 
starting to be statistically significant different from those mice infected with the wild-type 
strain on day 9 (Fig. 4A). Also, AVD101-infected mice showed signs of illness like ruffled 
fur and malaise on day 7 while the wild-type-infected mice still appeared healthy. The 
increase in liver and spleen weight was similar for 14028s and AVD101 infected mice (Fig. 
4B and 4C). All the mice showed a moderate increase in the number of bacteria in the 
inguinal lymph nodes (Fig. 4D) and no statistically significant differences could be 
observed between the two groups of mice. In the livers and spleens on the other hand, 
there was a large increase in bacterial numbers in both groups (Fig. 4E and 4F). The 
number of AVD101 was significantly higher than those of the wild-type strain on day 5 and 
remained increased as compared to the wild-type up to day 12, although at that timepoint 
the difference was no longer statistically significant. Thus, mutant AVD101 appeared to be 
at even more capable of replication than wild-type S. enterica serovar Typhimurium 14028s 
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Figure 4. Total body weight (A), induced pathology in the spleen (B) and liver (C), number of bacteria in the 
inguinal lymph nodes (D), liver (E), and spleen (F), and intracellular number of bacteria in the spleen (G). Mice were 
injected subcutaneously in the flanks with 3 × 104 CFU of 14028s (white dots and white bars), AVD101 (black 
squares and black bars). At the indicated time points, livers, spleens, and lymph nodes were aseptically removed and 
weighed. The viable counts within the organs were determined by making lysates and plating serial dilutions of the 
lysates, and are expressed as log10 viable counts (means ± standard errors of the means). Averages from 4-6 mice 
per time point and per group are shown. Asterisks indicate statistically significant differences of AVD101 compared to 
the wild-type 14028s-infected mice (Student's t test) and the gray dashed lines represent the detection limit of the 
microbiological method (50 CFU for the livers and 30 CFU for the spleens and lymph nodes). 
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The main findings of this study are that AVD101, a mutant lacking the expression of 
cold-shock-associated exoribonuclease polynucleotide phosphorylase (PNPase) due to 
MudJ transposon insertion into the promotor region of pnp, displays hypersusceptibility to 
superoxide in vitro, is attenuated after ingestion by macrophages in vitro, yet appears at 
least as or even more virulent than the wild-type strain in C3H/HeN (Ityr) mice. Western 
blot analysis revealed that this mutant AVD101 showed no expression of the protein 
PNPase and therefore can be considered a PNPase knock-out strain.  
Because the MudJ transposon had inserted into the promotor region of pnp, the MudJ 
transposon could have influenced the expression of pnp in two ways. The insertion might 
lead to a complete lack of pnp expression resulting in the absence of the protein PNPase. 
In addition, it might have a polar effect on the genes that are directly down-stream of pnp 
and that could have been affected by the MudJ transposon as well. By Western blot 
analysis it was confirmed that the mutant strain AVD101 lacks expression of PNPase and 
therefore, lacks phosphorylytic exoribonuclease activity. This means that our mutant 
should behave like the mutant MC71 described by Clements et al. which expresses a non-
functional truncated PNPase, shows an increased intracellular replication rate, and is able 
to cause persistent infection in BALB/c mice (3). However, whereas our mutant AVD101 
was not able to grow out as much as the wild-type strain in RAW264.7 macrophages, it 
was shown previously that  MC71 showed increased intracellular growth (3). Increased 
intracellular growth could lead to increased cytotoxicity and cell lysis, and reduced 
intracellular bacterial numbers due to cell loss which might be interpreted as attenuation. 
For AVD101, however, the in vitro attenuation of AVD101 could not be explained by 
increased cytotoxicity and increased cell-loss since the in vitro challenged cells were intact 
after 24 h and the induced cytotoxicity was similar to that induced by the parental wild-type 
strain (data not shown). Therefore, we concluded that this strain lacks the ability to 
replicate within RAW264.7 macrophages. Strikingly, this mutant was more virulent in vivo 
upon subcutaneous infection of C3H/HeN mice. This is based on the observation that the 
bacterial numbers were higher in the livers and spleens of AVD101 infected mice. Most 
strikingly and opposite to mice injected with wild-type S. enterica serovar Typhimurium, 
these mice showed weight loss on day 6 to 12 after infection (Fig. 5A). 
The question was what could be the mechanism explaining the diverse phenotype of 
the AVD101 strain. PNPase belongs to the family of the exoribonucleases (2) and in E. coli 
has been shown to be involved in adaptation to growth at low temperatures by degrading 
mRNA that encode cold shock proteins thereby allowing resumption of bacterial growth 
(23). The gene pnp in S. enterica serovar Typhimurium is homologous to the gene in E. 
coli and a mutant expressing a truncated and non-functional form of PNPase shows a 
restricted cold adaptation response as seen for E. coli mutants deficient in PNPase (3, 23). 
S. enterica serovar Typhimurium contains two important gene clusters in localized regions 
of the chromosome that are involved in the invasion of and survival within phagocytes. 
These regions are called Salmonella pathogenicity islands (SPI-1 and SPI-2) and they 
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contain several genes that are involved in the delivery of virulence proteins into the host 
cell (9, 15). The action of the proteins encoded by these genes leads to the uptake of the 
bacteria by epithelial cells and to intracellular survival and replication within macrophages, 
respectively. Recently, it has been shown that PNPase in S. enterica serovar Typhimurium 
is involved in the global regulation of the expression of genes encoded by SPI1 and SPI2 
(3). MC71, the mutant lacking functional PNPase showed increased mRNA levels coded 
by genes of SPI1 and SPI2 leading to increased bacterial replication rates in mice and 
murine macrophages (3). Our mutant AVD101 lacks the expression of PNPase and 
resembles the MC71 mutant. It is therefore most likely that mRNA levels coded by SPI1 
and SPI2 are increased in this mutant as well which could help explaining the increased in 
vivo virulence. In contrast to the MC71 mutant, the AVD101 mutant showed reduced 
intracellular survival within RAW264.7 macrophages that could not be explained by an 
increase in induced cytotoxicity as one would expect when bacteria show strongly 
increased intracellular growth as observed for the MC71 mutant (3). A possible explanation 
for the in vitro attenuation of AVD101 could be the extremely increased susceptibility to 
superoxide (Table 2). Superoxide plays a very important role in the host defense against S. 
enterica serovar Typhimurium as is shown by the susceptibility to infection of mice deficient 
in a functional superoxide generating NADPH oxidase system (16). Salmonella, on the 
other hand, has developed mechanisms to resist such killing by superoxide. It has been 
shown previously that the type III secretion system encoded by SPI2 is essential in this 
defense, as mutants deficient in one of these systems show reduced survival within 
macrophages (10, 22) but regain virulence in cells that cannot produce any superoxide 
(22). Expression of SPI2 genes needs to be regulated to allow the bacteria to survive and 
replicate intracellularly. Defects in functional PNPase resulted in increased levels of mRNA 
of SPI2 encoded genes and suggested a role for PNPase in SPI2 gene regulation (3). This, 
together with the role of SPI2-encoded genes in superoxide defense, suggests that the 
relatively decreased in vitro intracellular survival of AVD101 and MC71 compared to wild-
type despite the increased growth rate (3) is due to the increased susceptibility to 
superoxide. This suggests a role for PNPase in superoxide resistance and thus for survival 
within macrophages.  
The reason why the PNPase mutants display increased in vivo virulence might be 
explained by increased uptake of the bacteria since most of the mRNA regulated by 
PNPase are coded by genes of SPI1 and encode proteins involved in invasion of 
phagocytic as well as non-phagocytic cells. The pnp mutant might have ended up in a 
different compartment within the host allowing the bacterium to survive and replicate, and 
resulting in increased virulence. Based on these data, one would expect that the PNPase 
mutant invades the non-phagocytic cells at a higher rate than the wild-type strain and if it 
also displays increased intracellular growth within these non-phagocytic cells as it did in 
vitro within macrophages, then this would explain the enhanced in vivo virulence since 
these non-phagocytic cells are not equipped with the superoxide producing NADPH 
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One of the early host defense mechanisms against microorganisms like Salmonella 
enterica serovar Typhimurium is the production of superoxide radicals and derivatives (4, 
8). Salmonella, however, has developed mechanisms to resist this killing mechanism by 
preventing the production of these toxic compounds or by neutralizing the oxidants. A 
range of genes necessary for bacterial survival during oxidative stress has been identified 
but the exact role of many of these genes in survival of Salmonella within macrophages is 
still not completely understood. 
We have generated S. enterica serovar Typhimurium mutants by random MudJ 
transposon insertion and selected for those strains with increased susceptibility to redox 
cycling agents that release superoxide intracellularly and next tested these strains for their 
ability to replicate intracellularly within RAW264.7 macrophages. By inverse PCR we 
determined the position in the genome where the MudJ transposon had inserted. 
Combining the data from several mutants might yield insight into the survival mechanisms 
of S. enterica serovar Typhimurium during superoxide stress encountered outside and 
within macrophages. 
We have isolated 24 mutants that displayed hypersusceptibility to menadione. Of 
these 13 mutants retained full virulence, whereas 11 mutants were attenuated in vitro in 
macrophages. We have also isolated 6 mutants that were less susceptible to menadione 
than the wild-type strain and 4 were attenuated in vitro. We concluded that the fate of 
replication within macrophages cannot be predicted on the basis of the in vitro 
susceptibility to the redox cycling agent releasing intracellular superoxide, as some of the 
superoxide-susceptible mutants appeared to be just as or even more virulent than the wild-
type while in the group of superoxide-resistant strains four out of six mutants displayed an 
attenuated in vitro phenotype. Still, mutational analysis should be helpful to predict the in 
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Introduction 
 
 Research on mutant strains of Salmonella has led to the identification of a number of 
genes that are necessary for bacterial survival during oxidative stress but the exact 
contribution of many of these genes for survival of the bacteria within macrophages is still 
poorly understood (reviewed in (3)). To gain insight into strategies that are used by 
Salmonella to resist superoxide stress and to survive and replicate within macrophages, 
we generated S. enterica serovar Typhimurium mutants by random MudJ transposon 
insertion and selected for strains with increased susceptibility or resistance to superoxide. 
These strains were tested for their ability to replicate intracellularly within RAW264.7 
macrophages and by inverse PCR we determined the position in the genome where the 
MudJ transposon had been inserted. 
 
 
Materials and Methods 
 
Cells and culture conditions. RAW264.7 were grown in RPMI 1640 medium 
supplemented with 2 mM glutamine, 10% fetal bovine serum, penicillin (100 units/ml), and 
streptomycin (50 µg/ml) at 37ºC and 5% CO2.  
 
Bacterial strains. The bacterial strain used in this study is S. enterica serovar 
Typhimurium 14028s (ATCC). Single colonies of the different strains were grown in Luria-
Bertani (LB) medium (10 mg of tryptone, 5 mg of yeast extract, and 10 mg of NaCl/ml) at 
37°C while being shaken (225 rpm).  
 
Generation and isolation of S. enterica serovar Typhimurium mutants. Mutants 
were generated by random P22 MudJ transposon insertion in 14028s and selected for 
superoxide sensitivity by streaking single colonies onto series of M9 agar plates containing 
0.5 mg/ml, 0.25 mg/ml, or no menadione (Sigma).  
 
Disk diffusion assay. To determine susceptibility to superoxide, disk diffusion assays 
were performed as described by Bauer et al. (2). Briefly, overnight cultures of Salmonellae 
were spread on M9 plates. A cotton disk containing 30 mmol menadione was placed in the 
center. After overnight incubation at 37oC the diameter of the bacterium-free zone was 
determined (mm) as a measure for susceptibility. 
 
Inverse PCR. To identify the gene in which the MudJ transposon had inserted, the 
DNA flanking the left end of the transposon was amplified and sequenced by inverse PCR 
using primers: 5'-CCGGGAGGACATTGGATTAT-3' (sense) and 5'-
CGTACTTCAAGTGAATCAATAC-3' (antisense). The PCR product was purified using the 




Replication within macrophages. RAW264.7 cells (2 × 105) were challenged with S. 
enterica serovar Typhimurium at a 10:1 multiplicity of infection (MOI) as described 
previously (7). At 0 and 24 hours the cells were lysed in 1 ml milliQ and serial dilutions 
were made to determine the number of intracellular CFU.  
 
 
Results and Discussion 
 
By multiple random MudJ transposon insertions in wild-type S. enterica serovar 
Typhimurium 14028s a total of 306 mutants  were selected from the series of M9 plates 
supplemented with 0, 0.25, or 0.5 mg/ml menadione. These mutants were assayed for 
superoxide sensitivity using disk diffusion assays with the redox cycling agent menadione. 
Diameters of bacteria-free zones showed that from the mutants tested, 24 showed an 
increased and six showed a decreased susceptibility to intracellular superoxide induced by 
menadione when compared to the wild-type strain 14028s (Table 1). These mutants were 
selected for further research and were next tested for the ability to survive within 
RAW264.7 macrophages (Fig. 1).  
On the basis of the in vitro susceptibility to intracellular superoxide and in vitro 
replication potential within macrophages the mutants can be divided into four groups: 
susceptible/attenuated (group 1), susceptible/virulent (group 2), more resistant/attenuated 
(group 3), and more resistant/virulent (group 4). For some of the  mutants in each group, 
we identified the gene in which the MudJ transposon had inserted by amplifying and 
sequencing the left flanking DNA by inverse PCR. For reasons at present unknown, we so 
far succeeded in getting inverse PCR products for 9 mutants (Table 1). 
Group 1 consists of 11 mutants of which four (AVD101, MM4, DvD32, and DvD71) are 
extremely attenuated. For mutant MM4 the MudJ transposon had inserted into hycE, the 
gene encoding a protein that is similar to the E. coli large subunit of hydrogenase 3 (part of 
FHL complex) and for mutant DvD71 in ybiT, encoding a putative ATPase component of 
ABC transporter with duplicated ATPase domain. The other 7 mutants (MM11, MM18, 
MKS6.2, DvD46, and DvD66) were moderately attenuated compared to the wild-type 
strain. The position of the MudJ transposon is only known for mutant ND6, MM18 and 
MM11. The phenotype of mutant ND6 is caused by MudJ transposon insertion in pabC, the 
gene encoding PabC, a 4-amino-4-deoxychorismate lyase (ADC lyase) that converts ADC 
into p-aminobenzoate (PABA) which is a precursor of folate and component of folic acid 
(1). Folate cannot be taken up from the environment so endogenous synthesis is essential 
for growth and cell processes. For MM18 the transposon had inserted into nupC, the gene 
that encodes a protein similar to E.coli NUP family nucleoside transport protein. Mutant 
MM11 contains a MudJ transposon insertion in sitC that encodes a fur regulated 
Salmonella iron transporter. SitC is is part of the sit operon encoding an ABC transporter 
that is involved in the transport of a siderophore-iron complex across the inner membrane 
and that is regulated by fur (5). Fur is the regulator of genes involved in the uptake of iron 
from the iron-limiting environment such as within a host. Uptake of iron needs to be tightly 
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regulated since free Fe(II) is toxic to the bacteria as it reacts with hydrogen peroxide in the 
Fenton reaction. Chelation of intracellular iron is a method to protect the bacteria from 
killing by hydrogen peroxide (reviewed in (3)).  
 






in vitro phenotype 
14028s 26 ± 1      Vb 
ND102 36 ± 1  nda V 
ND103 30 ± 1 nd V 
MM3 37 ± 1 yhgE V 
MKS2 34 ± 1 kup V 
MKS6.2 36 ± 1 nd V 
DvD1 29 ± 2 nd V 
DvD50 30 ± 2 ybdM V 
DvD51 31 ± 3 nd V 
DvD54 31 ± 1 nd V 
DvD69 31 ± 1 nd V 
DvD70 32 ± 1 nd V 
M30 34 ± 2 nd V 
MdR2 37 ± 2 nd V 
ND6 32 ± 2 pabC     Ac 
AVD101 31 ± 1 pnp A 
ND104 34 ± 2 nd A 
MM11 31 ± 1 sitC A 
MM18 32 ± 1 nupC A 
MM4 40 ± 1 hycE A 
MKS6.1 40 ± 2 nd A 
DvD32 29 ± 1 nd A 
DvD46 29 ± 2 nd A 
DvD66 29 ± 1 nd A 
DvD71 30 ± 1 ybiT A 
    
ND23 21 ± 1 nd V 
MdR23 19 ± 1 nd V 
ND32 20 ± 1 nd A 
ND34 20 ± 1 nd A 
ND37 20 ± 1 nd A 
ND38 21 ± 1 nd A 












































Figure 1. Number of intracellular bacteria in RAW264.7 murine macrophage-like cells infected with wild-type S. 
enterica serovar typhimurium 14028s and several random MudJ transposon insertion mutants with increased or 
decreased susceptibility to intracellular superoxide induced by menadione. At 0 (A) and 24 h (B) after infection of the 
cells the numbers of intracellular bacteria were determined bacteriologically. Average data ± SEM from 2-6 in vitro 
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Seven strains in group 2 were as virulent as the wild-type (ND103, ND104, MKS2, 
MKS6.2, DvD50, DvD69, MdR2) and six mutants even seemed to be more virulent 
(ND102, DvD1, DvD51, DvD54, DvD70, M30). Of these mutants the MudJ transposon 
position is only known for MKS2 in which kup, encoding a protein similar to E. coli low 
affinity potassium transport system is inactivated and for DvD50 in which the putative 
transcriptional regulator of ybdN (= putative 3'-phosphoadenosine 5'-phosphosulphate 
sulfotransferase (PAPS reductase)/FAD synthetase encoded by ybdM is inactivated. 
Group 3 contains four mutants (ND32, ND34, ND37, and ND38) that are moderately 
attenuated in RAW264.7 macrophages. For neither of these mutants we were able to get 
an inverse PCR product, so the position of the MudJ transposon in the genome is 
unknown. 
Group 4 only consists of two mutants (ND23 and MdR23) that display an in vitro 
phenotype that is comparable to the wild-type strain. As for the mutants of group three no 
inverse PCR products were obtained. 
The main conclusion that can be drawn from the data presented here is that the in 
vitro phenotype cannot be predicted from the in vitro susceptibility to intracellular 
superoxide generated intracellularly by the redox cycling agent menadione. The in vitro 
phenotypes of the selected mutants were all completely different and this strongly suggests 
that factors other than susceptibility to superoxide play a role in in vitro virulence. With 
respect to prediction of virulence in mice, the situation becomes even more complex since 
strain AVD101, as described in Chapter 5, is extremely susceptible to intracellular 
superoxide, is attenuated in macrophages, but is more virulent than the wild-type strain 
upon subcutaneous infection of C3H/HeN mice (6). The genetic defects caused by the 
MudJ transposon insertion leading to increased susceptibility to superoxide also appeared 
to be very diverse and did not directly explain the observed in vitro susceptibility to 
superoxide nor the in vitro intracellular phenotype.  
To be able to predict the in vitro and in vivo phenotype on the basis of the in vitro 
susceptibility to superoxide in the future, more research is needed. Many more mutants 
need to be tested in in vitro infection experiments and for all mutants the inactivated gene 
should be identified. In addition, these mutants need to be tested in vivo as well, since 
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Upon contact with host cells, the intracellular pathogen Salmonella enterica serovar 
Typhimurium promotes its uptake, targeting and survival in intracellular niches. In this 
process, the bacterium evades the microbicidal effector mechanisms of the macrophage, 
including oxygen intermediates. This study reports the phenotypic and genotypic 
characterization of an S. enterica serovar Typhimurium mutant that is hypersusceptible to 
superoxide. The susceptible phenotype is due to a MudJ insertion-inactivation of a 
previously undescribed Salmonella gene designated sspJ that is located between 54.4 and 
64 minutes of the Salmonella chromosome, and encodes a 392 amino acid protein. In vivo, 
upon intraperitoneal injection of 104 to 107 bacteria in C3H/HeN and 101 to 104 bacteria in 
BALB/c mice, the mutant strain was less virulent than the wild type. Consistent with this 
finding, during the first hour after ingestion by macrophage-like J774 and RAW264.7 cells 
in vitro, the intracellular killing of strain sspJ::MudJ is enhanced 5-fold over that of wild-type 
microorganisms. Wild-type Salmonellae displayed significant intracellular replication during 
the first 24 hours after uptake but sspJ::MudJ mutants failed to do so. This phenotype 
could be restored to that of the wild type by sspJ complementation. The SspJ protein is 
found in the cytoplasmic membrane and periplasmic space. Amino acid sequence 
homology analysis did reveal a leader sequence and putative pyrroloquinoline quinone-
binding domains, but no putative protein function. We excluded the possibility that SspJ is 
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Introduction 
 
Intracellular pathogens like Salmonella enterica serovar Typhimurium respond to a 
specific host environment by selectively expressing appropriate factors which favor 
intracellular survival (10, 11, 14). Salmonella species predominantly invade the Peyer’s 
patches and later during infection survive in mononuclear phagocytes. Salmonellae can 
prevent the induction or neutralize the action of antimicrobial effector mechanisms within 
the macrophage and can therefore survive and multiply within phagosomes (5, 10, 11, 14, 
17). The ability of S. enterica serovar Typhimurium to enter and grow within epithelial cells 
and macrophages is essential for its survival, and mutants unable to do so are avirulent 
(9). Several genes involved in the intracellular survival of salmonellae have been identified. 
These genes include members of the phoP/Q regulon and housekeeping genes. In some 
cases, however, the function of the genes has yet to be determined (2); some of these 
genes are also found in Escherichia coli, making their relevance to the intracellular survival 
of salmonellae uncertain (13). 
One of the major macrophage microbicidal effector molecules is reactive oxygen-
intermediates, beginning with the production of superoxide by NADPH-oxidase. Since 
superoxide is a by-product of normal aerobic metabolism, both eukaryotic and prokaryotic 
cells have evolved ways to respond to superoxide stress by the activation of genes 
involved in a protective response (18). In E. coli, the soxR/S regulon is an important 
adaptive defense system against oxidative stress (19), and it is likely that the same holds 
for salmonellae. However, an S. enterica serovar Typhimurium soxS knockout strain is as 
virulent as the wild type, indicating that other systems can counteract the toxic effects of 
superoxide intermediates (8).  
To neutralize superoxide, salmonellae produce four superoxide dismutases (SODs): 
an Fe-SOD, an Mn-SOD and two Cu,Zn-SODs (4, 7). The first two are produced in the 
cytoplasm, and although deletion of these genes increases in vitro susceptibility to 
superoxide generating agents, it does not alter virulence. The periplasmic Cu,Zn-SODs 
however, are important for S. enterica serovar Typhimurium, as mutants carrying mutations 
in both SODs are attenuated (7). Another protein that is necessary for survival under 
oxidative stress is the zwf-encoded glucose-6-phosphate dehydrogenase (G6PDH) (15). 
Recently, it was proposed that salmonellae might evade the NADPH-oxidase activity of 
phagocytes through a mechanism that depends on the function of genes located within 
pathogenicity island-2 (12). This pathogenicity island is notable for containing genes that 
are involved in the translocation of bacterial proteins into the host cell cytoplasm. Taken 
together, these findings indicate that numerous genes scattered over the Salmonella 
chromosome are necessary for combating oxidative stress.  
In this study an S. enterica serovar Typhimurium mutant was identified that is 
hypersusceptible to superoxide due to disruption of a previously undescribed gene, 
designated sspJ (superoxide susceptibility protein). Based on protein sequence homology, 




Materials and Methods 
 
Bacterial strains, media and plasmids. The bacterial strains and plasmids used in 
this study are listed in Table 1. Bacteria were grown in Luria-Bertani (LB) or minimal 
medium (M9) at 37oC. Where required, the medium was supplemented with kanamycin (50 
µg/ml; Sigma) or ampicillin (50 µg/ml; Merck). Disk diffusion assays were performed on M9 
agar plates of standardized volume. 
 
DNA manipulations. Standard manipulations were performed as described by 
Maniatis et al (16). Restriction enzymes and other modifying enzymes were purchased 




Table 1. Salmonella strains and plasmids used in this study 
Strain or plasmid Characteristics Origin or reference 
S. enterica serovar Typhimurium   
ATCC 14028s  wild-type ATCC 
MD36 Resistance to menadione This study 
MD36.12 MudJ insertion in MD36 This study 
DLG294 14028s sspJ::MudJ This study 
DLG294-pWSK29 DLG294 with plasmid This study 
DLG294-pWSK-sspJ DLG294 complemented with sspJ This study 
   
Plasmid   
pWSK29 Low-copy-number plasmid (24) 
pTS175 pWSK29 containing sspJ This study 
pBluescript SK- Stratagene 
pTS125 pBluescript containing sspJ This study 
pET19b Prokaryotic expression vector Novagene 
 
 
Selection of superoxide-resistant and superoxide-hypersusceptible Salmonella 
mutants. S. enterica serovar Typhimurium ATCC strain 14028s was used as the parental 
strain to isolate mutants that displayed increased resistance against superoxide, by an 
indirect strategy employing menadione and antibiotics as described for the isolation of 
soxR/S mutants in E. coli (5). Wild-type S. enterica serovar Typhimurium was subjected to 
random chemical mutagenesis by exposure to the alkylating agent nitrosoguanidine 
(MNNG). Briefly, late-log-phase S. enterica serovar Typhimurium was washed and 
exposed to MNNG (0.1 mg/ml) in citrate buffer for 90 minutes at 37°C. Next, the mutagen 
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was removed by spinning and washing the bacteria, followed by recovery in LB. Bacteria 
were plated on M9 supplemented with menadione in concentrations varying from 0.05 to 
1.5 mg/ml. A concentration of 0.5 mg/ml menadione in M9 plates allowed the growth of 
only a few mutagenized bacteria.  
One of the S. enterica serovar Typhimurium mutants that was resistant to menadione 
was arbitrarily chosen as the recipient of random MudJ insertional mutagenesis. Next, 
kanamycin-resistant colonies were screened for hypersusceptibility to menadione. One 
hypersusceptible mutant was taken for further analysis. P22 transduction was carried out 
to backcross the hypersusceptible phenotype into wild-type salmonellae, resulting in a 
kanamycin-resistant (MudJ) menadione-hypersusceptible strain. 
 
Disk diffusion assay. To measure resistance against superoxide and antibiotics, disk 
diffusion assays were performed as described by Bauer et al. (1). Briefly, overnight and 
end-log-phase LB cultures of salmonellae were 1:10 diluted in phosphate-buffered saline 
(PBS) and spread on M9 plates. A cotton disk containing antibiotics (gentamicin, 100 µg; 
chloramphenicol, 30 µg) or redox cycling agents (menadione, 30 mmol; paraquat, 7.5 mg) 
was placed in the center. After overnight incubation at 37oC the diameter of the bacterium-
free zone was determined (mm) as a measure for resistance. 
 
Mice and mortality of infection. Salmonella-resistant (Ityr) C3H/HeN and 
Salmonella-susceptible (Itys) BALB/c female mice were injected intraperitoneally with 104 to 
107 (C3H/HeN) or 101 to 104 bacteria (BALB/c) and the course of infection followed (20). 
To this end, overnight bacterial cultures were pelleted, washed, and resuspended in PBS 
prior to intraperitoneal injection in 0.1 ml. The endpoints were percent mortality and the 
time to death. 
 
Intracellular killing of salmonellae. Early killing of Salmonella by J774 or 
persistence of salmonellae in RAW264.7 macrophage-like cells was determined as follows 
(20). Cells were allowed to adhere to plastic wells at a density of 105 cells/well during 
overnight incubation at 37oC in RPMI medium containing 10% (vol/vol) fetal calf serum. 
Bacteria grown overnight in LB were added to the wells at a macrophage-to-bacteria ratio 
of 1:10, and centrifuged (10 min at 1,200 rpm) onto the cells. Bacterial endocytosis was 
allowed to proceed for 30 min, and after three washes with PBS, the cells were 
reincubated at 37oC and 5% CO2 in medium containing gentamicin.  
For measurement of early killing by J774-cells, cells were lysed by water at 0, 1, and 2 
h of incubation, starting immediately after the washing procedure. To determine 
persistence in RAW264.7 cells, gentamicin was added (100 µg/ml) for 1 h to kill any 
remaining extracellular bacteria. After washing, the cells were again incubated in medium 
containing gentamicin (10 µg/ml) for determination of persistence after 0, 3 and 24 h. The 
survival of intracellular bacteria over time was determined by plate counts following the 
removal of medium and hypotonic lysis of cells. Statistical analysis was done using 
Student’s t test. 
Chapter 6 
112 
Mapping of MudJ insertion. To map the MudJ insertion, an F’::Mud-P22 insertion 
was transduced into DLG294, with selection for the donor Cmr marker, and next screened 
for homologous recombination by monitoring the loss of the Kmr marker of MudJ, as 
described by Youderian et al (22). Mitomycin C-induced Mud-P22 lysates were mixed with 
tails obtained in strain PY 13579, and used for transduction of auxotrophic recipient strains 
with characterized deletions (at 0, 7, 23, 33, 42, 49, 62, 72, 83 and 89 minutes of the 
Salmonella chromosome, respectively; kindly provided by Stan Malloy). Following the 
identification of the gross location of the MudJ insertion-inactivated gene, Southern blots 
were obtained using the collection of 57 Mud-P22 lysates as a source of DNA (3) and the 
MudJ-inactivated gene as the DNA probe. 
 
Identification of the gene inactivated by the MudJ transposon. MudJ-flanking 
DNA was cloned by inverse PCR using the following primers: 5'-
GTCGTTTACGCGTTGGCGTATAATGG-3' and 5'-GCTTTACCACAACCGGCGT 
GGT-3’ (2). The PCR product was cloned into the EcoRV site of pBluescript SK- 
(Stratagene) and sequenced using Amersham T7 sequence kit. A homologous gene of E. 
coli (ORF 392, coding for a protein of unknown function) was used to design a second set 
of primers for the isolation and sequencing of the whole ORF in S.enterica serovar 
Typhimurium (5’-CATCTAGAGGGACCCGATGC-3’ and 5’-
AACTCGAGTTTTCCTACGTTAGGGCG-3’). 
 
Isolation of recombinant SspJ and preparation of rabbit hyper-immune serum. 
The MudJ-inactivated gene was sub-cloned in pEt-19b, and the protein was expressed as 
fusion protein containing 10 histidine residues plus a 13-amino-acid linker attached to its N-
terminus. Overproduction was achieved in E. coli BL21, in which the T7 RNA polymerase 
is put under the control of the lac promotor. At an optical density at 600 nm (OD600) of 0.6, 
overproduction was induced with 1 mM IPTG (isopropylthiogalactopyranoside). After 5 h, 
bacteria were collected by centrifugation and the pellet was washed with 50 mM sodium 
phosphate (pH 8) and 300 mM NaCl. Pellets were stored at −20°C until purification affinity 
chromatography, according to the manufacturer’s recommendations (Qiagen, Chatsworth, 
CA). The protein was purified to >99% homogeneity (based on sodium dodecyl sulfate-
polyacrylamide gel electrophoresis), and rabbit hyperimmune serum was obtained 
following weekly intramuscular injection of the protein in Freund’s incomplete adjuvant into 
2 New Zealand rabbits. 
 
Expression of SspJ in bacterial cell extracts. To show expression of SspJ in wild-
type salmonellae and absence in DLG294, total bacterial extracts were prepared and 
tested in a Western blot. To investigate whether SspJ is released from S. enterica serovar  
Typhimurium, the supernatants of end-log-phase liquid cultures were collected, and the 
proteins were concentrated by protein A-coated beads (Pharmacia), and assayed in a 
Western blot. To check for lysis of bacterial cells that could have caused the release of 
cytoplasmic proteins into the liquid cultures, Western blots were assayed with antiserum 
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raised against a nucleoid protein of salmonellae (Tahar van der Straaten, unpublished 
data). 
 
Scavenging of xanthine oxidase-mediated superoxide production. Superoxide 
was generated in vitro using xanthine-oxidase (Sigma). Inhibition of superoxide formation 
was determined by using Stratagene’s Lumimax kit. To a tube containing 2 µl of xanthine-
oxidase (5 U/µl), 5 µl of 4 mM luminol and 93 µl of xanthine assay medium, 40 µl of various 
Salmonella strain lysates was added. Immediately prior to measuring the relative light units 
(RLU) by a luminometer, 50 µM xanthine in 100 µl of xanthine assay medium was added. 
The RLU were measured at 10-s intervals. 
 
SOD activity of bacterial lysates. In order to determine whether lysates of S. 
enterica serovar Typhimurium wild-type bacteria have a higher SOD activity than the 
superoxide-sensitive mutant, bacterial lysates were run on a native 11% protein gel which 
was stained by Nitro Blue Tetrazolium (NBT), resulting in nonstained bands when SOD is 
active. The bacterial lysates were loaded on the protein gel; the gel was rinsed with water 
and incubated in 1-mg/ml NBT for 20 min. After washing the gel with water, the gel was 
incubated for 20 min in a solution consisting of 10 ml of 50 mM TEMED (N,N,N’N’-





Isolation of S. enterica serovar Typhimurium mutants that display 
hypersusceptibility to superoxide. Following mutagenesis of S. enterica serovar 
Typhimurium, 53 mutants were obtained from M9 plates containing 0.5 mg/ml menadione. 
These mutants were assayed twice for increased resistance against menadione. One of 
the menadione-resistant Salmonella mutants, designated MD36, was selected for analysis. 
MD36 was more resistant to the redox cycling agents menadione and paraquat compared 
to the parental strain, and less susceptible to antibiotics with disparate mechanisms of 
action (Table 2). MD36 was chosen to be the recipient of random MudJ insertions, and the 
resultant library was screened for mutants with a reverse phenotype, i.e., 
hypersusceptibility to menadione. Out of about 50,000 kanamycin-resistant colonies, one 
hypersusceptible mutant strain, designated MD36.12, was isolated and used for further 
analysis. The phenotype was repeatedly backcrossed into wild-type salmonellae using 
phage P22 transduction. Clearing of phage resulted in strain DLG294, which still exhibited 








Table 2. Susceptibility of Salmonella strains to oxidants and antibiotics 
in disk diffusion assay 









14028s 30 ± 3 24 ± 4 27 ± 2 28 ± 1 
MD36 23 ± 2 39 ± 3 19 ± 2 28 ± 1 
MD36.12 34 ± 3 39 ± 4 30 ± 3 29 ± 1 
DLG294 41 ± 3 25 ± 4 31 ± 3 28 ± 1 
DLG294-pTS175 31 ± 4  nda nd 29 ± 1 
DLG294-pWSK29 41 ± 3 nd nd 28 ± 1 
a nd, not determined     
 
 
Mortality of Salmonella infection in resistant and susceptible mice. To investigate 
whether the gene that was inactivated by the MudJ insertion and rendered DLG294 
hypersusceptible to superoxide is relevant for the in vivo virulence of salmonellae, BALB/c 
and C3H/HeN mice were injected intraperitoneally with various numbers of DLG294 or the 
parental S. enterica serovar Typhimurium. DLG294 was less virulent than wild-type 
bacteria: in both strains of mice, about a 100-fold higher number of DLG294 than of wild-
type bacteria was necessary to reach a similar mortality and time to death (Table 3a and 
3b).  
Of note, the rate of growth of DLG294 was identical to that of wild-type salmonellae 
when cultured in rich LB or minimal M9 liquid medium at 37o C under vigorous shaking 
(data not shown).  
 
 
Table 3a. Mortality in C3H/HeN and BALB/c mice 
No. of mice dead/no. tested at inoculum Mouse and 
Salmonella strains 101 102 103 104 105 106 107 
C3H/HeN 
       
14028s    3/3 3/3 3/3 3/3 
DLG294    0/3 1/3 2/3 3/3 
BALB/c 
       
14028s 4/4 4/4  nda nd    
DLG294 1/4 4/4 nd nd    
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Table 3b. Time to death in C3H/HeN and BALB/c mice 
Median time to death (h) at inoculum Mouse and 
Salmonella strains 101 102 103 104 105 106 107 
C3H/HeN        
14028s    216 144 84 48 
DLG294    ---a --- 168 48 
BALB/c 
       
14028s 154 120  ndb nd    
DLG294 --- --- 132 96    
a ---, less than 50% of the mice died 
b nd, not done 
     
 
 
In vitro intracellular killing of salmonellae by macrophages. To investigate 
whether the gene that was inactivated by the MudJ insertion and rendered DLG294 
hypersusceptible to superoxide is involved in bacterial resistance against the microbicidal 
effector mechanism of mononuclear phagocytes, the intracellular killing of DLG294 and 
wild-type S. enterica serovar Typhimurium 14028s by macrophage-like J774 and 
RAW264.7 cells was determined. During the first hours after uptake by J774 cells, the 
number of intracellular microorganisms (range 1.4 × 105 to 4.6 × 105 bacteria per 5 × 105 
J774-cells) decreased exponentially (Fig. 1A). However, DLG294 was killed by J774 cells 
at twofold higher killing rates (killing rate, 0.031 ± 0.011/min; n = 3) than wild-type 
salmonellae (killing rate 0.014 ± 0.008/min; n = 3; P < 0.025). After 2 h, this difference in 
intracellular killing resulted in a 10-fold-lower number of intracellular DLG294 than for the 
wild type. Also in RAW264.7 cells, DLG294 was more easily contained than the parental 
strain: whereas the wild-type salmonellae replicated within RAW264.7 cells upon 
incubation over 24 h, DLG294 was unable to do so (Fig. 1B). To check for the ability of the 
cell lines to produce superoxide, NBT reduction was used as a measure of superoxide 
production. Both J774 and RAW264.7 were shown to produce superoxide during the 
uptake of inert particles and phorbol myristate acetate stimulation (data not shown). 
Taken together, the in vivo and in vitro findings reveal a biologically relevant 
attenuation of virulence of DLG294 compared with that of parental, wild-type S. 

























Figure 1. In vitro intracellular killing of DLG294 (ssp::MudJ; open circles) and wild-type S. enterica serovar 
Typhimurium 14028s (solid circles) by J774 macrophage-like cells (A). After uptake of the bacteria and removal of 
remaining extracellular microorganisms, at various time points the number of viable intracellular bacteria was 
determined microbiologically as a measure of intracellular killing, and expressed as percent viable intracellular 
bacteria left compared with the number present at the end of the uptake period. Data from a representative 
experiment are shown. After uptake by RAW264.7 cells (B), the changes in the number of intracellular wild-type S. 
enterica serovar Typhimurium 14028s (open bars), DLG294-pWSK29 (hatched bars) and DLG294- pTS175 (black 
bars) were determined at 0, 3, and 24 hours after infection. Data are the mean of three independently performed 
experiments. Asterisks indicate significant differences (p < 0.05). 
 
 
Mapping of the MudJ insertion. Starting with transduction of MudJ in DLG294, 
multiple Mud-P22 Q but no Mud-P22 P Cmr and Kms convertants were obtained . Three 
different Mud-P22 Q lysates reverted the auxotrophic phenotype of MST 10 (mutation at 49 
min) at very high efficiency (i.e. between 107 to 108 recombinants obtained; n = 3), that of 
MST 8 (mutation at 42 min) at moderate efficiency (i.e. 105 to 106; n = 3), and the other 
eight strains at low efficiency (less than 103 recombinants; n = 3). Thus, consistent with the 
counterclockwise packaging of the Mud-P22 Q lysate, these findings indicate that the MudJ 
in DLG294 had inserted between 62 and 49 minutes of the Salmonella chromosome.  
The exact location of the MudJ-inactivated gene of DLG294 was determined using a 
collection of 57 Mud-P22 lysates as the source of DNA. Hybridization with the MudJ-
inactivated gene as the DNA probe revealed positive spots on Mud-P22 lysates 
guaA5641::MudQ and purG2149::MudQ, indicating that the MudJ-inactivated gene lies 







Figure 2. Schematic drawing of homologous domains within SspJ protein, 392 aminoacids. Depicted are a 
leader sequence from amino acids 1 to 22, lipid membrane attachment site from amino acids 10 to 21, and four PQQ 
domains from amino acids 70 to 107, 120 to 157, 160 to 197 and 256 to 293. 
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Identification of the gene or gene cluster inactivated by the MudJ insertion. By 
inverse PCR, part of the gene in which the MudJ had inserted was cloned and sequenced. 
A database search revealed homology with ORF392 of E. coli (a gene of unknown 
function, accession number: AAC75565). Using primers based on this homologous 
sequence, the whole ORF was cloned and sequenced from S. enterica serovar 
Typhimurium. The sequence was determined in DLG294 as well as wild-type S. enterica 
serovar Typhimurium and has been deposited in the NCBI database (accession number 
AF314961). The sequence revealed an open reading frame of 1,176 bp, encoding a 392-
amino-acid protein with a predicted mass of 42.3 kDa. The gene was designated sspJ for 
superoxide susceptibility protein. Based on the predicted amino acid sequence from sspJ, 
a sequence homology search revealed the presence of a leader sequence and four 
putative pyrroloquinoline quinone (PQQ) domains thought to be specific for bacterial 
dehydrogenases (Fig.2) (6).  
 
Complementation of the superoxide hypersensitive phenotype. After identification 
of the gene in which the MudJ transposon was inserted, the gene was isolated by PCR and 
ligated into low-copy-number plasmid pWSK29 (21). Complementation of DLG294 was 
achieved by electroporation with pTS175. Disk diffusion assays using complemented 
DLG294 (expressing the low-copy-number plasmid pWSK29 carrying an intact copy of 
sspJ) resulted in reversal of the menadione-hypersusceptible phenotype of DLG294 into 
wild-type susceptibility (Table 2). 
Persistence in RAW264.7 was also restored to the wild type when SspJ was 
expressed on a low-copy-number plasmid in mutant DLG294. Transformation with the 
vector only did not affect the intracellular fate of DLG294 (Fig. 1B). 
 
Identification of SspJ in Salmonella cell extract and culture supernatant. A 
Western blot using rabbit hyperimmune serum raised against purified SspJ revealed a 
protein of the predicted size in a total cell lysate of wild-type salmonellae. Since the protein 
has a signal sequence, it is probably present in the periplasm. There was a total absence 
of this protein in DLG294, and it was overexpressed constitutively in DLG294 carrying an 
SspJ-encoding multicopy plasmid (Fig. 3). Furthermore, the protein was identified in 
supernatant of end log-phase growth liquid cultures of wild-type Salmonella and DLG294 
carrying an SspJ-encoding multicopy plasmid, but not in DLG294 (Fig. 3).  
An antiserum raised against a Salmonella DNA-binding protein was used to check for 
nonspecific bacterial cell lysis. This protein could not be detected in the same culture 
supernatants. In addition, several stress conditions (pH5 to 9, osmolarity of 0.15 to 1.0 M 
NaCl, superoxide at 10 mM, and temperature of 30 to 42º) did not affect expression of 
















Figure 3. Expression of SspJ by 
Salmonella strains. Panel A shows expression of 
SspJ in a total extract of S. enterica serovar 
Typhimurium (wild type) and in 
DLG294(sspJ::MudJ) complemented by plasmid 
pBluescript carrying sspJ (DLG294-pTS125)) 
(lanes 1 and 3, respectively), but not in DLG294 
(sspJ::MudJ) (lane 2). Panel B shows expression 
SspJ in culture supernatants, whereas panel C 
indicates that there is no expression of a 
cytoplasmic control protein. The first lane in all 
three panels is purified protein together with 




SspJ is not a superoxide scavenger. To determine whether DLG294 is less able to 
inhibit superoxide production or scavenge superoxide, supernatants of overnight cultures 
of Salmonella wild-type, DLG294 and DLG294- pTS175 were assayed for presence of 
such activity in a xanthine oxidase assay. Addition of 10 units of SOD to xanthine oxidase 
decreased the amount of superoxide generated by almost 100% within 10 s. The addition 
of DLG294 supernatant to xanthine oxidase decreased the amount of superoxide 
generated by 71% ± 1% (n = 3) of the control, whereas the addition of supernatants from 
the wild type or sspJ-complemented DLG294 did decrease the amount of superoxide 
generated by 63% ± 15% (n = 3) and 70% ± 5%  (n = 3) respectively This result indicate 
that the presence or absence of SspJ does not interfere with the production or scavenging 
of superoxide in this system.  
 
SspJ has no SOD activity. Since disruption of SspJ expression resulted in the 
inability to resist increased intracellular superoxide levels, we tested whether DLG294 
contains less SOD activity than the wild type and sspJ-complemented DLG294. Analysis of 
SOD activity in whole-cell bacterial lysates on non-denaturing gels showed no difference 
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Discussion 
 
Intracellular pathogens like S. enterica serovar Typhimurium are able to respond to the 
specific host environment by selectively expressing factors necessary for intracellular 
survival. Thus, despite the multitude of antimicrobial effector mechanisms of the host cells, 
the bacteria can multiply within spacious phagosomes of the macrophages.  
To identify bacterial proteins that play a role in the ability of salmonellae to prevent the 
induction or neutralize the activity of the antimicrobial effector mechanism of phagocytes, 
we screened for genes of S. enterica serovar Typhimurium involved in bacterial defense 
against superoxide and the ability to survive within mononuclear phagocytes. A mutant of 
S. enterica serovar Typhimurium that was resistant to the redox cycling agent menadione 
was isolated following random chemical mutagenesis of wild-type salmonellae. Next, this 
mutant was used to isolate menadione-hypersusceptible mutants by obtaining random 
MudJ insertions. In this way, a hypersusceptible strain designated MD36.12 was obtained. 
This phenotype was backcrossed into wild-type Salmonella, resulting in DLG294. This 
Salmonella strain was hypersusceptible to menadione compared to wild-type parental 
Salmonella strain 14028s. Complementing the MudJ insertion-inactivated gene in DLG294 
with the gene carried on a low-copy-number plasmid fully restored the phenotype back to 
wild type. 
The biological relevance of the MudJ-inactivated gene was evident from the 
decreased virulence of DLG294 compared to wild-type Salmonella after intraperitoneal 
injection into Salmonella-resistant and Salmonella-susceptible mice, and the enhanced 
intracellular killing of this mutant strain within macrophage-like cells in vitro. Furthermore, 
within cells cultured for 24 h, wild-type salmonellae were able to multiply to about fivefold 
their initial numbers, whereas DLG294 was unable to replicate at all. That the MudJ-
inactivated gene is essential for the survival and replication of S. enterica serovar 
Typhimurium within macrophages was confirmed by the finding that gene complementation 
could restore the wild-type phenotype.  
The MudJ transposon was found inserted in a previously undescribed Salmonella 
locus, designated sspJ (for superoxide susceptibility protein). Using MudP22 probe 
hybridization techniques and linkage analysis, the gene was mapped at 55 to 60 min on 
the Salmonella chromosome. SspJ displayed 78% sequence identity to a putative E. coli 
protein of unknown function that maps at 55.9 min in the xseA-hisS intergenic region. 
Analysis of the protein sequence revealed the presence of a leader, suggesting that SspJ 
is transported to the periplasmic side of the inner cell membrane. This was confirmed by 
the results of the Western blot that revealed a protein of predicted size in the soluble and 
inner membrane fraction of wild-type salmonellae and the total absence of this protein in 
DLG294, as well as overexpression of this protein in DLG294 carrying an sspJ-encoding 
plasmid. Furthermore, the protein was identified in end-log-phase supernatants of wild-type 
Salmonella and DLG294 carrying an sspJ-encoding plasmid, but not in DLG294, 
suggesting that the protein may be released into the medium. 
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The mechanism by which SspJ contributes to protection from oxidative stress remains 
to be elucidated. However, we excluded that it acts as a scavenger of superoxide and, 
although the phenotype of the mutant appear very similar to that of sodC knockouts, that it 
has SOD activity. Based on protein homology analysis, four putative PQQ-binding domains 
are present in SspJ. PQQ domains are thought to be specific for NAD(P)-independent 
bacterial dehydrogenases located in the periplasmic space and bound to the inner cell 
membrane; a location that is consistent with the results for SspJ in the Western blot. 
However, SspJ lacks specific sequence characteristics of bacterial dehydrogenases and a 
hypothesis involving PQQ binding cannot explain our findings that both in rich LB medium 
and in minimal M9 culture medium that lacks PQQ, DLG294 is much more susceptible to 
the redox cycling agent menadione than wild-type salmonellae.  
The homologue of SspJ in E. coli, ORF392, is 91% identical to Salmonella SspJ. It 
also contains the putative leadersequence and the PQQ domains. Based on this 
homology, it could be speculated that the SspJ homologue is functional in E. coli. We are 
currently investigating whether expression of ORF392 in DLG294 can also complement the 
superoxide-sensitive phenotype. The implications of the presence of this gene in E. coli 
however, are difficult to predict, since it is likely that E. coli killing is mediated by 
mechanisms other than oxidative stress, such as complement or low pH. 
Currently we are investigating whether SspJ acts in a regulatory pathway that protects 
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Salmonella enterica serovar Typhimurium is a gram-negative, facultative intracellular 
pathogen that predominantly invades mononuclear phagocytes and is able to establish 
persistent infections. One of the innate defense mechanisms of phagocytic cells is the 
production of reactive oxygen species, including superoxide. S. enterica serovar 
Typhimurium has evolved mechanisms to resist such radicals, and these mechanisms 
could be decisive in its ability to survive and replicate within macrophages. Recently, we 
described a superoxide-hypersusceptible S. enterica serovar Typhimurium mutant strain, 
DLG294, that carries a transposon in sspJ, resulting in the lack of expression of SspJ, 
which is necessary for resistance against superoxide and replication within macrophages. 
Here we show that DLG294, which is a 14028s derivative, hardly induced any 
granulomatous lesions in the livers upon subcutaneous infection of C3H/HeN (Ityr) mice 
with 3 × 104 bacteria and that its bacterial counts were reduced by 3 log units compared to 
those of wild-type S. enterica serovar Typhimurium 14028s on day 5 after infection. In 
contrast, DLG294 replicated like wild-type S. enterica serovar Typhimurium 14028s and 
induced a phenotypically similar liver pathology in p47phox-/- mice, which are deficient in the 
p47phox subunit of the NADPH oxidase complex and which do not produce superoxide. 
Consistent with these results, DLG294 reached bacterial counts identical to those of wild-
type S. enterica serovar Typhimurium 14028s in bone marrow-derived macrophages from 
p47phox-/- mice and in X-CGD PLB-985 cells at 24 h after challenge. These results indicate 
that SspJ plays a role in the bacterium’s resistance to oxidative stress and in the survival 
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Introduction 
 
Salmonella enterica serovar Typhimurium is a gram-negative, facultative intracellular 
pathogen that predominantly invades mononuclear phagocytes and that is able to establish 
persistent infections by evasion or disturbance of the host defense (14). Despite the 
multitude of antimicrobial mechanisms present as part of the innate defense of phagocytic 
cells, S. enterica serovar Typhimurium is able to survive and replicate within phagosomes 
of macrophages. This ability of S. enterica serovar Typhimurium to enter and replicate 
within phagocytic cells is essential for its survival, as mutants unable to do so are avirulent 
(9). Although little is known of the exact mechanisms by which S. enterica serovar 
Typhimurium is able to survive after phagocytosis, S. enterica serovar Typhimurium 
responds to the specific host environment by expressing factors that are necessary for 
intracellular survival and for resistance against the defense systems of the host (5, 10, 11, 
14, 18). 
One of the major early defense mechanisms of macrophages against microorganisms 
is the production of toxic superoxide by the phagocyte NADPH oxidase and the 
subsequent generation of superoxide derivatives, both in vitro (17) and in vivo (22, 23, 27). 
The phagocyte NADPH oxidase is a multiprotein enzyme complex that comprises a 
heterodimeric, membrane-bound, flavocytochrome b558 (composed of a 91-kDa 
glycoprotein and a 22-kDa protein) and four cytosolic factors (p47phox, p67phox, p40phox, and 
Rac GTPase; phox for phagocyte oxidase) that translocate to the plasma membrane upon 
activation to interact with cytochrome b558. This leads to the formation of an active NADPH 
oxidase complex that accepts electrons from NADPH and donates them to molecular 
oxygen, resulting in the generation of superoxide (O2-) (reviewed in (1)). Thus, upon 
stimulation of the phagocyte with opsonized microorganisms or other activating agents, the 
oxygen consumption increases dramatically (respiratory burst) and a large amount of 
superoxide is produced. This superoxide is converted into other, more potent, reactive 
oxygen species such as hydrogen peroxide, hydroxyl radicals, and hypochlorous acid. 
Many microorganisms, including Salmonella, have evolved a multitude of defense 
mechanisms to resist this superoxide-mediated killing by phagocytes. These mechanisms 
include avoidance of encounters with phagocyte-derived oxidants, neutralization of such 
oxidants, or prevention of their production. S. enterica serovar Typhimurium is highly 
dependent on such mechanisms as they help the pathogen to survive within the 
phagosome. Examples of such defense mechanisms used by S. enterica serovar 
Typhimurium include inhibition of protein kinase C activity in macrophages, production of 
antioxidant scavengers, formation of heat shock proteins, and production of superoxide 
dismutase (SOD) (reviewed in (18)) 
More recently, it was shown that S. enterica serovar Typhimurium could also prevent 
reactive oxygen species production by exclusion of NADPH oxidase from the phagosome 
in which Salmonella resides (12). The relative importance of each of these mechanisms for 
S. enterica serovar Typhimurium survival has not been elucidated; however, the 
periplasmic Cu,Zn-SOD and the type III secretion system encoded by Salmonella 
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pathogenicity island 2 (SPI2) are very important in this defense, as mutants deficient in one 
of these systems show reduced survival within macrophages (4, 12, 28).  
We have recently described the isolation of a mutant S. enterica serovar Typhimurium 
strain (DLG294) that showed decreased resistance to oxidative stress induced by 
menadione in vitro, due to the inactivation of a gene designated sspJ (for Salmonella 
superoxide protection) (25). In this report we describe the further investigation of 
superoxide-sensitive mutant strain DLG294 and show that the gene encoding SspJ is 
essential for resistance to oxidative stress and thus for survival and replication of S. 
enterica serovar Typhimurium both in vitro and in vivo.   
 
 
Materials and Methods 
 
Animals. Six- to 8-week-old female Salmonella-resistant (Ityr) C3H/HeN mice and 
Salmonella-sensitive (Itys) C57BL/6 mice were purchased from Harlan (Horst, The 
Netherlands) and Charles River Laboratories, respectively. Mice were maintained under 
standard conditions according to the institutional guidelines. Water and food were given ad 
libitum. Female mice homozygous for a targeted mutation in the p47phox subunit of the 
NADPH oxidase on a C57BL/6 background (p47phox-/-) were generated as described 
previously (13) and obtained from Taconic Laboratory (Germantown, N.Y.). All experiments 
were approved by the local Animal Ethical Committee. 
 
Bacterial strains and plasmids. Single colonies of wild-type S. enterica serovar 
Typhimurium 14028s (50% lethal dose after intraperitoneal injection: 5 × 103 bacteria for 
Ityr mice and <102 for Itys mice) and superoxide-sensitive derivative DLG294 (25) were 
grown overnight in Luria-Bertani (LB) medium (10 mg of tryptone, 5 mg of yeast extract, 
and 10 mg of NaCl/ml) at 37ºC while being shaken (225 rpm). In addition, DLG294 
supplemented with low-copy-number plasmid pWSK29 expressing the sspJ gene, which is 
inactivated in DLG294 (DLG294-pTS175), and with its vector control (DLG294-pWSK29) 
were used (25). These bacteria were grown in LB medium supplemented with 50 µg of 
ampicillin (Merck)/ml. For in vivo infection experiments, bacteria were grown to the end of 
log phase and were then washed and diluted in sterile phosphate-buffered saline (PBS). 
The CFU in the inoculum were determined by plating serial dilutions. 
 
Cells and culture conditions. PLB-985 and X-CGD PLB-985 cells (29) were grown in 
RPMI 1640 medium supplemented with 2 mM glutamine, 10% fetal bovine serum, penicillin 
(1,000 units/ml), and streptomycin (50 µg/ml) at 37ºC and 5% CO2. For granulocytic 
differentiation, the cells were exposed to 0.5% dimethylformamide for 5 to 6 days. Under 
these conditions, the PLB-985 cells acquire respiratory-burst activity, while the X-CGD 
PLB-985 cells do not (29).  
Bone marrow-derived macrophages from C57BL/6 and p47phox-/- mice were obtained 
and cultured as described previously (2) with a few modifications. Briefly, mice were killed 
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by cervical dislocation, and the femurs were isolated under sterile conditions. The bone 
marrow was flushed from the femurs in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% horse serum. The cells were resuspended in DMEM 
supplemented with 20% horse serum and seeded in 24-wells tissue culture plates 
(Greiner) at a concentration of 2 × 105 nucleated cells per well and were allowed to adhere 
for 2 h. Nonadherent cells were removed, and the remaining adherent cells were cultured 
for 1 week in DMEM supplemented with 20% horse serum and 20% embryonic mouse 
fibroblast-conditioned medium as the source of colony-stimulating factor. 
 
Replication of S. enterica serovar Typhimurium within macrophages. 
Macrophages (2 ×105) were challenged with S. enterica serovar Typhimurium at a 10:1 
multiplicity of infection. To promote the uptake of the bacteria, the bacteria were spun onto 
the macrophages by centrifugation at 300 × g for 10 min and the cells were allowed to 
internalize the bacteria for 30 min at 37ºC, 5% CO2. For determination of the replication of 
S. enterica serovar Typhimurium within macrophages and PLB-985 cells, we used the 
bacterial infection protocol described by Rathman et al. (20) with a few modifications. The 
cells were washed with PBS and incubated for 1 h in medium supplemented with 100 µg of 
gentamicin/ml to kill the extracellular bacteria and were then washed again. This time point 
is designated time point zero. Medium supplemented with 10 µg of gentamicin/ml was 
added to the cells to kill any remaining extracellular bacteria and to prevent reinfection. It 
has been reported that this concentration of gentamicin does not affect growth of 
intracellular bacteria (26). At 24 h, the cells were washed with PBS to remove the 
gentamicin and were lysed in 1 ml of distilled water. Serial dilutions of the lysate were 
plated for determination of the number of intracellular CFU. For examination of our S. 
enterica serovar Typhimurium strains in an in vitro model of NADPH oxidase deficiency, we 
used X-CGD PLB-985, a cell line in which the gp91phox gene was disrupted by homologous 
recombination in leukemic cell line PLB-985. As a consequence, these cells fail to produce 
superoxide mediated by NADPH oxidase (29). For in vitro replication experiments using 
the nonadherent PLB-895 and X-CGD PLB-985 cells, the bacteria were not spun onto the 
cells but were incubated together with the cells while rotating. Like the adherent bone 
marrow-derived macrophages, these cells were treated with 100 µg of gentamicin/ml to kill 
the extracellular bacteria. After the cells were washed with PBS, medium supplemented 
with 10 µg of gentamicin/ml was added to the cells to kill any remaining bacteria and to 
prevent reinfection. At 24 h, the cells were washed with PBS to remove the gentamicin and 
were lysed in 1 ml of distilled water. Serial dilutions of the lysate were plated for 
determination of the number of intracellular CFU. 
 
In vivo Salmonella infections. Mice were inoculated subcutaneously in the flanks 
with 0.1 ml bacterial suspension in PBS. Per group, four mice were used for each time 
point. Mice were sacrificed at several time points by carbon dioxide inhalation or by 
cervical dislocation. Blood was taken by cardiac puncture, and livers, spleens, and inguinal 
lymph nodes were aseptically removed. To determine the bacterial load within these 
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organs, single-cell suspensions were prepared using sterile 70-µm-mesh-size cell strainers 
(Falcon). Cells were pelleted by centrifugation for 10 min and were lysed in distilled water. 
The bacterial number per organ was determined bacteriologically by plating serial dilutions. 
 
Histopathology. Livers from infected mice were harvested, and a segment of tissue 
was fixed in 10% buffered formalin solution for histopathology. Tissues were embedded in 
paraffin and 3-µm-thick sections were prepared and stained with hematoxylin and eosin. 
The pathology in the livers was examined and judged microscopically. 
 
Statistics. Statistical analysis was performed using Student’s t tests and a P value 





In vivo growth of 14028s and DLG294 in Salmonella-resistant C3H/HeN mice. 
Because DLG294 had been shown to be unable to multiply within the macrophage-like cell 
line RAW264.7 and caused less deaths among intraperitoneally infected C3H/HeN and 
C57BL/6 mice than strain 14028s (25), we examined the course of infection for both strains 
in mice by determining the CFU counts and examining the induced pathology in the livers, 
spleens, and lymph nodes. C3H/HeN mice were infected subcutaneously in the flanks with 
~30,000 CFU of S.enterica serovar Typhimurium 14028S or DLG294. The inoculum was 
given subcutaneously to establish a reservoir in the lymph nodes, whence Salmonella 
readily spreads throughout the body via the lymph stream and becomes systemic, finally 
reaching the liver and the spleen (3). The mice challenged with wild-type S. enterica 
serovar Typhimurium 14028s showed a decrease in total body weight (Fig. 1A), while the 
DLG294-challenged mice did not. S. enterica serovar Typhimurium 14028s induced 
intense hepatosplenomegaly, while these organs of the DLG294-infected mice were only 
modestly enlarged, indicating that DLG294 caused less pathology than the wild-type 
14028s strain (Fig. 1A). This was confirmed by the bacterial counts and the macroscopic 
appearance of these organs. S. enterica serovar Typhimurium 14028s was able to multiply 
within the livers, spleens, and lymph nodes and reached a peak between days 5 and 12. In 
contrast, DLG294 was not able to replicate and the number of bacteria in the livers, 
spleens, and lymph nodes was reduced by 3 log units compared to the number of 14028s 
bacteria (Fig. 1B). Also the macroscopic lesions in the organs were less severe in mice 
infected with DLG294 than in mice infected with 14028s. Taken together, these data 
indicate that DLG294 is severely attenuated in vivo. This low virulence of DLG294 could be 
fully reversed to that of wild-type S. enterica serovar Typhimurium 14028s by the 
expression of sspJ on low-copy-number plasmid pWSK29 (DLG294-pTS175) (Fig. 1C). 
This, together with the previous results obtained in vitro, indicate that the SspJ protein is 
important in the in vivo replication of S. enterica serovar Typhimurium. 
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Figure 1. Total body weights and liver and spleen weights of (A) and bacterial counts in livers, spleens, and 
lymph nodes (B) of C3H/HeN mice infected with S. enterica serovar Typhimurium 14028s (open circles and white 
bars) and DLG294 (black squares and black bars) at several time points after infection. (C) Bacterial counts of 
C3H/HeN mice infected with S. enterica serovar Typhimurium 14028s (white bars) and DLG294 complemented by 
the low-copy-number plasmid pWSK29 carrying sspJ (DLG294-pTS175; checkered bars) on day 6 after infection. 
C3H/HeN mice were infected subcutaneously in the flanks with ~30,000 CFU of S. enterica serovar Typhimurium 
14028s, DLG294, or DLG294-pTS175. The actual dosage was confirmed by plating serial dilutions of the inoculum. 
At the indicated time points, livers, spleens, and lymph nodes were aseptically removed and weighed, and the viable 
counts within these organs were determined by plating serial dilutions (n=4 per group). The results are expressed as 
log10 viable counts (means ± standard errors of the means). Asterisks indicate that the number of bacteria of wild-











































































































































































































































































































































Figure 2. Microscopic appearance of livers from C3H/HeN mice infected with S. enterica serovar Typhimurium  
14028s and DLG294 at several time points after infection (A) and C57BL/6 and p47phox-/- mice at 4 days after infection 
with S. enterica serovar Typhimurium 14028s and DLG294 (B). Mice were infected subcutaneously in the flanks as 
described in Materials and Methods. Hematoxylin- and eosin-stained sections were prepared from livers that were 
isolated at different time points after infection. 
 
 
Histopathology of S. enterica serovar Typhimurium 14028s and DLG294 
infection in C3H/HeN mice. Microscopic examination revealed that the livers of mice 
infected with wild-type S. enterica serovar Typhimurium 14028s and DLG294 had a normal 
appearance on day 1. Microabscesses started to appear in the livers in 14028s-infected 
mice on day 5 and to a greater extent on day 12, when the highest numbers of bacteria 
were observed in the livers. Representative tissue sections of the livers are shown in Fig. 
2A. The microabscesses were still present on day 19, but the number was less than the 
number on day 12. Granulomatous lesions were first observed on day 5, but were more 
pronounced on day 12 of infection. On day 19, when the bacterial counts in the livers were 
reduced, the number of lesions was also reduced. Some microabscesses were present in 
livers of DLG294-infected mice on days 5, 12, and 19, but pathology was not as severe as 
in wild-type S. enterica serovar Typhimurium 14028s-infected mice. A few granulomas 
were also observed in the livers of DLG294-infected mice on days 5 and 12, but again the 
pathology was much less extensive as in 14028s-infected mice (Fig. 2A). 
14028
DLG294 
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In vitro intracellular replication of S. enterica serovar Typhimurium in bone 
marrow-derived macrophages. The protein encoded by the sspJ gene (SspJ) is essential 
for replication within macrophages and is crucial for resistance to oxidative stress induced 
by menadione (25), and its absence results in decreased virulence in vivo (Fig. 1 and 2A). 
This suggested a role for SspJ in preventing the induction of, or in neutralizing the activity, 
of superoxide-mediated antimicrobial effector mechanisms of phagocytes, such as the 
NADPH oxidase system. We hypothesized that if this protein is involved in escaping 
oxidative stress, the superoxide-sensitive mutant strain DLG294 would be able to survive 
and replicate within cells that do not produce any superoxide. This hypothesis was tested 
in a macrophage intracellular replication assay using bone marrow-derived macrophages 
from p47phox-/- mice in a Salmonella-susceptible C57BL/6 (Itys) genetic background, as 
these mice have been shown to produce no superoxide (13).   
There was no difference between the S. enterica serovar Typhimurium strains in 
replication in the bone marrow-derived macrophages of p47phox-/- mice (Fig. 3), indicating 
that the superoxide-sensitive mutant strain DLG294 was as virulent as 14028s in cells that 
do not produce any phagocyte superoxide. The numbers of intracellular bacteria of 14028s 
in the macrophages of the control C57BL/6 mice, which produce superoxide upon bacterial 
challenge, were higher than those of DLG294. The ability of DLG294 to replicate 
intracellularly was restored to wild type when sspJ was expressed on a low-copy-number 
plasmid (DLG294-pTS175), whereas introduction of the vector pWSK29 did not affect the 
intracellular count. For confirmation of superoxide deficiency in the macrophages of 
p47phox-/- mice, nitroblue tetrazolium reduction was determined. The macrophages of wild-
type C57BL/6 mice were shown to be able to produce superoxide, while the macrophages 















Figure 3. Intracellular S. enterica serovar Typhimurium in mouse bone marrow-derived macrophages from 
C57BL/6 and p47phox-/- mice. The cells were challenged with S. enterica serovar Typhimurium 14028s (white bars), 
DLG294 (black bars), DLG294-pWSK29 (hatched bars), and DLG294-pTS175 (checkered bars) as described in 
Materials and Methods. The numbers of intracellular bacteria were determined at 24 h after challenge. Asterisks 
indicate that the number of intracellular bacteria is significantly different from that of wild-type S. enterica serovar 



































































S. enterica serovar Typhimurium infection of wild-type and p47phox-/- mice. The in 
vitro infection assay showed that DLG294 was able to replicate intracellularly in bone 
marrow-derived macrophages from mice that do not produce any superoxide due to a 
homozygous mutation in the p47phox subunit of the NADPH oxidase (p47phox-/- mice). In 
these cells, DLG294 reached bacterial counts comparable to those of wild-type S. enterica 
serovar Typhimurium 14028s. To analyze whether both strains are also equally virulent in 
vivo under conditions when no superoxide is produced, we used the Salmonella infection 
model in these p47phox-/- mice and their superoxide-producing controls C57BL/6 (Itys). Since 
Itys mice are very sensitive to S. enterica serovar Typhimurium infection, the dose was 
decreased compared to the dose given to Ityr C3H/HeN mice. The p47phox-/- mice were 
expected to be even more sensitive to infection, and therefore, infection was only studied 
at early time points.  
The infected C57BL/6 mice showed a slight reduction in body weight, and there was 
hardly any difference between 14028s- and DLG294-infected mice at such early time 
points after infection. However, the liver and spleen weights of 14028s-infected wild-type 
mice strongly increased compared to those of DLG294-infected wild-type mice, but not 
until 6 days after infection (data not shown). The bacterial counts in the different organs 
show that DLG294 was less virulent than 14028s in the wild-type (Itys) mice (Fig. 4), which 











Figure 4. Bacterial counts in livers, spleens, and lymph nodes of p47phox-/- and wild-type C57BL/6 (Itys) mice 
infected with S. enterica serovar Typhimurium 14028s (white bars) and DLG294 (black bars). The p47phox-/- mice and 
the wild-type C57BL/6 mice were infected subcutaneously in the flanks with ~10,000 CFU of S. enterica serovar 
Typhimurium 14028s or DLG294. The actual dosage was confirmed by plating serial dilutions of the inoculum. 
Bacterial counts in livers, spleens, and lymph nodes were determined at days 2 and 4. The results are expressed as 
log10 viable counts (means ± standard errors of the means) obtained from groups of four mice per time point. 
Asterisks indicate that the number of wild-type 14028s bacteria is statistically different from that of DLG294 bacteria 
(Student’s t test). All Salmonella-infected p47phox-/- mice were dead by day 5. Dashed lines, detection limit. 
 
 
So, even in Salmonella-sensitive (Itys) mice, the superoxide-sensitive mutant strain 
DLG294 is attenuated. In p47phox-/- mice, however, 14028s induced no increase in liver 
weight within 4 days after infection, but did cause an increase in spleen weight. DLG294 
did not seem to cause hepatosplenomegaly in the p47phox-/- mice, as the liver weight 
declined and the spleen weight remained the same at the early time points after infection 
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were higher in the p47phox-/- mice than in the wild-type mice (Fig. 4), and after 5 days of 
infection all the p47phox-/- mice died from the infection. At days 2 and 4 after infection, with 
the exception of the livers at day 2, there was no difference in bacterial loads between 
DLG294- and 14028s-infected mice, indicating that the replication of the superoxide-
sensitive mutant strain was not hampered in mice that do not produce any superoxide. 
 
Histopathology of S. enterica serovar Typhimurium 14028s and DLG294 
infection in wild-type and p47phox-/- C57BL/6 mice. Microscopic examination of the 
organs of the C57BL/6 mice revealed that the livers appeared normal on day 1 for both the 
14028s- and the DLG294-infected mice. Infiltrating cells started to appear in the livers of 
14028s-infected wild-type mice on day 2, and large amounts of microabscesses and 
granulomatous lesions were present on day 4. Representative tissue sections are shown in 
Fig. 2B. Infiltrating cells and microabscesses were also observed in DLG294-infected wild-
type mice on days 2 and 4, but to a much lesser extent and with only a very few beginning 
lesions on day 4. In the livers of the p47phox-/- mice, on the other hand, infiltrating cells were 
already observed in the livers on day 1 after infection in both the 14028s- and the DLG294-
infected mice. Microabscesses started to appear on day 2. On day 4, the structure of the 
livers was destroyed in both groups of p47phox-/- mice, the microabscesses became very 
abundant, and many necrotic granulomatous lesions were present (Fig. 2B). Thus, the 
pathology induced by DLG294 was less severe in wild-type mice but was as severe as that 
induced by 14028s in the p47phox-/- mice, which do not produce any superoxide. Thus, 
when no superoxide was produced, superoxide-sensitive mutant strain DLG294 appeared 
to be as virulent and as pathogenic as wild-type S. enterica serovar Typhimurium 14028s. 
This strongly suggests a role for SspJ in the defense mechanisms of S. enterica serovar 














Figure 5. Intracellular S. enterica serovar Typhimurium in PLB-985 and X-CGD PLB-985 cells. The cells were 
challenged with S. enterica serovar Typhimurium 14028s (white bars), DLG294 (black bars), DLG294-pWSK29 
(hatched bars), and DLG294-pTS175 (checkered bars) as described in Materials and Methods. The numbers of 
intracellular bacteria were determined at 24 h after challenge. Asterisks indicate that the number of intracellular 
bacteria is significantly different from that of wild-type S. enterica serovar Typhimurium 14028s. Mean data of two 

































































In vitro intracellular growth of S. enterica serovar Typhimurium in PLB-985 cells. 
The p47phox-/- mice showed an autosomal recessive deficiency in the p47phox subunit of the 
NADPH oxidase complex and were therefore unable to produce any superoxide. To 
exclude the possibility that the observed effect in the bone marrow-derived macrophages 
from p47phox-/- mice was due to the deficiency in the p47phox protein itself and not to the 
inactivation of the NADPH oxidase complex, we wanted to examine our S. enterica serovar 
Typhimurium strains in another in vitro model for NADPH oxidase deficiency. Therefore, 
we used X-CGD PLB-985, a cell line in which the gp91phox gene was disrupted by 
homologous recombination in the human leukemic cell line PLB-985 and which, as a 
consequence, fails to produce any superoxide (29). Cells were infected with S. enterica 
serovar Typhimurium 14028s, DLG294, DLG294-pWSK29, and DLG294-pTS175 as 
described for the replication assay in macrophages. Mean data from two independently 
performed experiments are shown in Fig. 5. At 24 h after infection, bacterial loads of wild-
type S. enterica serovar Typhimurium 14028s within wild-type PLB-985 cells were higher 
than those of mutant strain DLG294. In the X-CGD PLB-985 cells, however, there was no 
difference in the intracellular CFU count after 24 h between the S. enterica serovar 
Typhimurium strains. The diminished intracellular replication of DLG294 could be fully 
reversed to that of wild-type S. enterica serovar Typhimurium 14028s by the expression of 
sspJ on the low-copy-number plasmid pWSK29 (DLG294-pTS175), whereas introduction 
of the vector (DLG294-pWSK29) did not affect the intracellular count. These data are in 
concordance with the data obtained with the macrophages of wild-type and p47phox-/- 





The main findings of this study are that the superoxide-sensitive S. enterica serovar 
Typhimurium mutant strain DLG294 (25) is attenuated in vivo and causes less pathology 
than wild-type S. enterica serovar Typhimurium 14028s but that it regains virulence in X-
CGD PLB-985 cells and in p47phox-/- mice that show a deficiency in the phagocyte NADPH 
oxidase and therefore do not produce any superoxide. In addition, the  decreased virulence 
of DLG294 is a direct cause of the defect in sspJ and is not a polar effect caused by 
diminished transcription of genes directly downstream of sspJ, since the virulence can be 
fully restored to that of the wild type by the expression of sspJ on a low-copy-number 
plasmid (DLG294-pTS175). These results suggest that the protein encoded by sspJ (SspJ) 
is necessary for virulence and plays a very important role in the defense mechanisms of S. 
enterica serovar Typhimurium against superoxide produced by the phagocyte NADPH 
oxidase. 
We examined the in vivo course of infection of S. enterica serovar Typhimurium 
14028s and DLG294 in the typhoid mouse model by infecting C3H/HeN mice (Ityr) 
subcutaneously in the inguinal region to establish a reservoir near the lymph nodes; 
Salmonella readily spreads from this reservoir via the lymph stream, and the infection 
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becomes systemic, finally reaching the liver and spleen (3). This model gives rise to a 
more subtle chronic infection than the intraperitoneal, intravenous, and oral infection 
models that give rise to peracute and overwhelming systemic infections. As shown with this 
model, DLG294 is highly attenuated both in the relatively resistant Ityr mice and in S. 
enterica serovar Typhimurium-sensitive Itys mice. This is remarkable, since Itys C57BL/6 
mice have somewhat reduced phagocyte production of reactive nitrogen and oxygen 
species (6, 19, 21) and yet our mutant strain DLG294 still was attenuated. Apparently, Itys 
C57BL/6 mice produce sufficient superoxide to prevent DLG294 replication. In contrast, the 
virulence of DLG294 was completely restored in p47phox-/- mice, which do not produce any 
superoxide. These results were confirmed by in vitro replication experiments with bone 
marrow-derived macrophages from the wild-type (superoxide-positive) and p47phox-/- 
(superoxide-negative) mice and with X-CGD PLB-985 cells (29). Thus, when no 
superoxide was produced, superoxide-sensitive mutant S. enterica serovar Typhimurium 
strain DLG294 was able to replicate independent of the underlying genetic defect in the 
genes encoding the NADPH oxidase, which causes the defect in superoxide production. 
We observed severe pathology in the livers of C3H/HeN and C57BL/6 mice infected 
with wild-type S. enterica serovar Typhimurium 14028s and in p47phox-/- mice infected with 
14028s or DLG294. Liver pathology can be induced by superoxide produced upon 
activation of macrophages, as shown in mice chronically treated with alcohol (15). In our 
experiments, however, the liver pathology is induced by S. enterica serovar Typhimurium 
itself and is not caused by superoxide produced upon infection, as the p47phox-/- mice 
produce no superoxide but do develop severe liver damage upon infection with S. enterica 
serovar Typhimurium 14028s and DLG294. In addition, the pathology is most severe when 
bacterial numbers are highest.  
A mutant that has a phenotype similar to that of DLG294 is a zwf mutant that is 
deficient in glucose-6-phosphate dehydrogenase (G6PD) (16). G6PD catalyzes the first 
step in the pentose phosphate cycle, which provides ribose for nucleoside synthesis and 
reducing equivalents in the form of NADPH. G6PD is very important in defense against 
oxidative and nitrosative stress because it provides NADPH, thereby maintaining the 
cellular redox state, regenerating reduced thiols, and repairing oxidative and nitrosative 
damage (8, 24). Mutants deficient in zwf show increased susceptibility to reactive oxygen 
and nitrogen intermediates and are attenuated in mice (16). Also the in vivo virulence of 
these mutants can be fully restored to that of the wild type by elimination of the phagocyte 
respiratory-burst oxidase (gp91phox-/- mice) (16). However, the zwf mutant is also more 
sensitive to hydrogen peroxide (16), whereas DLG294 is not (25), suggesting that SspJ is 
not a dehydrogenase.  
It has previously been reported that periplasmic Cu,Zn-SOD (SodC) is very important 
in the defense of S. enterica serovar Typhimurium against oxidative stress, as was evident 
from sodC mutants, which showed reduced survival within macrophages and attenuated 
virulence in mice (4, 7). S. enterica serovar Typhimurium contains two periplasmic SODs, 
SodCI and SodCII (7). When one of these SODs is deleted, S. enterica serovar 
Typhimurium is slightly attenuated, but when both SODs are deleted, S. enterica serovar 
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Typhimurium is highly attenuated (7). The phenotype of DLG294 resembles that of this 
SodC double mutant and suggests a role for SspJ as an SOD. However, we have 
previously shown that SOD activities of DLG294 and wild-type S. enterica serovar 
Typhimurium 14028s are the same (25). In addition, SodCII expression is upregulated in 
stationary phase (7), while SspJ is constitutively expressed, and so far no inducing 
conditions have been found (25). These results indicate that the SspJ protein is not an 
SOD. However, SspJ does play a crucial role in the defense against superoxide. It could 
act in a regulatory pathway as a sensor or cofactor for SOD, it could be involved in 
neutralizing the toxic effects of superoxide, or it could even prevent the production of 
superoxide.  
The last mechanism has been described for mutants deficient in SPI2, which have the 
same phenotype as DLG294 (12, 28). It is proposed that the proteins encoded by the 
genes located within this SPI2 defend the bacterium against superoxide by preventing the 
NADPH oxidase from trafficking toward the Salmonella-containing vacuoles (28) or by 
preventing the assembly of the NADPH oxidase at the phagosomal membrane (12). We 
are currently investigating whether sspJ has a role in this mechanism of preventing 
superoxide production.  
The sodCI and -CII, the zwf, and the type III secretion mutants descibed above have 
diverse genetic defects, but they all have the same phenotype. Apparently, the interplay 
between all these distinct factors determines resistance to superoxide. It is clear that sspJ 
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Upon activation, macrophages initiate the transcription of genes coding for the 
expression of proteins and enzymes that participate in mounting the host response against 
pathogens such as Salmonella. DLG294 is an S. enterica serovar Typhimurium mutant 
strain that is hypersusceptible to superoxide and is attenuated due to its lack of expression 
of sspJ. To further characterize DLG294 we evaluated whether macrophages responded 
differently upon challenge with the virulent wild type strain 14028s than upon challenge 
with this attenuated superoxide-hypersusceptible strain DLG294 by defining the transcript 
profiles of RAW264.7 cells exposed to either on of these strains.  
Infection with either one of these strains resulted in altered expression of a lot of 
genes involved in all kinds of cellular processes and defense mechanisms. By comparing 
the transcript profiles of RAW264.7 macrophages exposed to wild-type S. enterica serovar 
Typhimurium 14028s or DLG294 for 4 h, however, no great differences could be observed, 
indicating that the intracellular presence of either of these two strains does not elicit a 
different host-cell response. Therefore, the differences in outgrowth between wild-type S. 
enterica serovar Typhimurium and DLG294 could only be explained by the lack of 
expression of sspJ in DLG294, although the exact function and mechanism of action of the 




























Salmonellae are gram-negative, facultative intracellular pathogens that can cause a 
variety of diseases in animals and man, ranging from mild gastroenteritis to severe 
systemic infections like typhoid fever. Salmonella enterica serovar Typhimurium may 
cause gastroenteritis in man, but causes systemic infection in mice comparable to typhoid 
fever in man (15). S. enterica serovar Typhimurium predominantly invades mononuclear 
phagocytes and is able to cause persistent infections by evasion or disturbance of the host 
immune system (13). Despite the fact that these cells contain a multitude of antimicrobial 
defense mechanisms as part of the innate immune defense system, S. enterica serovar 
Typhimurium is able to enter, survive, and even replicate within these phagocytes. The 
exact mechanisms by which S. enterica serovar Typhimurium is able to survive after 
phagocytosis are unknown, but S. enterica serovar Typhimurium responds to the specific 
host environment by expressing factors that are necessary for intracellular survival and for 
resistance against the defense systems of the host (4, 8, 9, 13, 17). Like for most 
intracellular bacteria, this ability of S. enterica serovar Typhimurium to enter and replicate 
within phagocytic cells is essential for survival and pathogenesis, as mutants unable to do 
so are avirulent (7). In vitro studies have shown that S. enterica serovar Typhimurium is 
able to survive and replicate within non-activated macrophages and that this can also lead 
to the induction of apoptosis (18). The outcome of infection, however, strongly depends 
upon the interaction between the pathogen and its host.  
Upon infection, the host will develop an immune response that limits bacterial growth 
and eventually kills and eliminates the pathogen. Although Salmonella resides and 
replicates within macrophages, these macrophages do play an important role in the host 
defense against Salmonella. In fact, interactions between the macrophage and Salmonella 
are necessary for the early control of infection, and subsequently, for the induction of 
acquired immunity (11, 16). Also in immune mice that developed a Salmonella-specific 
response including antigen-specific antibodies, macrophages played a major role in 
restricting early bacterial growth since in vivo depletion of macrophages in these mice 
resulted in increased susceptibility and mortality (25). In vivo, macrophages are mainly 
activated through T lymphocyte-dependent responses, but are also activated upon 
infection with live bacteria or upon contact with several bacterial components called 
Pathogen Associated Molecular Patterns (PAMPs) (including LPS, porins and outer 
membrane proteins, fimbrial proteins, flagella, lipoproteins, glycoproteins, and 
peptidoglycan) (10). Macrophages have evolved mechanisms to recognize such PAMPs 
by expressing pattern recognition receptors that recognize the PAMPs and then initiate the 
innate immune response to clear the infection (20). Upon activation, macrophages induce 
the transcription of genes coding for the expression of proteins and enzymes that 
participate in mounting the host response against the pathogens. The induced gene 
expression profile seems to be dependent upon the activation state of the macrophages 
(19) and might therefore give an indication on how the macrophages respond to infection 
with a certain pathogen. 
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Recently, we have described the isolation and characterization of a superoxide 
hypersusceptible S. enterica serovar Typhimurium mutant strain DLG294 (21). This mutant 
strain DLG294 lacks the expression of sspJ and is highly attenuated in vivo in C3H/HeN 
mice and in vitro in macrophages, but is able to grow out as much as the wild-type strain in 
cells and mice that cannot produce any superoxide due to a non-functional NADPH 
oxidase complex (21, 24). These studies showed that expression of sspJ in S. enterica 
serovar Typhimurium plays an important role in resistance against superoxide, but its exact 
function and mechanism of action remained to be elucidated. Additional experiments have 
shown that DLG294 is not only hyper-sensitive to superoxide, but is also more susceptible 
to certain antibiotics (Tahar van der Straaten, unpublished data). Although 
hypersusceptibility to superoxide could be the major cause of attenuated virulence of 
DLG294, it cannot be excluded that other factors might also play a role. Since a lot of 
strains that are highly susceptible to menadione, i.e. intracellular superoxide, are not 
attenuated in mice it is clear that superoxide sensitivity alone does not determine virulence. 
For example, we have recently described S. enterica serovar Typhimurium mutants that 
are much more susceptible to menadione, yet are not attenuated at all (22, 23). These 
data suggest that other factors play a role. For instance the macrophage response to 
Salmonella, which determines the level of macrophage activation, may be an important 
factor. Therefore we decided to study whether the macrophage responds differently to 
DLG294 than to wild-type S. enterica serovar Typhimurium 14028s. A possible difference 
in the activation status of the macrophages might explain the differences in virulence of 
DLG294 and the wild-type strain and might clarify whether attenuation of DLG294 is solely 
due to its hypersusceptibility to superoxide produced by the macrophages or that additional 
mechanisms play a role.  
 
 
Materials and Methods 
 
Bacterial strains. Single colonies of wild-type S. enterica serovar Typhimurium strain 
14028s and superoxide-sensitive derivative DLG294 (21) were grown overnight in Luria-
Bertani (LB) medium (10 mg of tryptone, 5 mg of yeast extract, and 10 mg of NaCl/ml) at 
37ºC while being shaken (225 rpm).  
 
Cells and cell culture conditions. The mouse macrophage cell line RAW264.7 
(ATCC TIB71) and the human granulocyte-like cell lines PLB-985 and X-CGD PLB-985 
(26) were maintained at 37ºC with 5% CO2 in RPMI 1640 medium supplemented with 2 
mM glutamine, 10% fetal calf serum, penicillin (100 U/ml), and streptomycin (50 µg/ml). For 
granulocytic differentiation, the PLB-985 and X-CGD PLB-985 cells were exposed to 0.5% 
dimethylformamide for 5-6 days. Under these conditions, the PLB-985 cells acquire 
respiratory burst activity, while the X-CGD PLB-985 cells do not (26). 
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Replication of S. enterica serovar Typhimurium within RAW264.7 macrophages 
and PLB985 cells. One day before challenge RAW264.7 cells were seeded in 6-wells 
plates in RPMI 1640 medium supplemented with 2 mM glutamine and 10% fetal calf 
serum, but without antibiotics at 1 × 106 cells per well. The cells were challenged with S. 
enterica serovar Typhimurium at a 10:1 multiplicity of infection. To promote the uptake of 
the bacteria, the bacteria were spun onto the macrophages by centrifugation at 300 × g for 
10 minutes and the cells were allowed to internalize the bacteria for 30 minutes at 37ºC 
with 5% CO2. The cells were washed with phosphate-buffered saline (PBS) and were 
treated with 100 µg/ml gentamicin for 10 minutes to kill the extracellular bacteria and were 
then washed again. Medium supplemented with 10 µg/ml gentamicin was added to the 
cells to prevent reinfection and to kill any remaining bacteria. At 4 hours after infection, the 
cells were washed thoroughly with PBS and total RNA was isolated from 4 of the wells. As 
a control for infection, cells from duplicate wells were lysed with water and the number of 
intracellular bacteria was determined by plating serial dilutions. To obtain RNA from 
uninfected cells, the cells were treated exactly like the infected cells, but no bacteria were 
added. For infection of the non-adherent (X-CGD) PLB-985 cells, 1 × 105 cells were 
infected by incubating the cells together with 1 × 106 bacteria while rotating for 30 min at 
37°C. The cells were then treated with 100 µg/ml gentamicin for another 60 min to kill the 
extracellular bacteria. After washing with PBS, the cells were lysed in 1 ml of distilled 
water. Serial dilutons of the lysate were made and plated for determination of the number 
of intracellular CFU. 
 
In vivo Salmonella infection. Mice were inoculated subcutaneously with 3 × 104 CFU 
in the flanks with 0.1 ml bacterial suspension in PBS. Per group 4 mice were used to 
determine the bacterial load within the organs. On day 1 after infection, mice were 
sacrificed by carbon dioxide inhalation and the inguinal lymph nodes, livers and spleens 
were aseptically removed. The bacterial load within these organs was determined by 
preparing single-cell suspensions using 70-µm-mesh-size cell strainers (Falcon). The cells 
were pelleted by centrifugation for 10 min and the cells were lysed in distilled water. Serial 
dilutions of the lysate were made to determine the bacterial loads within the organs. 
 
RNA sample preparation. Samples were prepared according to the protocols in the 
Affymetrix Gene Chip Expression Analysis technical manual (Affymetrix, Inc., Santa Clara, 
California) and were obtained from two independently performed in vitro replication 
experiments. Total RNA was isolated from the S. enterica serovar Typhimurium infected 
RAW264.7 cells at 4 hours after infection using TRIzol Reagent (Gibco BRL Life 
Technologies) according to the manufacturer’s protocol. The RNA obtained from the 
uninfected cells was pooled, while the RNA samples from the infected cells were 
individually processed. After the ethanol precipitation in this TRIzol extraction procedure, 
the total RNA was cleaned up using the Qiagen RNeasy Total isolation Kit according to the 
manufacturer’s protocol. The RNA was checked by gel electrophoresis before proceeding. 
Double stranded cDNA was prepared using the Gibco BRL SuperScript Choice System 
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and T7-(dT)24 primer (Genset Corp., La Jolla, California). The cDNA was purified by 
phenol/chloroform extraction and ethanol precipitation. Biotin-labeled cRNA was 
synthesized in an in vitro transcription reaction using the ENZO BioarrayTM HighYieldTM 
RNA Transcript Labeling Kit (ENZO Diagnostics, Inc. Farmingdale, New York) according to 
the manufacturer’s recommendations. Finally, the biotin-labeled cRNA was purified using 
the Qiagen RNeasy Total Isolation Kit and was fragmented in 40 mM Tris-acetate, pH 8.1, 
100 mM KOAc, and 30 mM MgOAc at 94°C for 35 minutes. 
 
Microarray. Microarray analysis was performed at the Leiden Genome Technology 
Center by Eveline Mank (Leiden, The Netherlands). The fragmented labeled cRNA (15 µg) 
was hybridized to GeneChip murine genome U74Av2 oligonucleotide arrays (Affymetrix, 
Santa Clara, CA). The chips were washed and stained with streptavidin-phycoerythrin in a 
GeneChip Fluidics station 400 (Affymetrix) and were then scanned using an Affymetrix 
GeneArray. Affymetrix Microarray Suite 5.0 (MAS5.0, Affymetrix) was used to analyze the 
data. The chips that were hybridized with cRNA from RAW264.7 cells infected with either 
S. enterica serovar Typhimurium 14028s or DLG294 were compared to a chip that was 
hybridized with pooled cRNA from uninfected cells to analyze which gene expression was 
changed by the infection. Difference calls were assigned as described previously (6): 
increased, 2; marginally increased, 1; nor changed, 0; marginally decreased, -1; 
decreased, -2. The sum of difference calls was calculated and a sum of ≥3 or  ≤-3 was the 
cut off value for increase or decrease, respectively. We have converted the signal log ratio 
output of increased and decreased expression into fold change for convenience using the 
formula recommended by Affymetrix:  
 
Fold increase = 2signal log ratio , if signal log ratio >0 
Fold decrease = 2-signal log ratio, if signal log ratio <0 
 
To ensure that the data are reliable, genes were considered to be differentially expressed if 
P < 0.01 (Student t-test) and fold increase ≥ 2.0 and fold decrease ≥1.75. 
 
Cytometric bead array. At 4 h after infection, supernatant from RAW264.7 cells 
infected with wild-type S. enterica serovar Typhimurium or DLG294 or from uninfected 
cells was taken, diluted 10 times, and used in a Mouse Inflammation Cytometric Bead 
ArrayTM (CBA; BD Biosciences, San Jose, CA) according to the manufacturer's 
recommendations to compare the type and amount of cytokines produced by these cells 
and is schematically depicted in Fig. 1. The CBA assay contains six populations of 
polysterene beads that have been coated with capture antibodies directed against either 
IL-6, IL-10, MCP-1, IFNγ, TNFα, or IL-12p70. These beads are of equal size but differ in 
fluorescence intensities and can be discriminated by detection in the FL3 channel of a flow 
cytometer. The six bead populations are mixed and 50 µl of this mixed suspension, 
together with 50 µl phycoerythrin(PE)-labeled detection antibodies are added to 50 µl of 
the test samples or cytokine standards and were incubated for 2 h at room temperature to 
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form the sandwich complexes. After washing the bead-cytokine-antibody-PE complexes, 
FACS analysis was performed on a  BD FACSCaliburTM flow cytometer and data were 
acquired and analyzed using Becton Dickinson (BD) Cytometric Bead Array (CBA) 
software. Forward vs side scatter were used to gate on the beads. The fluorescence 
intensity detected in the FL-3 channel discriminates the six different bead populations and 
the mean fluorescence intensity measured with PE in the FL-2 channel is proportional to 
the cytokine concentration in the sample. By two-color dot plotting the FL-2 vs FL-3 the 
change in fluorescence intensity measured with PE for each of the six bead populations 
could be compared. The cytokine standards were used to make standard curves from 
which cytokine concentrations in the test samples could be calculated.   
 
 
Results and Discussion 
 
Early in vitro intracellular growth of S. enterica serovar Typhimurium. DLG294 is 
an S. enterica serovar Typhimurium mutant strain that is hypersusceptible to superoxide 
due to its lack of expression of sspJ (21). This mutant strain is attenuated in vivo in 
C3H/HeN mice and in vitro in RAW264.7 macrophages, but regains virulence in cells and 
mice that do not produce any superoxide due to a non-functional NADPH oxidase complex 
(21, 24). These previous studies showed that sspJ is involved in the defense against 
superoxide produced by macrophages, but its exact function and mechanism of action 
were still unknown. From this we concluded that attenuation of DLG294 is due to its 
hypersusceptibility to superoxide. However, when we examined at bacterial counts very 
early after infection of X-CGD PLB985 cells we observed that bacterial loads of DLG294 
were lower than those of the wild-type strain both in the wild-type, superoxide producing 
PLB985 cells as well as in the X-CGD PLB985 cells that cannot produce any superoxide 
due to disruption of the gp91phox gene (26) (Fig. 2A). Despite the fact that these X-CGD 
PLB-985 cells cannot produce any superoxide, DLG294, although not statistically 
significant, still showed lower bacterial numbers that the wild-type strain. When the cells 
were cultured for another 24 hours, DLG294 and the wild-type strain reached equal 
bacterial numbers in the X-CGD PLB985 cells while DLG294 is attenuated in PLB985 cells 
as described before (24). Similar data were observed in vivo, i.e. even though DLG294 
reached similar bacterial numbers to wild-type 4 days after infection of mice (22), we 
observed that at 1 day after infection, bacterial numbers were lower than for the wild-type 
suggesting that early killing is different for wild-type and DLG294 (Fig. 2B and 2C). This 
suggests that attenuation of DLG294 is not solely due to increased susceptibility to 
superoxide and that additional factors such as the activation status of the cells play a role 
in the increased susceptibility and attenuation of DLG294 very early after infection. Once 
these early additional factors are overcome, DLG294 is able to grow out as much as the 
wild-type strain reaching comparable bacterial numbers in cells and mice that cannot 











































Figure 1. Schematic overview of the Cytometric Bead Array. Supernatant from RAW264.7 cells infected with 
wild-type S. enterica serovar Typhimurium or DLG294 or from uninfected cells was taken, diluted 10 times, and used 
according to the manufacturer's recommendations to compare the type and amount of cytokines produced by these 
cells. 
 
Supernatant from S. typhimurium

















































































































Figure 2. Bacterial numbers in (X-CGD) PLB985 cells after incubation with bacteria (MOI 10) (A) and in livers, 
spleens, and inguinal lymph nodes of C57BL/6 (B) or p47phox-/- mice (C) at 1 day after infection.  Cells were incubated 
or mice were infected with wild-type S. enterica serovar Typhimurium 14028s (white bars), DLG294 (black bars), 
DLG294-pWSK29 (dashed bars), or DLG294-pTS175 (checkered bars). Asterisks indicate that the number of 
intracellular bacteria is significantly different (P<0.05) from that of wild-type S. enterica serovar Typhimurium 14028s. 
 
 
Comparison of gene expression profiles of uninfected, wild-type, and DLG294 
infected RAW264.7 cells. Next we studied the activation status of RAW264.7 
macrophages infected with wild-type or DLG294 by determining gene expression profiles. 
Fig. 3 shows that the number of intracellular DLG294 was much lower than wild-type S. 
enterica serovar Typhimurium 14028s at 4 h after infection as shown previously (21). 
Bacterial numbers were equal between wild-type and DLG294 at 30 minutes after infection 
(data not shown), but the wild-type reached much higher bacterial counts after 24 h than 
DLG294, indicating that the uptake of DLG294 by the macrophages is similar to that of the 
wild-type strain, but its replication is severely impaired. 
Infection with wild-type or DLG294 resulted in the induction of 174 genes. Only 9 
of these genes were induced to a different extent in DLG294 and wild-type infected 
macrophages (Table 4). We will discuss genes that are highly induced, moderately 
induced, or that are repressed by infection and highlight the differences between wild-type 
and DLG294 infected cells. Genes showing down-regulated expression upon infection are 
shown in Table 3 that shows that the gene-expression was only moderate decreased 
compared to uninfected cells. The fold decreases do not exceed 3.9, while for the 
upregulated genes the expression increased up to more than a 100-fold for Cxcl2 (Table 
1). Genes showing decreased expression were mainly involved in cell cycle processes, 



















































































































































































































Figure 3. Number of intracellular bacteria in 
RAW264.7 macrophages at 4 h after infection (A). The 
cells were challenged with S. enterica serovar 
Typhimurium 14028s (white bars) or DLG294 (black 
bars) as described in Materials and Methods. Asterisks 
indicate that the number of intracellular bacteria is 
significantly different (P<0.05) from that of wild-type S. 




Strongly induced genes. A lot of the genes that are up-regulated by the infection are 
involved in inflammatory processes and apoptosis, but also in signal transduction and 
transcription (Tables 1 and 2). The genes showing the most pronounced increase in 
expression are genes involved in inflammation and chemotaxis and was highest for Cxcl2, 
a gene encoding macrophage inflammatory protein 2 that is involved in the chemotaxis of 
leukocytes, but that does not induce chemokinesis or an oxidative burst.  
Other genes showing highly increased expression are genes involved in the defense 
response and include cytokines, chemokines, MHC Class II, activation markers, and IFNγ 
or LPS induced genes involved in the immune response. 
 
 
Table 1. Macrophage gene expression strongly induced by S. enterica serovar 
Typhimurium infection 
Accession Nr. Fold Increase Gene Gene or Protein 
 14028s DLG294   
Inflammation, Cytokines,and Chemokines 
  
M13926 12.06 14.06 Csf3 Colony-stimulating factor 3 (granulocyte) 
M14639 8.21 10.57 Il1a Interleukin 1 alpha 
AF065947 75.41 59.18 Ccl5 Chemokine (C-C motif), ligand 5 
U16985 29.27 34.63 Ltb Lymphotoxin B 
M33266 25.24 19.09 Cxcl10 Chemokine (C-X-C- motif), ligand 10 
X53798 115.43 124.31 Cxcl2 Chemokine (C-X-C- motif), ligand 2 
X62502 5.47 5.10 Ccl4 Chemokine (C-C motif), ligand 4 
X70058 8.49 8.29 Ccl7 Chemokine (C-C motif), ligand 7 
D84196 9.52 10.93 Tnf Tumor necrosis factor  
     
Transportation and Binding Proteins   
AI844128 6.75 7.56 Ehd1 EH-domain containing 1 
AI747899 2.32 2.94 Pitpnb Phosphatidylinositol transfer protein, beta 
AF006467 12.62 6.15 Pitpnm Phosphatidylinositol membrane-associated 
     
Apoptosis     
U44088 36.38 21.39 Phlda1 Pleckstrin homology-like domain, family A, member 1 
     
Cell Cycle, Differentation, and Proliferation   
M64849 3.45 5.15 Pdgfb Platelet-derived growth factor chain B precursor (sis) 
AF099973 6.56 6.83 Slfn2 Schlafen 2 
     
Biosynthesis     
U00978 12.29 11.75 Impdh1 Inosine-5’-monophosphate dehydrogenase 1 
X07888 16.00 19.75 Hmgcr 3-hydroxy-3-methylglutaryl coenzyme A reductase 
     
Defense Response    
AF002719 6.19 6.59 Slpi Secretory leukoprotease inhibitor  
X54149 6.08 8.76 Gadd45b Growth arrest and DNA damage-inducible protein GADD45 be
(myeloid differentiation primary-response protein Myd118)  
     
Protein Degradation and Processing   
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Table 1. -continued- 
Accession Nr. Fold Increase Gene Gene or Protein 
 14028s DLG294   
Immune Response    
X56602 41.79 39.05 Isg15 Interferon stimulated protein 
U43084 62.02 41.79 Ifit1 Interferon-induced protein with tetratricopeptide repeats 1 
AV152244 18.02 13.02 G1p2 Interferon, alpha-inducible protein 
AI323667 93.76 91.38 Irg1 Immunoresponsive gene 1 
L38281 76.36 57.99 Irg1 Immunoresponsive gene 1 
     
Antigen Presentation    
X52914 10.23 10.50 H2-K Histocompatibility 2, K region  
D90146 22.06 32.48 H2-Q7 Histocompatibility 2, Q region locus 7 
M27134 23.12 25.85 H2-K2 Histocompatibility 2, K region locus 2 
     
Signalling Receptors    
U65747 7.07 4.77 Il13ra2 IL-13 receptor, alpha 2 
     
Transcription     
X53654 6.30 6.64 Pou2f2 POU domain, class 2, transcription factor 2 
Y11245 5.28 5.33 Foxm1 Forkhead box M1 
X95316 5.48 4.04 Usf1 Upstream transcription factor 1 
L00039 6.30 6.74 Myc Myelocytomastosis oncogene 
     
Regulatory     
AJ222800 8.00 8.49 Smpd2 Shingomyelin phosphodiesterase 2, neutral 
M89800 10.20 11.31 Wnt6 Wingless-related MMTV integration site 6 
U57524 4.64 5.33 Nfkbia Nuclear factor of kappa light chain enhancer in B-cells 
inhibitor, alpha 
     
Signal Transduction    
AB016589 13.50 21.11 Ikbke Inhibitor of kappa-B kinase epsilon 
M63659 17.93 21.93 Gna12 Guanine nucleotide binding protein, alpha 12 
L35302 57.99 51.70 Traf1 TNF receptor-associated factor 1 
AF053974 5.47 3.35 Swap70 Swap complex protein, 70 kDa 
U58203 4.87 5.48 Arhgef1 Rho guanine nucleotide exchange factor (GEF) 1 
U34960 4.09 5.28 Gnb2 Guanine nucleotide binding protein, beta 2 
X61399 7.25 7.12 Mlp MARCKS-like protein 
AW120722 5.63 6.56 Mapkapk2 MAP kinase-activated protein kinase 2 
AV374868 6.75 6.19 Socs3 Suppressor of cytokine signalling 3 
M83380 5.78 6.08 Relb Avian reticuloendotheliosis viral (v-rel) oncogene related B 
U88328 32.48 28.08 Socs3 Suppressor of cytokine signalling 3 
     
Other     
AF084480 6.14 8.30 Baz1b Bromodomain adjacent to zinc finger domain, 1B 
AF037437 4.15 7.56 Psap Prosaposin 
AB002136 7.32 7.84 Gpaa1 Glycosylphosphatidylinositol anchor attachment protein 1 
U82610 16.24 27.00 Lcp1 Lymphocyte cytosolic protein 1 
     
Unknown Gene Function     
AF064447 3.61 5.47 Fem1a Feminization 1 homolog a 
U50384 4.48 9.55 Smyd5 SET and MYND domain containing 5 
AF073882 14.64 14.50 Mtmr7 Myotubularin related protein 7 
U89434 10.06 16.15 Tbgr4 Transforming growth factor beta regulated gene 4 
X67644 7.73 8.57 Ier3 Immediate early response 3 
AA822413 5.89 5.86 Fbxw5 F-box and WD-40 domain protein 5 
AW060657 7.73 8.59 Pmf1 Polyamine-modulated factor 1 
AI837006 14.23 15.46 Cotl1 Coactosin-like 1 
 
 
The production of cytokines and chemokines and the induction of activation markers 
are all processes involved in innate defense against Salmonella. Cytokines are small 
soluble proteins that mediate and regulate the (anti-) inflammatory responses and can 
have local or systemic effects on several components of the immune system. Upon 
infection of RAW264.7 macrophages with S. enterica serovar Typhimurium, expression of 
genes encoding cytokines involved in innate defense are induced, such as granulocyte 
colony-stimulating factor 3, Interleukin 1 α, lymphotoxin β, Tumor necrosis factor (encoded 
by Csf3, Il1a, Ltb, and tnf, respectively) (Table 1), and to a lesser extent, Interleukin 1 
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receptor antagonist (encoded by Il1rn) which regulates the expression and bioactivity of IL-
1 (Table 2). Also genes encoding receptors involved in cytokine signaling such as TNF 
receptor, superfamily, members 5 and 1b (tnfrsf5 and tnfrsf1b) and IL-13 receptor, alpha 2 
(Il13ra2) are upregulated upon infection (Tables 1 and 2, signaling receptors).  
 
 
Table 2. Macrophage gene expression moderately induced by 
S. enterica serovar Typhimurium 
Accession Nr. Fold Increase Gene Gene or Protein 
 14028s DLG294   
Inflammation, Cytokines,and Chemokines 
  
X03505 2.74 4.15 Saa3 Serum amyloid A3 
L32838 2.66 1.69 Il1rn IL-1 receptor antagonist 
M88242 4.78 4.00 Ptgs2 Prostaglandin-endoperoxide synthase 2 
     
Transportation and Binding Proteins   
U95145 3.37 3.01 Akap1 A kinase (PRKA) anchor protein 1 
X57349 3.37 3.81 Trfr Transferrin receptor 
U15976 1.68 2.55 Slc27al Solute carrier family 27 (fatty acid transporter, member 1 
L23755 2.25 2.93 Slc19a1 Solute carrier family 19 (sodium/hydrogen exchanger), member 1 
D21207 2.50 3.06 Bzrp Benzodiazepine receptor, peripheral 
AI852578 4.01 3.87 Slc11a2 Solute carrier family 11 (proton-coupled divalent metal ion 
transporters), member 2 
AI747899 2.32 2.94 Pitpnb Phosphatidylinositol transfer protein, beta 
     
Extracellular Matrix and Adhesion   
U91513 3.37 3.19 Ninj1 Ninjurin 1 
M90551 2.55 3.01 Icam1 Intercellular adhesion molecule 1 
X79003 4.45 3.87 Itga5 Integrin alpha-5 (fibronectin receptor alpha) 
     
Apoptosis     
X67914 2.86 2.47 Pdcd1 Programmed cell death 1 
AF032459 4.59 3.61 Bcl2l11 BCL2-like 11 (apoptosis facilitator) 
U59758 3.28 3.32 Trp53 Transformation related protein 53 
L37296 2.89 2.93 Bad Bcl-associated death promotor  
M83649 4.83 4.69 Tnfrsf6 Tumor necrosis factor receptor superfamily, member 6  
(Fas antigen) 
AJ242778 4.04 4.30 Tnip1 TNFAIP3 interacting protein 1 
     
Cell Cycle, Differentation, and Proliferation   
D29678 2.52 2.75 Cdk5 Cyclin-dependent kinase 5 
M95200 2.70 2.80 Vegfa Vascular endothelial growth factor A 
M64849 3.45 5.15 Pdgfb Platelet-derived growth factor chain B precursor 
AJ009862 3.66 3.62 Tgfb1 Transforming growth factor, beta 1 
U09507 3.17 3.23 Cdkn1a Cyclin-dependent kinase inhibitor 1A (p21) 
AI849928 2.65 2.38 Ccnd1 Cyclin D1 
AW047032 3.19 4.16 Pin1 Protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1 
AW045530 2.02 2.49 Incenp Inner centromere protein 
     
DNA replication     
AW213225 2.61 3.77 Ddx18 DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 
     
RNA processing     
AW120557 3.25 4.59 Lsm4 LSM4 homolog,U6 small nuclear RNA associated 
     
Biosynthesis     
AB005623 2.55 2.55 Agpat1 1-acylglycerol-3-phosphate O-acetyltransferase 
(lysophosphatidic acid acyltransferase, alpha) 
AW122653 3.26 2.65 Mvk Mevalonate kinase 
     
Cytoskeleton and Membrane Proteins   
J04181 2.83 3.88 Actb Actin, beta, cytoplasmic 
AJ249706 3.70 4.26 Myo10 Myosin X 
AB024717 2.83 2.73 Clecsf9 C-type lectin (calcium-dependent, carbohydrate recognition domai
lectin, superfamily member 9 
D14883 2.56 3.16 Kai1 Kangai 1 (suppression of tumorigenicity 6, prostate) 
D00472 2.75 2.55 Cfl1 Cofilin 1, non-muscle 
X56123 2.45 2.59 Tln Talin 
AI837100 3.62 3.77 Cd83 CD83 antigen 
AI842889 2.49 2.75 Atp6v0b ATPase, H+ transporting, V0 subunit B 
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Table 2. -continued- 
Accession Nr.        Fold Increase         Gene Gene or Protein 
 14028s DLG294   
Protein Synthesis and Modification   
M76131 2.55 2.55 Eef2 Eukaryotic translation elongation factor 2 
X69656 2.39 2.65 Wars Tryptophanyl-tRNA synthetase 
X05021 3.00 3.96 Rpl27a Ribosomal protein L27a 
AI265655 2.59 2.86 Ppil2  Peptidylprolyl isomerase (cyclophilin)-like 2 
AV380793 2.39 2.93 Eif4g1 Eukaryotic translation initiation factor 4, gamma 1  
     
Mitochondrion     
U85089 2.30 2.83 Txn2 Thioredoxin 2 
AF043249 3.19 2.97 Tomm40 Translocase of outer mitochondrial membrane 40 homolog 
D17571 2.23 2.73 Por P450 (cytochrome) oxidoreductase 
AI849904 2.17 2.74 Dlst Dihydrolipoamide S-succinyltransferase (E2 component of 2-
oxoglutarate complex) 
     
Lipid Catabolism    
AA408341 3.10 3.52 Pla2g5 Phospholipase A2, group V 
     
Metabolism     
AF032466 2.56 2.49 Arg2 Arginase type II 
Z84471 2.30 2.75 G6pdx Glucose-6-phosphate dehydrogenase, X-linked 
AI843795 2.56 3.28 Pgls 6-phosphogluconolactonase 
AW047185 2.56 3.38 Thop1 Thimet oligopeptidase 1 
AI060798 3.38 4.16 Ptges Prostaglandin E synthase 
AI852592 2.18 3.07 Ndufb2 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 
     
Defense Response    
AV090497 4.44 3.66 Solpi Secretory leukoprotease inhibitor 
    
Superoxide Production    
AB002663 2.28 2.52 Ncf1 Neutrophil cytosolic factor 1 (p47phox) 
U43384 2.55 2.93 Cybb Cytochrome b-245, beta polypeptide 
M31775 3.66 4.64 Cyba Cytochrome b-245, alpha polypeptide 
     
Protein Degradation and Processing   
M25149 2.49 2.89 Psmd3 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 
AW124386 2.61 3.15 Ubl5 Ubiquitin-like 5 
AI850365 2.38 2.65 Ubc-rs2 Ubiquitin C, related sequence 2 
     
Regulatory     
X70764 3.46 4.09 Mark2 MAP/microtubule affinity-regulating kinase 2 
AF018262 2.46 2.93 Ppp5c Protein phosphatase 5, catalytic subunit 
U20857 3.15 4.38 Rangap1 RAN GTPase activating protein 1 
J02935 3.29 4.34 Prkar2a Protein kinase, cAMP-dependent regulatory, type II-alpha 
AF043070 2.30 3.04 Bckdk Branched chain ketoacid dehydrogenase kinase 
AW049387 2.56 2.86 Arl2 ADP-ribosylation factor-like 2 
     
Intracellular Trafficking    
D87900 1.62 2.50 Arf3 ADP-ribosilation factor 3 
Y13361 2.27 2.86 Rab7 RAB7, member RAS oncogene family 
     
Signalling Receptors    
U05673 3.74 3.38 Adora2b Adenosine A2b receptor 
M83312 3.37 3.48 Tnfrsf5 TNF receptor superfamily, member 5 
X62700 4.15 4.51 Plaur Urokinase plasminogen activator receptor 
X87128 4.38 4.87 Tnfrsf1b TNF receptor superfamily, member 1b 
AA608277 2.65 2.75 Adora2b Adenosine A2b receptor 
AI838195 3.46 4.26 Ogfr Opioid growth factor receptor 
     
Signal Transduction    
X95761 2.62 3.08 Lbcl1 Lymphoid blast crisis-like 1 
X76850 3.98 2.62 Mapkapk2 MAP kinase-activated protein kinase 2 
X84797 3.46 4.20 Hcls1 Hematopoietic cell specific Lyn substrate 1 
X80638 3.77 4.46 Arhc Ras homolog gene family , member C 
Y17808 2.59 3.49 Ptk91 PTK9 protein typrotein tyrosine kinase 9-like (A6-related protein) 
U20159 2.64 2.73 Lcp2 Lymphocyte cytosolic protein 2 
U42383 2.73 2.47 Ppm1g Protein phosphatase 1G (formarly 2C), magnesium-dependent, 
gamma isoform 
AI642662 2.55 2.22 Dusp16 Dual specific phosphatase 16 
AA153773 2.74 3.53 Tbl3 Transducin (beta)-like 3 
AA764261 2.77 2.97 Pim1 Proviral integration site 1 
AW124934 3.46 3.06 Peli1 Pellino 1 
AA762522 4.38 4.59 Dtx2 Deltex 2 homolog 
     
Chapter 8 
152 
Table 2. -continued- 
Accession Nr.        Fold Increase         Gene Gene or Protein 
 14028s DLG294   
Transcription     
U09419 2.93 4.09 Nr1h2 Nuclear receptor subfamily 1, group H, member 2 
AF015881 2.93 3.15 Nfe2l1 Nuclear factor, erythroid-derived 2, -like 1 
AF043220 3.06 3.98 Gtf2i Genereal transcription factor II I 
AB009693 4.51 4.94 MafG V-maf musculoaponeurotic fibrosarcoma oncogene family, 
protein G 
AF060076 2.62 2.66 Phc2 Polyhomeotic-like 2 
X55038 2.77 3.74 Cenpb Major centromere autoantigen B 
U20735 2.66 2.77 JunB Jun-B oncogene 
X14678 4.05 2.33 Zfp36 Zinc finger protein 36 
U47543 2.45 2.87 Nab2 Ngfi-A binding protein 2 
M61007 2.93 3.23 Cebpb CCAAT/enhancer binding protein (C/EBP), beta 
L03215 2.59 2.84 Sfpi1 SFFV proviral integration 1 
AF017085 3.10 3.88 Gtf2i General transcription factor II 1 
J04103 2.73 2.55 Ets2 E26 avian leukemia oncogene 2, 3’domain 
AI846152 2.74 2.70 Dscr1 Down syndrome critical region homolog 1 
AW047899 2.97 2.75 Nfkb2 Nuclear factor of kappa light polypeptide gene enhancer in B 
cells 2, p49/p100 
AI850881 2.47 2.65 Gtf2h4 General transcription factor II H, polypeptide 4 
     
Other     
L24118 2.93 3.14 Tnfaip2 Tumor necrosis factor, alpha-induced protein 2 
U60884 2.62 2.77 Bin1 Bridging integrator 1 
U32197 2.86 3.62 Fpgs Folylpolyglytamyl synthetase 
U05837 2.83 3.26 Hexa Hexoaminidase A 
     
Unknown Gene Function     
AF061346 2.22 2.86 Tnfaip2 TNFα induced protein 1 
U87965 2.32 2.65 Gtpbp1 GTP-binding protein 1 
AF033201 2.65 2.84 Cpsf4 Cleavage and polyadenylation specific factor 4 
M59821 4.30 4.29 Ier2 Immediate early response 2 
AW210320 2.62 2.59 Ptov1 Prostate tumor overexpressed gene1 
AW125378 2.66 2.94 Aamp Angio-associated migratory protein 
AW122679 2.59 2.47 Prrg2 Proline-rich Gla (G-carboxyglutamic acid) polypeptide 2 
AW122052 2.16 2.86 Nans N-acetylneuraminic acid synthase (sialic acid synthase) 
AW125157 2.45 2.63 Fbxw1b F-box and WD-40 domain protein 1B 
AI837492 2.39 3.14 Orf61 Open reading frame 61 
 
 
These genes are upregulated upon infection with wild-type S. enterica serovar 
Typhimurium 14028s as well as by the superoxide-hypersusceptible mutant DLG294 and 
only the expression of Il1rn is statistical significantly different being more expressed in wild-
type 14028s-infected cells (Table 4) indicating that the inflammatory response induced by 
DLG294 is only slightly lower than that induced by the wild-type. 
Chemokines are small molecules that are involved in chemotaxis and activation of 
leukocytes at the site of inflammation. These chemotactic cytokines can be divided into 
four subfamilies, designated C, CC, CXC, and CX3C chemokine ligands, based on the 
positions of their cysteine residues (2, 3). Genes encoding chemokines are induced upon 
infection with wild-type S. enterica serovar Typhimurium as well as with DLG294. The gene 
expression of Ccl5, Cxcl10, Cxcl2, Ccl4, and Ccl7 are all highly induced (Table 1). Only the 
expression of Cxcl10 differs significantly between 14018s and DLG294 infected cells being 
more expressed in 14028s infected cells (Table 4).  
Isgl5, Ifit1, Glp2, and Irg1 are genes involved in immune responses and the 
expression of these four genes was highly induced upon infection of RAW264.7 cells with 
either wild-type or DLG294 Isgl5, Ifit1, and Glp2 are genes that are induced upon 
stimulation with IFNγ while Irg1 is an LPS inducible gene (14). The expression of all four 
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genes seemed slightly lower for the DLG294 infected cells (Table 1). Gene expression of 
Ifit1 appeared to be significantly lower for DLG294 infected cells compared to the wild-type 
infected cells (Table 4) suggesting that the IFNγ response may be slightly lower in DLG 
infected cells. Also the expression of the H2 genes involved in antigen presentation were 
highly induced in the infected cells (Table 1), although no differences could be observed 
between the wild-type and DLG294 infected cells.  
 
 
Table 3. Macrophage gene expression reduced by S. enterica serovar Typhimurium  
Accession nr.  Fold Decrease Gene Gene or Protein 
 14028s DLG294   
Transportation and Binding Proteins 
AW227545 2.02 2.30 Strn Striatin, calmodulin binding protein 
     
Extracellular Matrix and Adhesion 
D50086 3.25 3.25 Nrp Neuropilin 
U47323 2.00 2.46 Stim1 Stromal interaction molecule 1 
     
Apoptosis     
AI643420 1.52 1.81 Bag3 Bcl2-associated athanogene 3 
     
Cell Cycle, Proliferation, and Differentiation 
AF003000 1.86 1.62 Terf2 Telomeric repeat binding factor 2 
U95826 3.88 3.16 Ccng2 Cyclin G2 
D78382 2.02 2.10 Tob1 Transducer of ErbB-2.1 
D87326 1.81 2.30 Gsg2 Germ cell-specific gene 2 
U42384 1.88 1.74 Fin15 Fibroblast growth factor inducible 15 
AF086905 1.93 1.94 Chek2 CHK2 checkpoint homolog 
M36033 1.69 1.76 Ptpra Protein tyrosine phosphatase, receptor type A 
Z35294 1.53 2.00 Mtcp1 Mature T-cell proliferation 1 
M57647 2.64 3.62 Kitl Kit ligand 
AB033921 1.80 1.96 Ndr2 N-myc downstream regulated 2 
Y12474 1.76 1.88 Cetn3 Centrin 3 
AW121600 2.10 2.25 Ndr4 N-myc downstream regulated 4 
AW209238 1.74 1.93 Tacc3 Transforming, acidic coiled-coil containing protein 2 
AV349686 1.87 1.96 Ndr2 N-myc downstream regulated 2 
     
Cytoskeleton and Membrane Proteins 
X98471 1.93 1.93 Emp1 Epithelial membrane protein 1 
M58661 1.78 1.81 Cd24a CD24a antigen 
U38967 1.83 1.91 Tmsb4x Thymosin, beta 4, X chromosome 
AW121972 2.15 2.00 Waspip Wiskott-Aldrich syndrome protein interacting protein 
AI505453 1.63 1.87 Myhg Myosin heavy chain IX 
AW121840 1.99 2.23 Sel1h Sel1 (suppressor of Lin-12) 1 homolog 
     
DNA replication     
AI447783 2.22 2.46 Helb Helicase (DNA) B 
AA681520 1.81 2.02 Gmnn Geminin  
AW060791 1.76 1.69 Pole4 Polymerase (DNA-directed), epsilon 4 (p12 subunit) 
     
RNA Processing     
U22262 2.75 2.66 Apobec1 Apolipoprotein B editing complex 1 
     
Protein Synthesis     
M61215 1.64 1.93 Fech Ferrochelatase 
AF076681 1.93 1.74 Eif2ak3 Eukaryotic translation initiation factor 2 α kinase 3 
AB004789 1.63 1.75 Dpm1 Dolichol-phosphate (beta-D-mannosyltransferase 1 
     
Mitochondrion     
X51941 1.81 1.80 Mut Methylmalonyl-Coenzyme A mutase 
AF017175 2.16 2.07 Cpt1a Carnitine palmitoyltransferase 1 (liver) 
U07159 1.80 1.81 Acadm Acetyl-Coenzyme A dehydrogenase, medium chain 
AI842835 1.76 1.69 Uqcrc2 RTKubiquinol cytochrome c reductase core protein 2 
     
Metabolism     
X77731 2.15 2.56 Dck Deoxycytidine kinase 
AI851983 1.66 1.81 Gsr Glutathione reductase 1 
AI842808 1.76 1.68 Ndufb5 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 
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Table 3. -continued- 
Accession Nr.  Fold Decrease Gene Gene or Protein 
 14028s DLG294   
Biosynthesis     
X86000 2.50 3.30 Siat8d Sialyltransferase 8 (alpha-2, 8-sialyltransferase) D 
U85414 2.55 2.30 Gclc Glutamate-cysteine ligase, catalytic subunit 
M26270 1.78 1.73 Scd2 Steaoryl-Coenzyme A desaturase 2 
AW060843 1.78 1.96 Lias Lypoic acid synthetase 
D16333 1.46 1.75 Cpo Coproporphyrinogen oxidase 
     
DefenseResponse    
M29394 1.57 2.07 Cat Catalase 
U77461 1.63 1.81 C3ar1 Complement component 3a receptor 1 
     
Protein Degradation and Processing  
AB007139 1.52 1.81 Psme3 Proteasome (prosome, macropain) 28, subunit 3 
AF079565 3.01 2.65 Usp2 Ubiquitin-specific protease 2 
AW122823 2.08 2.00 Ube2r2 Ubiquitin-conjugating enzyme E2R2 
AI844932 1.94 2.23 Fbxo8 F-box only protein 8 
     
Immune Response    
AB007599 1.87 1.93 Ly86 Lymphocyte antigen 86 
U15635 1.91 2.10 Samhd1 SAM domain and HD domain, 1 
     
Intracellular Trafficking    
D49544 2.16 2.39 Kifc1 Kinesin family membe C1 
AI847561 1.81 1.87 Ap4s1 Adaptor-related protein complex AP-4, sigma 1 
AV059766 1.71 1.86 Kif20a Kinesin family member 20a 
     
Signalling Receptors    
D13458 2.55 2.08 Ptger4 Prostaglandin E receptor 4 (subtype EP4) 
AF031127 1.57 1.78 Itpr5 Inositol 1,4,5-triphosphate receptor 5 
AV012229 1.78 2.00 Fcer1g Fc receptor, IgE, high affinity 1, gamma polypeptide 
     
Regulatory     
D86344 2.47 2.47 Pdcd4 Programmed cell death 4 
U20238 2.94 2.47 Rasa3 RAS p21 protein activator 3 
AW122931 1.81 1.81 Ikbkg Inhibitor of kappaB kinase gamma 
AI835963 2.15 2.02 Pias3 Protein inhibitor of activated STAT3 
AI851250 1.75 1.81 Spred2 Sprouty protein with EVH-1 domain 2, related sequence 
AV335997 2.08 2.07 Rgs10 Regulator of G-protein signalling 10 
     
Signal Transduction    
U37465 2.93 2.46 Ptpro Protein tyrosine phosphatase, receptor type O 
L11316 1.76 1.86 Ect2 Ect2 oncogene 
AF068182 2.30 2.30 Blnk B-cell linker 
L21671 1.46 1.93 Eps8 Epidermal growth factor receptor pathway substrate 8 
U67187 1.57 1.76 Rgs2 Regulator of G-protein signalling 2 
AF079528 3.03 2.39 Ier5 Immediate early response 5 
AF020313 1.68 1.75 Apbb1ip Amyloid beta (A4) precursor protein-binding, family B, 
member 1 interacting protein 
AA981154 1.53 1.96 Srpk2 Serine/Arginine-rich protein specific kinase 2 
AI317205 2.30 2.47 Map3k1 Mitogen activated protein kinase kinase kinase 1 
AW124633 1.69 2.07 Nek7 NIMA (never expressed in mitosis gene-a)-related 
expressed kinase 7 
AI849416 2.00 1.87 Lats2 Large tumor suppressor 2 
AI847399 1.87 1.68 Rgs10 Regulator of G-protein signalling 10 
AI835968 2.65 2.46 Rin2 Ras and Rab interactor 2 
AI846534 1.62 1.94 Nek6 NIMA (never in mitosis gene-a)-related expressed kinase 6 
     
Transcription     
M22115 1.88 1.80 Hoxa1 Homeo box A1 
AF020200 1.88 2.35 Pbx3 Pre B-cell leukemia transcription factor 
AF062567 1.58 1.83 Sp3 Trans-acting transcription factor 3 
M32057 1.68 1.75 Zfp239 Zinc finger protein 239 
AF000581 2.08 1.99 Ncoa3 Nuclear receptor coactivator 3 
AF064088 2.00 2.07 Tieg1 TGFB inducible early growth response 1 
AF064088 1.74 1.80 Tieg1 TGFB inducible early growth response 1 
X64840 1.75 1.75 Tcf12 Transcription factor 12 
AF077861 2.14 2.39 Idb2 Inhibitor of DNA binding 2 
AI449034 2.23 1.86 Rest RE1-silencing transcription factor  
AI847906 1.80 1.75 Tcf20 Transcription factor 20 
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Table 3. -continued- 
Accession Nr.  Fold Decrease Gene Gene or Protein 
 14028s DLG294   
Other     
L27439 1.53 2.19 Pros1 Protein S (alpha) 
AF040252 2.02 1.75 Fkbp7 FK506 binding protein 7 
U70674 2.38 2.22 Numb Numb gene homolog 
X74351 1.83 1.75 Xpa Xeroderma pigmentosum, complementation group A 
U64450 1.57 2.15 Npm3 Nucleoplasmin 3 
AF004326 2.46 2.89 Agpt2 Angiopoietin 2 
AF041472 1.62 1.81 Sca2 Spinocerebellar ataxia 2 homolog 
AI987985 2.86 3.26 Zfp288 Zinc finger protin 288 
AW060819 1.80 1.80 Twsg1 Twisted gastrulation homolog 1 
AA733664 2.15 2.52 Cpeb2 Cytoplasmic polyadenylation element binding protein 2 
AW125218 1.53 1.76 Hat1  Histidine aminotransferase 
Unknown Gene Function  
  
U73039 1.94 1.88 Nbr1 Neighbor of Brca1 gene 1 
M18070 1.69 1.75 Prnp Prion protein 
AF058797 1.51 1.68 Ywhab Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, beta polypeptide 
AW120605 1.83 1.81 Mllt3 Myeloid/lymphoid or mixed lineage-leukemia translocation 
to 3 homolog 
AI842472 3.19 2.49 Zdhhc14 Zinc finger, DHHC domain containing 14 
AA930526 1.81 2.04 Mtmr13 Myotubularin related protein 13 
AA968123 1.96 2.04 Nav1 Neuron navigator 1 
AW120725 1.81 1.81 Ubl3 Ubiquitin-like 3 
AW060827 2.02 2.00 Them2 Thioesterase superfamily, member 2 
 
 
Moderately induced genes. Genes showing only moderate induced expression are 
mostly genes involved in cell cycle and cell death and apoptosis (Table 2). For all genes, 
no differences could be observed between wild-type and DLG294 infected cells. Pdcd1, 
Bcl2l11, Trp53, Bad, Tnfrsf6 (Fas antigen), and Tnip1 are all genes encoding proteins that 
are involved in apoptosis and all genes show a 2-4 fold induction in expression. Also the 
expression of some genes involved in cell cycle (regulation) such as Cdk5, Cdkn1a, Ccnd1 
are induced upon infection. Again, these genes show only a slight increase in expression. 
 
Direct comparison of gene expression profiles of 14028s and DLG294. Direct 
comparison of the gene expression profiles of RAW264.7 cells infected with either wild-
type S. enterica serovar Typhimurium or the superoxide hypersusceptible mutant strain 
DLG294 revealed only small differences in the expression in only a few genes (Table 4). 
Nine genes showed increased expression in wild-type infected cells compared to DLG294 
infected cells encoding proteins that are involved in inflammation and immune responses, 
RNA processing, transcription, and regulation. Most of these genes play a role in innate 
defense of the macrophages against pathogens such as Salmonella. Cxcl10 encodes a 
chemokine (C-X-C motif) that is also known as IFNγ-induced protein 10. For 
Mycobacterium tuberculosis infected cells it has been shown that optimal expression of 
cxcl10 is dependent upon TNFα (1). Tnf expression is induced in both wild-type and 
DLG294 infected cells (Table 1). Although not statistical significantly different in the direct 
comparison, from Table 1 it seems that tnf is induced even more in the DLG294 infected 









Change Gene Gene or Protein Function 
M33266 1.4 Cxcl10 Chemokine (C-X-C- motif), ligand 10 Inflammation, Cytokines, and Chemokines 
L32838 1.6 Il-1rn IL-1 receptor antagonist Inflammation, Cytokines, and Chemokines 
AF037437 -1.5 Gtrgeo22 Gene trap ROSA b-geo 22 Cytoskeleton and Membrane Proteins 
AW213225 -1.4 Ddx18 DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 8 
DNA Replication 
L17076 1.6 Raly HnRNP-associated with lethal yellow RNA Processing 
AI852592 -1.5 Ndufb2 NADH dehydrogenase (ubiquinone) 1 
beta subcomplex, 2 
Metabolism 
U43084 1.5 Ifit1 Interferon induced protein  
with tetratricopeptide repeats 1 
Immune Response 
X14678 1.4 Zfp36 Zinc finger protein 36 Transcription 
M31418 1.5 Ifi202a Interferon activated gene 202A Transcription 
L20450 1.6 Zfp97 Zinc finger protein 97 Transcription 
AA981581 1.9 Hnrpu Heterogeneous nuclear 
ribonucleoprotein U 
Regulatory 
AF037437 -1.8 Psap Prosaposin Other 
U82610 -1.5 Lcp1 Lymphocyte cytosolic protein 1 Other 
X05546 -1.7 Iap2 Intracisternal A particle 2 Other 
AI645561 1.4 Narg1 NMDA receptor-regulated gene 1 Other 
 
 
Protein Assay as Confirmation of Microarray Analysis. One way to validate the 
results form the mRNA expression levels by microarray analysis is to determine the protein 
levels of certain genes involved in defense against S. enterica serovar Typhimurium. We 
decided to assess proteins secreted into the supernatant of infected RAW264.7 cells at 4 h 
after infection. This was done by a Mouse Inflammation Cytometric Bead Array, which 
allows the analysis of six proteins simultaneously. As shown in Figure 3, we observed that 
uninfected RAW264.7 cells secrete no detectable amounts of IL-6, IL-10, IFNγ, and IL12-





Figure 4. Mouse 
Inflammation Cytometric 
Bead Array analysis of 
supernatant from 
RAW264.7 cells that were 
left untreated or that were 
infected with S. enterica 
serovar Typhimurium 
14028s or DLG294. Cells 
were challenged as 
described in Materials and 
Methods. At 4 h after 
challenge, the supernatant 
was taken and used for 
analysis in the Cytometric 
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The secretion of MCP-1 and TNFα is induced strongly upon infection of the cells with 
either wild-type S. enterica serovar Typhimurium 14028s or the mutant strain DLG294. 
MCP-1 is a chemotactic factor encoded by Ccl2 that is secreted by the macrophages to 
attract monocytes, but not neutrophils. Upon infection of the cells with wild-type or DLG294 
the production of MCP-1 increased 3-fold to 60.3 and 64.5 ng respectively (Fig. 4). Both 
strains induced the production and secretion of MCP-1 to a similar extent, which 
corresponds to the relative increases in mRNA expression of the gene encoding MCP-1 
(Ccl2) in the microarray analysis (2.10 fold for wild-type and 1.94 fold for DLG294 infected 
cells; data not shown). Expression levels of mRNA for TNFα, however, increased 9.5 and 
10.9 fold for wild-type- and DLG294-infected cells respectively, while the secreted TNFα 
levels were induced 22.9 fold to 100.6 ng for wild-type and 33.6 fold to 147.9 ng 
respectively. These results show that the increase in secreted amounts of the protein does 
not correspond exactly to the increase in mRNA expression, but they do show that the 
relative induction of mRNA expression and secreted product by wild-type and DLG294-
infected cells do correlate and confirms the data observed in the microarray analysis. The 
other four proteins were not detected within the supernatant of uninfected and infected 
RAW264.7 cells.  
 
Concluding remarks. Since the gene expression profiles are dependent upon the 
activation status of the macrophages (19) and no clear differences in the gene expression 
profiles of RAW264.7 cells infected with wild-type S. enterica serovar Typhimurium or 
DLG294 were observed, it might be concluded that the activation status of the 
macrophages is not altered by infection with DLG294 compared to the wild-type strain. 
Apparently, lack of expression of sspJ in DLG294 does not result in stronger or lesser 
activation of the macrophages, indicating that both strains are equally capable of 
modulating the macrophages' response. This strongly suggests that attenuation of 
DLG294 is not due to the hosts' macrophages, but is due to the lack of expression of sspJ 
in DLG294 causing its pleiotropic phenotype, including hypersusceptibility to superoxide. 
This is supported by the fact that DLG294 is able to grow out in cells and mice that do not 
produce any superoxide (24), although the activation statuses of these cells are unknown.  
Research on S. enterica serovar Typhimurium mutants, including DLG294, has led to 
the isolation and identification of mutants that are either more susceptible or more resistant 
to superoxide. From these studies it became clear that Salmonella has evolved many 
mechanisms to cope with superoxide stress that may either prevent production or limit the 
damage that is done by these compounds (reviewed in (12)). It also became clear that 
mutants might share the same in vitro phenotype according to superoxide sensitivity, but 
they might have different in vivo phenotypes and very diverse genetic defects, ranging 
from defects in SOD's, glucose-6-phosphate dehydrogenase, or DNA repair mechanisms. 
So from the in vitro phenotype it cannot be predicted what the consequences of this 
mutation are for the in vivo and in vitro virulence. And reversely, from the in vivo and in 
vitro phenotype it cannot be predicted what the underlying genetic and proteomic defects 
might be. One way to understand the differences in the in vitro and in vivo phenotype is to 
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do research on host genes induced upon infection with Salmonella as is done in this study. 
Another approach would be to look at in vivo-regulated genes of S. enterica serovar 
Typhimurium itself during infection of host cells (5). Direct comparison of gene expression 
profiles of intracellular DLG294 and wild-type S. enterica serovar Typhimurium might 
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DLG294 is a Salmonella enterica serovar Typhimurium mutant that is 
hypersusceptible to intracellular superoxide that is highly attenuated in vivo in C3H/HeN 
mice and in vitro in macrophages. The altered virulence of DLG294 is not due to increased 
activation of the macrophage but must be due to the lack of expression of sspJ. With the 
study presented here, we tried to address the role of sspJ by checking the broad spectrum 
phenotypes of DLG294 and the wild-type strain using phenotype microarrays and by 
looking at in vivo-regulated genes of S. enterica serovar Typhimurium itself during infection 
of host cells. 
In this study we show that DLG294 is more susceptible to acid, lixivium, and antibiotics 
that inhibit protein synthesis, suggesting that the interior defense against toxic compounds 
is wrongly regulated/disregulated in DLG294. Comparison of the gene expression profiles 
of intracellular DLG294 and wild-type 14028s revealed only a few small differences. This 
indicates that sspJ does not have an important role in regulating (virulence) gene 
expression but that it has a direct role in survival under stress conditions like those 
encountered inside the macrophage. We propose that the absence of SspJ alters the 
integrity of the Salmonella membrane leading to increased permeability and thus enhanced 
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Introduction 
 
Salmonellae are Gram-negative facultative intracellular pathogens that can cause a 
variety of diseases in animals and man, ranging from mild gastroenteritis to severe 
systemic infections like typhoid fever. Salmonella enterica serovar Typhimurium may cause 
gastroenteritis in man, but causes systemic infection in mice comparable to typhoid fever in 
man (17). Salmonella predominantly invades mononuclear phagocytes and is able to 
cause persistent infections by evasion or disturbance of the host immune system (16). 
Upon infection with Salmonella, the host will try to develop an immune response to limit 
bacterial growth and to eventually kill and eliminate the pathogen. Despite the presence of 
a multitude of antimicrobial defense mechanisms as part of the innate immune defense 
system in phagocytes, Salmonella is able to enter, survive, and even replicate within these 
cells. S. enterica serovar Typhimurium responds to the specific host environment by 
expressing factors that are necessary for intracellular survival and for resistance against 
the defense systems of the host (6, 8, 9, 16, 20), but the exact mechanisms by which it is 
able to survive after phagocytosis are largely unknown.  
One of the major early defense mechanisms against Salmonella is the production of 
reactive oxygen intermediates (ROI), both in vitro (18) and in vivo (24, 25, 33). Since 
superoxide is a by-product of normal aerobic metabolism, both eukaryotic and prokaryotic 
cells have evolved ways to respond to superoxide stress by the activation of genes 
involved in a protective response (23). Several genes and systems have been described 
that play a role in the defense response of S. enterica serovar Typhimurium against ROI, 
such as the SoxR/S regulon, the OxyR system, katE encoding cytosolic catalase, and the 
superoxide dismutases SocCI and SodCII (reviewed in (14)). The relative importance of 
each of the mechanisms involved in defense against oxidative stress for S. enterica 
serovar Typhimurium intracellular survival has not been elucidated. However, the 
periplasmic Cu,Zn-SOD and the type III secretion system encoded by Salmonella 
pathogenicity island 2 (SPI2) have been shown to be important in this defense, as mutants 
deficient in one of these systems show reduced survival within macrophages (5, 10, 34).  
We have recently identified a superoxide hypersusceptible S. enterica serovar 
Typhimurium sspJ mutant strain DLG294 that is highly attenuated in vivo in C3H/HeN mice 
and in vitro in macrophages (27, 32). The attenuated phenotype is related to its 
hypersusceptibility to superoxide since DLG294 is able to grow out as much as the wild-
type strain in cells and mice that lack one of the components of the NADPH-oxidase and 
as a result cannot produce superoxide (32). The exact function and mechanism of action of 
sspJ, however, are still unknown. Although hypersusceptibility to superoxide could be the 
major cause of attenuated virulence of DLG294, it cannot be excluded that other factors 
might also play a role. Virulence is not determined by superoxide sensitivity sec since 
many menadione-susceptible mutants are not attenuated at all (28, 29, 31). These data 
suggest that other factors play a role. 
One way to address the differences in virulence of DLG294 and the wild-type strain is 
to study the macrophage activation status by comparing the gene expression profiles of 
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infected macrophages (22) as this might give an indication on how the macrophages 
respond to infection with a certain pathogen. We previously addressed the question if a 
possible difference in the activation status of the macrophages might explain and might 
clarify whether attenuation of DLG294 is solely due to its hypersusceptibility to superoxide 
produced by the macrophages or that additional mechanisms play a role. Since we 
observed no or only minor differences in gene expression profiles between DLG294 or 
wild-type-infected RAW264.7 macrophages (30) we have performed another study in 
which we checked the broad spectrum phenotypes of DLG294 and the wild-type strain 
using phenotype microarrays and have assessed in vivo-regulated genes of S. enterica 
serovar Typhimurium during infection of host cells as described by Eriksson et al. (7).(12) 
 
 
Materials and Methods 
 
Bacterial strains and culture conditions. The bacterial strains used in this study are 
listed in Table 1. Bacteria were grown overnight (ON) on LB broth plates at 37°C. The day 
of infection, a large number of bacterial cells were resuspended in 10 ml PBS. The 
bacterial cells were pelleted and resuspended in 1 ml PBS. For opsonization, 10% mouse 
serum was added and bacteria were incubated at 37°C for 30 min. 
 
 
Table 1. S. enterica serovar typhimurium strains used in this study 
Strain characteristics origin or reference 
14028s wild-type ATCC 
DLG294 14028s sspJ::MudJ (27) 
SL1344 rpsL hisG (13) 
 
 
In vitro acid challenge. ON cultures of bacteria grown in LB medium pH7.0 were 
diluted 1:100 in LB medium + 0.4% glucose pH 7.0 (unadapted) of in LB medium + 0.4% 
glucose pH 4.5 (adapted) and were incubated at 37°C for 1 h. A sample was taken to 
determine the number of bacteria before challenge with acid (t=0 h) and the remaining 
bacteria were spun down and resuspended in LB medium + 0.4% glucose pH 3.0 and were 
incubated at  37°C. At 1 and 2 h after challenge, samples were taken to determine the 
number of bacteria that were still viable. 
 
Cell culture and in vitro infection model. RAW264.7 cells were grown in RPMI 1640 
medium supplemented with 10% FCS, 25 mM HEPES, L-Glutamine, 100 U/ml penicillin, 
and 50 mg/ml streptomycin. For each extraction of RNA 1 × 108 cells were seeded in four 
225 cm2 tissue culture flasks (Costar) in RPMI 1640 medium supplemented with 10% FCS, 
25 mM HEPES, and L-Glutamine. Cells were infected at an MOI of 100 with bacteria that 
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were opsonized or non-opsonized for 1 h at 37°C and 5% CO2 to allow uptake of the 
bacteria. Then extracellular bacteria were killed by adding medium containing 30 µg/ml 
gentamicin. After 1 h incubation at 37°C and 5% CO2 the medium was replaced for 
medium containing 5 µg/ml gentamicin and were incubated for another 2 h. 
 
Phenotype Microarray (PM). PM tests were performed in duplicate by Biolog Inc. 
(Hayward, California, U.S.A.) as described in (3). All PMs were incubated at 36°C in an 
OmniLog and monitored for color change in the wells. Kinetic data were analyzed with 
OmniLog-PM software. The phenotype of mutant DLG294 was compared to that of the 
wild-type 14028s. 
 
RNA extraction. After 4h, the infected RAW264.7 macrophages were lysed on ice for 
30 min in 0.1% SDS, 1% acidic phenol, 19% ethanol in water. Bacterial pellets were 
collected by centrifugation and RNA was extracted using the Promega SV total RNA 
purification kit. Approximately 108 CFU were isolated on each time point and yielded 3-5 µg 
RNA. Size chromatography was done with an Agilent 2100 Bioanalyser.  
 
Microarray. DNA microarray analysis was performed as described in (4), except that 
the arrays were printed on Corning CMT-GAPSTM-coated slides and contained 666 extra 
genes from S. enterica serovar Typhimurium DT104 and SL1344, S. enterica serovar 
enteritidis PT4, and S. enterica serovar Galinarum 287/91 ("Salsa" microarray, 
http://www.ifr.bbsrc.ac.uk/Safety/Microarrays/default.html). 
 
Probe labeling and scanning. RNA was first reverse transcribed into cDNA and was 
then labeled by random priming. For labeling protocols, see 
http://www.ifr.bbsrc.ac.uk/Safety/Microarrays/Protocols.html. Fluorescently labeled 
genomic DNA was used as a reference in each experiment. After hybridization, the slides 
were scanned using a GenePix 4000 A scanner (Axon Instruments). The fluorescent spots 
and the background signals were then quantified using GenePix Pro software (Axon 
Instruments). All RNA samples were hybridized to microarrays in duplicate.  
 
Data analysis. Spots that showed a reference signal lower than the background 
signal plus two standard deviations were excluded from the analysis. The background 
signal was subtracted from each spot signal and fluorescence ratios were calculated. After 
performing data centring, data were analyzed using GenespringTM software (Silicon 
Genetics) as described previously (7). Only coding regions showing at least a two-fold 
difference in the mutant compared to the wild-type strain were regarded as being 
differentially expressed. Hierarchal clustering of gene expression profiles was performed 






Results and Discussion 
  
In vitro phenotypes lost by DLG294 vs 14028s. In order to address the role of sspJ 
in S. enterica serovar Typhimurium, we compared the broad spectrum phenotypes of the 
sspJ mutant DLG294 and the wild-type strain using phenotype microarrays. In this assay, 
the ability of wild-type S. enterica serovar Typhimurium and DLG294 to grow in the 
presence of 2000 different nutrients, antibiotics, and toxic compounds was evaluated by 
determining metabolic rates. With this assay most known aspects of cell function can be 
monitored and the range of phenotypes include cell surface composition and transport, 
catabolism, biosynthesis, macromolecules, cellular machinery, respiratory functions, and 
stress and repair functions. Quite a few phenotypes were lost by the sspJ mutant 
compared to the wild-type strain (Table 2).  DLG294 was more sensitive to an acidic or 
alkalic environment as its growth is impaired at pH9.5 and pH4.5 compared to that of the 
wild-type strain (Table 2). We have further tested the sensitivity to acid in an in vitro 
challenge assay in which we used logphase LB cultures of 14028s and DLG294 grown at 
pH 7.0 and challenged with LB medium pH 3.0. The numbers of  DLG294 declined faster 
than those of the wild-type strain confirming the increased susceptibility to acid (Fig. 1). 
However, when DLG294 bacteria were allowed to adapt at intermediate pH (pH 4.5) and 
were then challenged with pH 3.0, DLG294 behaved like the wild-type strain (Fig. 1). 
 
 
Figure 1.  In vitro acid 
challenge assay. Percentage 
viable count of wild-type S. 
enterica serovar Typhimurium 
14028s (white bars) and 
DLG294 (black bars) at 0, 1, 
and 2 h after challenge with 
LB medium pH 3.0. The 
bacteria were allowed to 
adapt in LB medium with 
intermediate pH 4.5 for 1 h 
before challenge or were left 





DLG294 also has diminished resistance to protein synthesis inhibiting antibiotics. The 
macrolides inhibit bacterial protein synthesis by inhibiting the 50S ribosomal subunit. The 
other protein synthesis inhibitors have more diverse mechanisms of action such as 
inhibition of polymerization of glycoproteins (vancomycin), premature termination of chains 
during translation (puromycin), inhibition of translocation during protein synthesis (fusadic 
acid), or inhibition of peptide bound formation in the ribosomal machinery (blasticidin S). 
The resistance to the β-lactam type of antibiotics as well as the related cephalosporins was 
also impaired in the DLG294 mutant compared to the wild-type strain. These antibiotics 
inhibit bacterial wall synthesis and are therefore bactericidal for rapidly dividing cells.  
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Table 2. Phenotypes lost by DLG294 compared to wild-type 14028s 
testa differenceb mode of action 
 min max  
Ketoprofen -70 anti-capsule, anti-inflammatory 
Sanguinarine -102 ATPase, Na+/K+ and Mg2+ 
sodium pyrophosphate -59 chelator, hydrophilic 
2,2'-dipyridyl -108 chelator, lipophilic 
orphenadrine -108 cholinergic antagonist 
Prinidol -55 cholinergic antagonist 
promethazine -76 cyclic nucleotide phosphodiesterase 
9-aminoacridine -75 DNA interchelator 
4-hydroxycoumarin -89 DNA interchelator 
Acriflavine -44 DNA interchelator 
novobiocin -87 DNA topoisomerase 
domiphen bromide -78 fungicide 
D-serine               -60 inhibits 3PGA dehydogenase  
(L-serine and pantothenate synthesis) 
trifluoperazine -94 ion channel, Ca2+ 
dequalinium chloride -72 ion channel, K+ 
benzothonium chloride -100 membrane, detergent, cationic 
poly-L-lysine -110 membrane, detergent, cationic 
lauryl sulfobetaine -73 membrane, detergent, zwitterionic 
amitriptyline -95 membrane, transport 
Lys-Gly -140 N-source 
Val-Lys -81 N-source 
3% urea -86 osmotic sensitivity, urea 
plumbagin -121 Oxidizing agent 
potassium superoxide -112 Oxidizing agent 
D, L-thioctic acid -59 Oxidizing agent 
cysteamine-S-phosphate -118 P-source 
pH 9.5 + amino acidsc -150     -66 pH, deaminase 
pH 4.5 + amino acidsd -100 -62 pH, decarboxylase 
chlorpromazine -108 phenothiazine 
compound 48/80 -53 phospholipase A, ADP ribosilation 
antibioticse -223 -68 protein synthesis 
respiration influencing agentsf -135 -55 respiration 
rifamycin SV -189 RNA polymerase 
rifampicin -112 RNA polymerase 
transport influencing agentsg -161 transport, toxic anion 
D, L-methionine hydroxamate -64 tRNA synthetase 
antibioticsh -216 -66 wall, cephalosporin 
a chemicals were tested in 96-well PMs 
b The OmniLog-PM software generates time course curves for respiration (tetrazolium color formation) and calculates 
differences in the areas for mutant and control cells. The units are arbitrarily.  
c L-phenylalanine; L-tryptophan; L-leucine; L-isoleucine; L-norvaline; glycine; L-homoserine; L-methionine; agmatine; b-
hydroxy glutamate 
d urea; D, L diaminopimelic acid; L-lysine, g-hydroxy glutamic acid; L-ornithine 
e vancomycin; tylosin; puromycin; fusidic acid; blasticidin S; spiramycin; oleandomycin; josamysin; troleandomycin; 
erythromycin  
f tetrazoleum violet; thioridazine; crystal violet; iodonitro tetrazoleum violet; sorbic acid; FCCP; sodium caprylate, cinnamic 
acid; CCCP; ruthenium red 
g sodium metasilicate; sodium cyanate; chromium chloride; lead (II) nitrate; manganese (II) chloride 
h cefoxitin; cephaloridine; piperacillin; oxacillin; nafcillin; cloxacillin; pheneticillin; aztreonam 
    
 
Another major difference in phenotypes is the increased sensitivity of DLG294 to 
agents that influence the respiratory chain such as the respiratory uncoupler carbonyl 
cyanide 3-chlorophenylhydrazone (CCCP) a drug known to inhibit the efflux systems that 
use the proton motive force. CCCP, however, has no effect on resistance to menadione as 
has been shown previously for the wild-type strain 14028s (28). 
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Taken together, the phenotypes lost by DLG294 could suggest that the membrane 
integrity of DLG294 has changed compared to the wild-type strain and, as a result, has 
become more leaky resulting in enhanced susceptibility to certain toxic compounds  such 
as the macrolides, β-lactams, and cephalosporins, to stress inducing  conditions such as 
acidic and alkalic pH, and menadione.   
 
In vitro phenotypes gained by DLG294 vs 14028s. The phenotype microarray 
analysis revealed that some phenotypes were gained (Table 2) by DLG294 compared to 
wild-type. Since DLG294 contains a kanamycin resistance cassette in the MudJ 
transposon that has inserted into sspJ, it is more resistant to kanamycin and some other 
aminoglycosides (Table 3). DLG294 also has increased ability to use nitrogen-sources for 
growth which is consistent with the hypothesis that the membrane integrity of DLG294 has 
changed compared to the wild-type strain and has become more permeable for nutrients 
and certain toxic compounds. 
 
 
Table 3. Phenotypes gained by DLG294 compared to wild-type 14028s 
Testa differenceb mode of action 
L-arabinose 62 C-source 
L-rhamnose 58 C-source 
chloroxylenol 140 Fungicide 
ethylamine 117 N-source 
acetamide 103 N-source 
g-D-Glu-Gly 100 N-source 
Phe-Trp 83 N-source 
Tyr-Ile 79 N-source 
cytosine 78 N-source 
b-Ala-Gly 75 N-source 
b-Ala-Phe 72 N-source 
D-Leu-D-Leu 56 N-source 
D-Ala-Leu 55 N-source 
D-lysine 55 N-source 
nitrite 52 N-source 
Gly-D-Val 51 N-source 
adenosine 136 nutrient stimulation 
2'-deoxy-adenosine 76 nutrient stimulation 
thymidine-5'-monophosphate 52 P-source 
phosphono acetic acid 51 P-source 
kanamycin 212 protein synthesis, aminoglycoside 
paromomycin 201 protein synthesis, aminoglycoside 
neomycin 162 protein synthesis, aminoglycoside 
geneticin (G418) 148 protein synthesis, aminoglycoside 
a chemicals were tested in 96-well PMs 
b The OmniLog-PM software generates time course curves for respiration (tetrazolium color formation) and calculates 
differences in the areas for mutant and control cells. The units are arbitrarily. 
 
 
Transcriptional profiling of intracellular 14028 and SL1344. We used the recently 
described method for isolating S. enterica serovar Typhimurium RNA from intracellular 
bacteria (7) to compare the gene expression profiles of different strains that resided and 
replicated within RAW264.7 macrophages. RAW264.7 macrophages were infected as 
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described in Materials and Methods. At 4 h after infection, the cells were lysed and 
bacterial pellets were isolated and used for RNA extraction. Since the bacterial RNA was 
immediately stabilized, there is only minimal degradation (Fig. 2). The extracted bacterial 
RNA was labeled and hybridized to the S. enterica serovar Typhimurium "Salsa" array with 
labeled bacterial DNA from SL1344 grown to mid-logphase in LB medium pH 7.0 as a 
reference. The genes that are 2-fold differentially expressed in the intracellular bacteria 
compared to mid-logphase grown SL1344 in LB broth pH7.0 were equally distributed in the 
genome as shown for 14028s in Figure 3B. We first compared the gene expression profile 
of intracellular 14028s to that of SL1344 at 4 h. This was done to evaluate whether these 
profiles are comparable since most intracellular S. enterica serovar Typhimurium array 
data have been are generated with this SL1344 strain (7). The patterns of gene expression 
after normalization were only slightly different for certain genes of the 14028s strain 
compared to the  SL1344 strain (Fig. 3C). The similarity in gene expression profiles of 
intracellular 14028s and SL1344 becomes even more apparent from the cluster diagram 










Figure 2. Size chromatographic separation of RNA. Total RNA was extracted 
from intracellular 14028s, DLG294 and SL1344 and analyzed on a Bioanalyser. 
 
 
Direct comparison of gene expression profiles of intracellular 14028s and 
DLG294. We next evaluated the gene expression profile of DLG294 compared to the wild-
type strain 14028s to look for genes that are differentially expressed. What becomes clear 
from Figure 4C is that only a few of the genes were differentially expressed and that they 
are located all over the S. enterica serovar Typhimurium genome with a few small clusters 
of genes showing altered gene expression. The genes that showed altered expression for 
DLG294 only show only a small difference in expression level as can be seen in the cluster 
diagram (Fig. 4B) and the relative gene expression profile of DLG294 versus the wild-type 
strain 14028s stays within the range of 0.3-5 fold change (Fig. 4A). For each of the genes 
showing altered gene expression, the relative expression was depicted in Figure 5. The 
expression of only 11 genes was increased for intracellular DLG294 compared to the wild-
type strain and 19 genes showed decreased expression. None of the genes of the 
virulence gene clusters such as SPI-1 and SPI-2, nor genes encoding the superoxide 
dismutases were altered, indicating that the DLG294 mutant does not lack expression of 
































































Figure 3. Cluster diagram (A), gene map (B), and gene expression profile (C) of the two-fold differentially 
expressed genes in intracellular 14028s, DLG294, SL1344 and SL1344 control compared to mid-logphase SL1344 
grown in LB pH7.0. Each line represents one gene. Red indicates at least a twofold increase, yellow indicates no 
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Figure 4. Relative gene expression profile (A), cluster diagram (B), and gene map (C) of two-fold differentially 
expressed genes in intracellular DLG294 compared to intracellular wild-type 14028s. Each line represents one gene. 
Red indicates at least a twofold increase, yellow indicates no change, and blue indicates a minimum twofold 


































































































































































Genes downregulated in intracellular DLG294. The MudJ-inactivated gene sspJ 
was among the 19 down-regulated genes as well as the two genes that are located directly 
downstream of sspJ, i.e. engA and yfgJ (Fig. 5 and Table 4). These three genes, together 
with yfgM, are part of the yfg-eng locus in which the ORFs are all transcribed in the same 
direction (2, 19). The MudJ transposon did have a polar effect on the expression of engA 
and yfgJ since the expression of these genes was decreased in intracellular DLG294 
compared to the wild-type. EngA encodes a GTP binding protein of which the physiolocical 
role is unknown and yfgJ encodes a putative cytoplasmic protein. The attenuated in vivo 
and in vitro phenotype of DLG294, however, cannot be explained by the polar effect of the 
MudJ transposon on these genes since complementation with a low-copy-number plasmid 
expressing only the sspJ gene completely restored the in vitro and in vivo phenotype to 
that of the wild-type strain and confirmed that the superoxide hypersusceptibility and 
attenuated phenotypes are due to the lack of expression of sspJ (27, 32). Recently, Amy et 
al. have described the attenuated in vivo phenotype of an yfgL (=sspJ) S. enterica serovar 
Enteritidis in chickens and suggested a role for the yfg-eng locus in colonisation of 
chickens (2). As for our sspJ mutant DLG294, this mutant showed lower bacterial numbers 
within macrophages after 3.5 h. The S. enterica serovar Enteritidis yfgL mutant, however, 
was shown to lack motility due to lack of production of the fliC and fliD encoded proteins 
flagellin and filament capping protein as well as the SPI-1 encoded protein SipA. For our 
mutant DLG294, however, no decrease in gene expression of fliC and fliD was observed 
nor did we observe differences in SPI-1 or SPI-2 encoded genes. DLG2294 even showed 
an increase in expression of genes involved in flagellar biosynthesis as the expression of 
the genes encoding the flagellar biosynthesis proteins FliP and FliR were increased for 
DLG294 compared to the wild-type strain (Fig. 5 and Table 4) and could suggest enhanced 

















Figure 5. Fold change in gene expression of selected genes that were 2-fold differentially expressed in 
intracellular DLG294 compared to intracellular wild-type 14028s. 
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Other genes of which the expression was down-regulated in DLG294 are rpsP 
encoding 30S ribosomal subunit protein 16S, yfiD encoding a putative formate 
acetyltransferase, yibR encoding a putative inner membrane protein, nmpC encoding a 
predicted bacterial porin, and several other of which the gene name and function are 
unknown or that are orthologues to certain E. coli genes (Table 4). For most of these 
genes it is hard to predict their role in attenuated virulence of DLG294. RepA3, however, is 
a gene that is lower in DLG294 compared to the wild-type strain and that could have 
influenced the attenuation of DLG294 since this gene is present on the pSLT plasmid. This 
plasmid pSLT is the virulence plasmid of S. enterica strains (1) that enhances the growth 
rate of the bacterium during systemic phase of disease (11). The gene repA3 is encoding a 
protein that is involved in the initiation of replication of this plasmid. Reduced plasmid 
replication might lead to reduction of virulence of the mutant strain. However, the 
expression of genes present on the plasmid are not altered compared to wild-type and are 
all upregulated to a similar extent as for the SL1344 strain in J774A.1 cells (7). 
 
 
Table 4. Up- and downregulated genes in intracellular DLG294 vs 14028s 
Downregulated Upregulated 
gene function gene function 
enA putative GTP-binding protein yaiY putative inner membrane protein 
GL028990 no orthologues fliP flagellar biosynthesis 
GL029007 orthologous to pepA htrA periplasmic serine protease 
GL029029 orthologous to E. coli yjhP yddX putative cytoplasmic protein 
GL029035 no orthologues wzzB putative regulator of length of O-antigen 
component of LPS chains 
STM3894 unknown wcaH GDP-mannose mannosyl hydrolase in 
colanic acid biosynthesis 
GL031243 putative flutathione S-transferase cdaR putative inner membrane protein 
STM2725 unknown gmd GDP-D-mannose dehydratase in  
colanic acid biosynthesis 
GL029072 putative PTS permease wcaG bifunctional GDP fucose synthetase 
rpsP 30S ribosomal subunit S16 fliR putative flagellar biosynthetic protein 
yfiD putative formate acetyltransferase yiaD putative outer membrane lipoprotein 
GL031264 orthologous to E. coli yeiG   
yibR outative inner membrane protein   
yfgJ putative cytoplasmic protein   
STM2703 Fels2 prophage; similar to invertase 
(pin) in phage E14 
  
repA3 DNA replication   
yfgL/sspJ putative serine/threonine kinase   
nmpC predicted bacterial porin (outer 
membrane protein) 
  
STM2728 Fels-2 prophage; hypothetical protein   
 
 
Genes upregulated in intracellular DLG294. Only 11 genes showed increased 
expression in intracellular DLG294 (Fig 5 and Table 4). Two genes (fliP and fliR) are 
involved in flagellar biosynthesis as mentioned above. Again, for four genes, i.e. yaiY, 
yddX, cdaR, and yiaD encoding putative inner membrane, outer membrane, and 
cytoplasmic proteins (Table 4), the exact function of the proteins is unknown. Three of the 
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induced genes (wcaH, gmd, and wcaG) are involved in colanic acid biosynthesis. WcaH 
encodes the GDP-mannose mannosyl transferase, gmd the GDP-D-mannose 
dehydratase, and wcaG the bifunctional GDP fucose synthetase. Colanic acid, or M(ucous) 
antigen, is a repeat unit polysaccharide that forms a capsule and that is produced by most 
enteric bacteria, presumably as a means of protection against desiccation. The gene 
expression profiles from 14028s and DLG294 in comparison with the reference showed 
that the expression of these three genes was induced in intracellular bacteria and that this 
was higher for the superoxide-hypersusceptible mutant DLG294. This could suggest that 
the mutant produces more colanic acid for protection against the influx of damaging agents 
that act inside the macrophage as a kind of compensatory mechanism.  
The gene htrA, encoding a periplasmic serine protease, is induced in intracellular 
DLG294 compared to wild-type. It has been described previously that inactivation of htrA or 
inactivation of rpoE, the sigma factor identified in E. coli as being important for survival 
under extreme heat-stress and that controls htrA, leads to  a phenotype that is identical to 
that of DLG294 (26). These mutants display increased susceptibility to superoxide and are 
attenuated in mice and that, just like the sspJ mutant DLG294, are able to cause fatal 
infections in mice deficient in NADPH oxidase as well (21).(15) One could explain 
sensitivity of the mutants to exogenous superoxide by assuming that exposure to 
superoxide results in direct damage to periplasmic proteins. Elimination of these damaged 
proteins by HtrA, the periplasmic protease which is under control of rpoE, would then 
protect against this damage. The increase in htrA expression in DLG294 could suggest 
that this mutant imagines that it is under extreme heat stress and starts producing this heat 
stress protein since the conditions inside the bacteria are not right as was suggested by 
the lost phenotypes in the in vitro phenotype array (Table 2). Increased expression of htrA 
could also suggest a mechanism to try and compensate for the lack of expression of sspJ, 
although this "compensatory" mechanism is not sufficient to protect against oxidative 
damage and to restore virulence since DLG294 is still hypersusceptible to superoxide and 
displays an attenuated in vitro and in vivo phenotype. 
 
Concluding remarks. DLG294 has a completely different phenotype compared to the 
wild-type. It is hypersusceptible to intracellular superoxide generated by menadione. It is 
attenuated in macrophages and in mice and regains virulence in p47phox-/- mice. However, 
when we compared gene expression profiles of intracellular DLG294 and wild-type 14028s 
we found that the expression profiles were only slightly altered. This indicates that sspJ 
does not have an important role in regulating (virulence) gene expression but that it has a 
direct role in survival under stress conditions like those encountered inside the 
macrophage. We propose that the absence of SspJ alters the integrity of the Salmonella 
membrane leading to increased permeability and subsequent accumulation of toxic 
compounds. This in turn would lead to enhanced susceptibility to these toxic compounds 
(like menadione) and antibiotics and to the attenuated in vivo phenotype of DLG294. The 
small differences in gene expression probably reflect a difference in intracellular 
environment as a result of this increased membrane permeability. 
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Salmonella is a rod-shaped bacterium that occurs ubiquitous in nature. Most strains in 
the soil are not dangerous to human or animal life. However, some of the Salmonellae are 
able to survive within their host and can cause disease in humans and animals. Salmonella 
infections are one of the most common food-related illnesses in the world and form a major 
problem for people in developing countries. In industrialized countries, the microorganisms 
are a threat especially to people with an impaired immune system. Symptoms of disease 
may vary from asymptomatic carriage in which the bacteria reside within the intestines and 
are shedded via the stool, to life-threatening sepsis in which the bacteria enter the blood 
stream. The type of disease is dependent upon the Salmonella strain the person gets 
infected with and the defense system of the host. Many infections are due to S. enterica 
serovar Enterica or serovar Typhimurium via food or water that is contaminated with animal 
waste. 
Salmonella infection occurs through the ingestion of contaminated food or drinks. The 
acid in the stomach kills most of the ingested bacteria. However, in particular when the pH 
in the stomach is slightly higher than normal, some of the bacteria will pass the stomach. In 
the intestines, Salmonella has to compete with other defense mechanisms such as a thick 
mucus layer and the natural flora of the gut. If Salmonella succeeds in this task and 
survives, it eventually reaches the M cells in the Peyers’ patches of the small intestines. 
Salmonella invades these M cells and depending on the Salmonella strain, two types of 
disease can occur. During infection with the solely human typhoidal strains S. enterica 
serovar Typhi or serovar Paratyphi, the bacteria will spread to the underlying lymphoid 
tissues where they will infect macrophages. Next, the bacteria will enter the bloodstream 
and will reach the liver and spleen where Salmonella initiates a severe inflammatory 
response that is characteristic for typhoid fever and will be lethal in about 10-15% of the 
cases if not treated. However, when a person gets infected with the non-typhoidal strains 
such as S. enterica serovar Typhimurium, the bacteria usually stay within the Peyers’ 
patches and induce a local inflammatory response that is mediated by cytokines, 
chemokines, and neutrophils. This type of disease is called gastroenteritis and is 
characterized by diarrhea and is usually self-limiting. In certain groups of patients such as 
immunocompromised individuals, however, infection with this “harmless” bacterium may 
lead to severe disease. Another problem in this group of patients is the reactivation of 
latent S. enterica serovar Typhimurium infection. Patients then suffer from recurring 
infections with the same strain, as has been described for instance for AIDS patients.    
In many scientific studies on Salmonella an in vivo mouse model is used. Murine 
infection with S. enterica serovar typhimurium, causing gastroenteritis in humans, leads to 
disease in mice that is comparable to typhoid fever in man and therefore, serves a model 
for human infection with S. enterica Typhi or Paratyphi. The natural infection is the oral 
route, but experimental infections can also be induced by intravenous, intraperitoneal, or 
subcutaneous injection of bacteria. A soon as the bacteria have reached the blood, all 





humans. The bacteria spread to the liver and spleen where they reside and multiply within 
macrophages. This, together with the influx of immune cells (macrophages and 
neutrophils) leads to enlargement of the liver and spleen (hepatosplenomegaly). 
Depending on Salmonella strain and dosage, an immune response is initiated that allows 
the mice to survive and that protects against secondary infection. Natural protection 
against S. enterica serovar Typhimurium infection is partly determined by the genes Ity and 
lps. Ity is the gene encoding Nramp1, a membrane phosphoglycoprotein that is expressed 
in macrophages of liver and spleen. Mice expressing the resistant allele (Nramp1G169) can 
control the initial in vivo replication of S. enterica serovar typhimurium allowing time for the 
development of a T cell-mediated immune response needed for clearance of the bacteria. 
However, mice expressing the sensitive allele Nramp1D169 cannot control the infection and 
will die. Expression of Nramp1 is enhanced upon activation of the macrophages by IFNγ 
and LPS. Another gene protecting against Salmonella infection is lps, the gene encoding 
Toll-like receptor 4 (TLR4). TLR4 is a receptor involved in the recognition of 
lipopolysaccharide (LPS) that is abundantly expressed by Gram-negative bacteria such as 
Salmonella. Upon activation, an intracellular signaling cascade is initiated leading to the 
transcription of genes encoding cytokines such as IFNγ, Il-18 en TNFα. These cytokines 
play an important role in the activation of macrophages and thus in the defense against S. 
enterica serovar Typhimurium. Mice such as the C3H/HeJ strain that have a mutation in 
lps, cannot respond to LPS due to a non-functional TLR4 and as a consequence, are 
extremely sensitive to S. enterica serovar Typhimurium infections. 
In defense against S. enterica serovar Typhimurium macrophages play a major role. 
Macrophages are phagocytic cells that contain a multitude of antimicrobial defense 
mechanisms. However, S. enterica serovar Typhimurium has evolved to survive and even 
replicate within this hostile environment. An important defense mechanism of macrophages 
against microorganisms is the production of oxygen radicals. These radicals are highly 
toxic and would probably result in bacterial death if Salmonella had not adapted. In the 
genome of Salmonella there are two Salmonella pathogenicity islands (SPI-1 and SPI-2) 
that encode type III secretion systems (TTSS). The first TTSS encoded by SPI-1 is 
involved in the uptake by the host cell and encodes a kind of syringe apparatus through 
which certain proteins can be injected into the host cell cytosol thereby inducing changes in 
the cell membrane that leads to the uptake of the bacterium, even by non-professional 
phagocytes. This process is called Salmonella-induced uptake. Salmonella enters a 
vacuole where it can survive due to the induction of the second TTSS encoded by SPI-2. In 
this process proteins are injected into the host cell cytosol and lead to the disturbance of 
essential antibacterial processes, allowing Salmonella to survive. For instance, SPI-2 
encoded proteins prevent the translocation and assembly of the active NADPH oxidase 
complex and in this way, Salmonella can prevent the production of superoxide. Besides 
SPI-1 and SPI-2 encoded proteins, other genes such as soxR/S and phoP/Q play an 
important role in defense against superoxide and in survival within the host.  
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Chapter 1 gives an overview of what is currently known about Salmonella, the 
interaction with the host and systems that play a role in the defense against superoxide 
and in survival within macrophages. 
In Chapter 2 the development is described of an in vivo model for reactivating S. 
enterica serovar Typhimurium infection through total body irradiation or CD4+ T cell 
depletion. An important complication of S. enterica serovar Typhimurium infection in certain 
groups of patients is the recurrence of infection. The infection is cleared, but Salmonella 
may reside within the body despite the host immune system, and will strike again as soon 
as the immune system is impaired. It is unknown at which niche Salmonella hides and 
which processes play role in the suppression of growth during the phase of persistency. 
Reactivating Salmonella infections have been mainly described for patients who underwent 
irradiation or received glucocorticoids and for individuals with AIDS or other immune 
impairments. Our model shows that CD4+ T cells play a role in the suppression of growth 
of S. enterica serovar Typhimurium during the phase of persistency.  
Since a couple of years, patients suffering from rheumatoid arthritis or Crohn’s 
disease are being treated with the tumor necrosis factor α (TNFα) neutralizing antibodies 
Infliximab or Ethanercept. This type of treatment has proven to be of great benefit to these 
patients, but makes them susceptible to primary as well as reactivating infection with 
intracellular bacteria such as Mycobacterium tuberculosis. TNFα is a cytokine that plays an 
important role in the activation of macrophages and in defense against pathogens including 
Salmonella. For Salmonella infections it is known that neutralization of TNFα leads to 
increased risk of severe infections, but whether such treatment may also lead to 
reactivation of a latent Salmonella infection, as in latent Mycobacterium tuberculosis 
infection, is not clear. In Chapter 3 we investigated whether TNFα plays a role in the 
suppression of S. enterica serovar Typhimurium during the phase of persistency in mice. In 
the model used, we did not observe reactivation of the S. enterica serovar Typhimurium 
infection after treatment with antibodies to TNFα. In addition, we observed that addition of 
anti-TNFα to IFNγ-stimulated mouse macrophages (RAW264.7) had no effect on the IFNγ 
induced effect of reduced outgrowth of S. enterica serovar typhimurium. This could mean 
that TNFα plays a minor role compared to IFNγ during infection with S. enterica serovar 
Typhimurium. As long as IFNγ produced by CD4+ T cells remains present, latent S. 
enterica serovar Typhimurium infection will be suppressed and reactivation will not occur.   
In Chapter 4 we describe the research on bacterial mutants that are able to survive for 
a longer period of time within macrophages. We have created S. enterica serovar 
Typhimurium mutants by random P22 MudJ transposon insertion. In this way we have 
created several mutants that were selected for the ability to survive for a longer period of 
time than wild-type S. enterica serovar Typhimurium within mouse macrophages. 
Eventually, two mutants were selected that after inverse PCR and sequence analysis 
appeared to be the same. The MudJ transposon had inserted into rmlC, the gene encoding 
dTDP-4-deoxyrhamnose 3,5-epimerase, an enzyme involved in the formation of the O-
antigen of the lipopolysaccharide (LPS). Analysis of the LPS showed that this mutant had 





rough Ra chemotype. This is a mutant lacking the O-antigen and contains only the lipid A 
and the core region of the LPS. Also the Ra mutant was able to survive for a longer period 
of time in RAW264.7 macrophages; even after 48 h high numbers of bacteria could still be 
detected. Despite this ability to survive longer, these mutants were not capable of inducing 
severe infection in mice. These LPS mutants are killed in vitro by rat or human 
complement, and likely, the attenuated phenotype in mice can be explained by this 
increased in vitro susceptibility to complement, although we could not confirm this with high 
numbers of bacteria  in mouse serum that has low levels of complement. 
By random MudJ transposon insertion in wild-type S. enterica serovar Typhimurium 
14028s we have created mutants that were next selected for their susceptibility to 
intracellular superoxide, as described in Appendix 1. By inverse PCR and sequence 
analysis we determined the position in the genome where the MudJ transposon had been 
inserted and which gene might have been inactivated. One of the mutants obtained in this 
way was studied in further detail and has been described in Chapter 5. In this mutant, 
designated AVD101, the MudJ transposon had inserted into the promotor region of pnp, 
the gene encoding PNPase. This protein is involved in the degradation of mRNA and in the 
growth adaptation at low temperatures and it is considered a regulator of virulence and 
persistence of S. enterica serovar Typhimurium. We described an additional role for 
PNPase in the resistance to superoxide and for intracellular survival within macrophages. 
In the research on superoxide-resistance genes we describe in Chapter 6 the isolation 
and characterization of DLG294, an S. enterica serovar Typhimurium mutant in which, 
through MudJ transposon insertion, an as yet unknown gene was inactivated. This gene 
was designated sspJ. The protein SspJ is no longer produced by this mutant resulting in 
increased susceptibility of this mutant to menadione, a redox cycling agent that generates 
superoxide radicals within the bacterium. DLG294 appeared to be attenuated in vitro in 
macrophages and in vivo in mice. By constitutive expression of sspJ on a plasmid the 
phenotype of DLG294 was restored to that of the wild-type strain. This confirmed the role 
of SspJ in the defense against superoxide and in virulence. However, the exact role and 
functioning of SspJ is not clear yet.  
DLG294 was next studied in vivo in mice, as described in Chapter 7. DLG294 induced 
hardly any granulomatous lesions in the liver after subcutaneous infection of Salmonella-
resistant (Ityr) C3H/HeN mice with 3 × 104 CFU and the numbers of bacteria were 3 log 
units lower than those of the wild-type strain on day 5 after infection. However, DLG294 
appeared to be as virulent as the wild-type strain and induced similar liver pathology in 
p47phox-/- mice. These mice lack a functional NADPH oxidase system because of a lack of 
p47phox and as a result cannot produce superoxide. Also in bonemarrow-derived 
macrophages of these p47phox-/- mice and in X-CGD PLB985 cells the bacterial numbers of 
DLG294 were as high as those of the wild-type strain. These results suggest that SspJ 
plays a role in resistance against oxidative stress and in survival and replication of S. 
enterica serovar Typhimurium both in vitro and in vivo.   
Macrophages play an important role in Salmonella infections. They exert a dual role; 
that of a host cell possibly hiding the bacterium from the hostile exterior, and that of an 
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effector cell in acquired immunity. DLG294 is more sensitive to superoxide and attenuated 
in macrophages, and we hypothesized that hypersusceptibility to superoxide plays a 
causative role in its attenuated behavior. However, other processes might play a role as 
well leading to the reduced ability of DLG294 to survive within macrophages. Infection with 
S. enterica serovar Typhimurium leads to the activation of the macrophages to kill and 
eliminate the bacteria. Diverse mechanisms play a role in this activation process. In 
Chapter 8 we have investigated the effect of wild-type and DLG294 infection on the gene 
expression in macrophages using Affymetrix gene chips. Using these chips, the 
expression of 6,400 genes can be studied simultaneously. Wild-type S. enterica serovar 
Typhimurium and DLG294 appeared to influence the expression of many genes, however, 
no differences between the two types of infected cells were apparent. From this we 
concluded that the reduced outgrowth of DLG294 in macrophages must be attributed to 
the mutation in sspJ and not to a different, indirectly induced, activation status of the 
macrophages compared to that of wildtype-infected macrophages.  
To further characterize DLG294, we have studied the in vitro phenotype of DLG294 
further in Chapter 9 using a phenotypical array in which several hundreds of processes can 
be studied at the same time. This makes it possible to compare the in vitro phenotype of 
DLG294 to that of the wild-type strain. Also, we have looked at the intracellular gene 
expression profile of DLG294 in RAW264.7 macrophages and compared that to 
intracellular wild-type S. enterica serovar Typhimurium. The phenotypical array revealed 
that DLG294 gained the ability to use nitrogen sources for growth, has hampered 
resistance to several antibiotics, and shows increased susceptibility to acidic and alkalic 
pH. Comparison of the gene expression profile of intracellular DLG294 with that of the wild-
type strain revealed only a few differences. Most likely, DLG294 has reduced membrane 
integrity that leads to increased uptake of toxic compounds and as a result, more damage 





Most S. enterica serovar Typhimurium mutants described in this thesis were 
generated by ramdom MudJ transposon insertion into the wild-type 14028s strain and 
those mutants were selected that displayed increased or decreased susceptibility to 
intracellular superoxide generated by menadione. Menadione is a synthetic Vitamin K3 
supplement that is fat-soluble and is used in medicine to help in the clotting of blood. 
Menadione is a quinone (2-methyl-1,4-naphtoquinone; Fig. 1) that is converted into 













Quinones are widely distributed in nature as they are abundant in burnt organic 
material and in food (reviewed in (1, 24)) and have  antitumor activity (6, 20). Quinones are 
substrates for several flavoenzymes such as NADPH cytochrome P-450 reductase, DT-
diaphorase, NADH-cytochrome b5 reductase, and NADH-ubiquinone oxidoreductase, and 
can be converted into hydroquinone via a two-electron reduction or reaction with 
glutathione (GSH) and into semiquinone radical via a one-radical reduction (Fig. 2 and 
reviewed in (19)). In the two-electron reduction pathway that is catalyzed by the FAD-
dependent DT-diaphorase, the quinones are converted into hydroquinone and is 
considered a cellular protector against oxidative stress. However, hydroquinones can be 
converted into quinones in the presence of oxygen and in this reaction superoxide radicals 
are formed. Xanthine oxidase and Xanthine dehydrogenase can also catalyze the two-
electron reduction of quinones, but these enzymes are also capable of catalyzing the one-
electron reduction of quinones that leads to the formation of semiquinone radicals causing 
damage to the cell by covalent binding to proteins or nucleic acids or by influencing the 
cells' metabolism. Semiquinones can react together to form hydroquinones and quinones, 
but in aerobic conditions, most of these semiquinones react with O2 to regenerate the 
quinone and to form O2-•. These radicals react with hydrogen peroxide, which is formed by 
dismutation of superoxide, and the more toxic radical HO• is formed which can damage the 
cell by causing DNA strand breaks, lipid peroxidation, or enzyme inactivation (Fig. 2). 
However, the cell is equipped with defense mechanisms such as superoxide dismutases, 
catalases, glutathione reductase, and glutathione peroxidase to convert these toxic 
compounds into H2O2 and H2O. However, if either one of these mechanisms is not working 
properly, the cell might get damaged.  
 
Figure 2. 
schematic overview of 
the redox cycle of 
quinones, the damage 
that can be induced by 
the radicals that are 
formed, and defense 
mechanisms of the host 
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Mutants with increased susceptibility to the redox cycling agent menadione, can 
display several underlying defects causing this phenotype. The first option is the decreased 
detoxification of the toxic compounds that are formed inside the cell and might involve, for 
instance, mutants deficient in SOD, catalase, glutathione peroxidase, and glutathione 
dismutase. However, since the redox cycle of the quinones is rather complicated as many 
enzymes are involved and is strongly dependent upon the circumstances and the host's 
reaction to this compound, mutations in either one of the routes involved might cause the 
same menadione-susceptible phenotype. Other types of mutants might be those with 
reduced capacity to repair the damage that is caused by the radicals. Since semiquinone 
radicals can directly influence the proteins and nucleic acids by covalent binding and can 
influence metabolism, it is likely that mutants unable to deal with this are hypersusceptible. 
Menadione also induces the formation of the highly reactive hydroxyl radicals (OH•) that 
can cause DNA strand breaks, lipid peroxidation, and enzyme inactivation and can kill 
Salmonella through these mechanisms if it is unable to repair or prevent the damage. 
Another explanation for increased susceptibility to menadione might be decreased efflux or 
increased influx of this redox cycling agent resulting in concentrations of this toxic 
compound that are too high for Salmonella to deal with. All intracellular defense 
mechanisms will be turned on and will be able to prevent or clear part of the damaging 
radicals, but this will not be sufficient and the bacterium will die as a consequence. For the 
menadione-hypersusceptible mutant DLG294 described in this thesis, it is most likely that 
the in vitro and in vivo phenotypes can be explained by decreased membrane integrity and 
subsequent increased uptake of toxic compounds such as menadione. Since the known 
defense and virulence mechanisms of DLG294 were not differently expressed compared to 
the wild-type strain as was shown in Chapter 9, this mutant probably has a leaky 
membrane through which more menadione and other toxic compounds can enter the cell 
and can cause damage when the defense systems are completely occupied. 
 
 
Salmonella genes involved in oxidative stress 
 
Research on many mutant strains of E. coli as well as Salmonella has led to the 
identification of a range of genes that are necessary for survival during oxidative stress 
generated in vitro. However, the exact role of many of these genes both in survival within 
macrophages and in virulence in mice is not understood. With the studies described in 
Chapter 5 and Appendix 1 we tried to identify more genes that are involved in resistance to 
superoxide stress and analyzing them for the ability to survive within macrophages. In 
literature, many mutants have been described that can be divided in different classes 
based on their phenotypes (Fig. 3, Table 1). These studies have shown that the 
mechanisms that Salmonella uses to cope with superoxide stress are very diverse and 






Figure 3. Classification of 
Salmonella mutants by in vitro and 
in vivo phenotype. Mutants that 
are sensitive to exogenous 
superoxide generated by the host 
NADPH-oxidase, endogenously 
produced superoxide and 
hydrogen peroxide are shown, and 
the consequences for virulence in 
mice are indicated. soxR/S, ramA, 
mar, acrA and oxyR encode 
transcriptional regulators; sodCI 
and sodCII encode periplasmic 
copper-zinc superoxide 
dismutases; sodA encodes the 
cytoplasmic manganese 
superoxide dismutase; zwf 
encodes the glucose 6-phosphate 
dehydrogenase; htrA encodes a 
periplasmic protease; rpoE 
encodes an "extracytoplasmic 
function" sigma factor; rpoS and 
slyA encode transcriptional 
regulators; recA encode a 
recombinase important for DNA 
repair; sspJ encodes a periplasmic 
protein that interferes with 
superoxide levels; Spi2 is the 
pathogenicity island of Salmonella 
that contains genes encoding the 
second type-III secretion system.  
 
 
Mutants sensitive to endogenously produced superoxide 
One of the methods to identify genes involved in survival under superoxide stress is 
the isolation of mutant strains that are either more sensitive or more resistant to redox-
cycling agents that generate intracellular superoxide (Appendix 1). A range of mutants that 
are more sensitive to the redox-cycling agents menadione and paraquat has been isolated 
in this way. Whereas the in vitro phenotype, i.e., sensitivity to intracellular superoxide, is 
the same, there are huge differences between these mutants in the importance of the 
inactivated gene products in the survival of Salmonella in macrophages and in virulence in 
mice.  
For instance, mutants in the soxR/S regulon, the cytoplasmic manganese dismutase 
SodA, the transcriptional regulator RamA, or the global regulator AcrA are all highly 
susceptible to superoxide in vitro, however, these mutants are not attenuated in vivo (9, 16, 
18, 25, 28). It cannot be ruled out, however, that following interaction with the host in vivo, 
alternative mechanisms are activated and compensate for lack of expression of either one 













































Regulators of gene expression    
acrA c  S V (16) 
oxyR S  S  (5) 
ramA S  R V (28) 
rpoE S S  A (23) 
rpoS S  S A (8, 22) 
slyA S  S A (2) 
soxR/S S R  V (9) 
Neutralization of scavenging of ROI    
katE   S V (3) 
katG   S V (3) 
mntH R  S V (15) 
sodA S R S V/A (25) 
sodCI R S  V/A (7, 21, 26) 
sodCII R S  V/A (7, 21) 
sodCIII R    (10) 
zwf S S  A (17) 
Protection against ROI damage    
htrA S/R R S V (14, 23) 
recA S   A (3) 
Prevention of ROI production by macrophages    
Spi-2 encoded genes    A (11, 31) 
Unknown function      
sspJ S R  A (27, 29) 
a R: resistant, S: sensitive. 
b V: virulent, A: attenuated, V/A: conflicting data. 
c Open space: no data available 
    
 
 
Mutants sensitive to endogenous and exogenous superoxide 
In contrast to the mutants described above, the same experimental approach has also 
led to identification of genes that are important for survival in the host. For instance, sspJ 
encoding a putative serine/threonine kinase-like protein, htrA encoding a periplasmic 
protease, rpoE encoding the sigma factor identified in E. coli as being important for survival 
under extreme heat-stress, zwf encoding the glucose-6-phosphate dehydrogenase, or the 
transcriptional regulator rpoS and slyA  (2, 8, 14, 17, 23, 27). All these mutants show 
increased susceptibility to endogenously as well as exogenously produced superoxide and 





mutants it is not completely known whether the attenuation is due to the superoxide 
susceptibility or that additional factors are responsible for the reduced virulence.   
 
Mutants sensitive to exogenous, NADPH-oxidase-generated superoxide 
The identification of periplasmic superoxide dismutases in Salmonella has led to the 
observation that mutants in the two sodC genes do not display an increased sensitivity to 
redox-cycling agents but are sensitive only to extracellular superoxide generated by the 
xanthine/xanthine oxidase system in vitro or superoxide produced by the macrophage. 
Although periplasmic SodC proteins are important for virulence, the exact role of each of 
the two SodC proteins is still unclear and rather confusing (7, 21, 26). To add to the 
confusion, the group of Imlay has proposed a model that Salmonella SodC mutants are 
killed because they are more sensitive to hydrogen peroxide (12). Interestingly, not all 
Salmonella strains contain two periplasmic superoxide dismutases. For instance, S. typhi 
and some S. paratyphi strains only contain the sodCII gene (7). E. coli also contains this 
sodCII gene. This must mean that periplasmic Sod’s are not always essential determinants 
of virulence of Salmonella.  
 
Mutants disturbed in prevention of NADPH-oxidase-generated superoxide 
It is clear that Salmonella has evolved mechanisms to cope with both superoxide 
released endogenously as a by-product of its own respiration and superoxide produced by 
macrophages. When cells are infected with wild-type S. typhimurium there is hardly any 
superoxide production in the vicinity of internalized bacteria, indicating that Salmonella can 
prevent superoxide production by phagocytes (reviewed in (30)). The mechanism is 
dependent on the second type-III secretion system encoded by SPI2, since mutants in this 
system are unable to inhibit superoxide production by phagocytes (31). Recently, it 
became apparent that translocation of gp91phox and gp47phox of the NADPH-oxidase 
complex to the Salmonella-containing phagosome is inhibited in phagosomes containing 
wild-type Salmonella (11, 31). In addition, it appeared that relocalization of iNOS to 
Salmonella - containing phagosomes is also inhibited by a type-III secretion system-
dependent mechanism (4), suggesting that this system is involved in interfering with 
vesicular transport in host cells. Clearly, prevention of superoxide production in the vicinity 
of intracellular Salmonella is an excellent survival strategy. If this survival mechanism is 
very efficient, and as a result, the levels of superoxide encountered by Salmonella in vivo 
are very low, this would also explain why so many mutants that are superoxide-sensitive in 
vitro are not attenuated in vivo. All the mechanisms described in the above paragraphs 
would then be a second barrier against ROI. When Salmonella is no longer able to prevent 
superoxide production, for instance, in activated phagocytic cells, these systems will 
become active and neutralize toxic oxygen intermediates or repair or prevent the damage 








Salmonella has evolved complex mechanisms to cope with ROI, and it is clear that 
different defense barriers exist that either prevent production of these compounds 
altogether or limit the damage that is done by the low amounts of toxic compounds that are 
still produced. In addition, like every aerobically growing organism, Salmonella and E. coli 
also have to protect themselves from endogenously produced ROI or environmental 
conditions that increase the endogenous superoxide concentration. Extensive research on 
gene-deleted E. coli and Salmonella strains has vastly increased our knowledge about the 
mechanisms that these bacteria employ to cope with ROI. As illustrated, it is at present not 
possible to adequately predict from the in vitro phenotype of a mutant, what the 
consequences of this mutation are for in vivo virulence. Although mutants that are overly 
sensitive to extracellular superoxide are likely to be attenuated in vivo, it is conceivable that 
mutants made using such a selection criterion could also lead to the identification of genes 
that are not essential for intracellular survival and virulence of Salmonella. It is clear that 
several "barriers of defense" against ROI exist. Some of these mechanisms may only be 
important for coping with ROI-inducing substances in the environment and may in this way 
determine Salmonella fitness, whereas other mechanisms are also crucial for virulence and 
determine survival of Salmonella in the host. Novel techniques, such as microarray 
analysis, have already contributed to our understanding of the various oxidative stress 
regulons. In the near future more extensive use of such techniques to analyze the 
response of Salmonella or E. coli to either intracellular or extracellular superoxide stress 
will give a more detailed view of the regulons induced, and from this point the contribution 
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Salmonella is een staafvormige bacterie die overal in de natuur voorkomt. De meeste 
Salmonella’s kunnen geen ziekte veroorzaken doordat ze niet overleven in dieren of 
mensen. Deze komen alleen in de natuur of in het riool voor en zijn ongevaarlijk. Er zijn er 
echter een aantal die wel kunnen overleven en dit zijn de soorten die verantwoordelijk zijn 
voor ziekte in mens en dier. Salmonella infecties zijn een van de meest voorkomende 
voedsel-gerelateerde infecties in de wereld en vormen een groot probleem voor mensen in 
ontwikkelingslanden en voor mensen met een niet goed functionerend immuunsysteem. 
Ziektebeelden kunnen variëren van asymptomatisch dragerschap waarbij de bacteriën in 
de darm blijven en via de ontlasting uitgescheiden worden, tot levensbedreigende sepsis 
waarbij de bacteriën in het bloed terecht komen. Het ziektebeeld is afhankelijk van de 
Salmonella stam waarmee iemand besmet raakt en betreft meestal besmettingen met S. 
enterica serovar Enterica of serovar Typhimurium via met dierlijk afval besmet voedsel of 
water. 
Besmetting met Salmonella gebeurt via het eten of drinken van besmet voedsel of 
water. Het maagzuur zorgt ervoor dat een groot deel van de bacteriën gedood wordt. 
Echter, wanneer de zuurgraad iets hoger is dan normaal, dan krijgt een deel van de 
bacteriën de kans om de maag te passeren en in de darm terecht te komen. Daar komen 
de bacteriën verscheidene andere afweermechanismen tegen zoals een dikke slijmlaag en 
de natuurlijke darmflora waarmee Salmonella een competitie om voedsel moet aangaan. 
Als Salmonella dit redt, zal het uiteindelijk in de dunne darm de Peyerse platen bereiken 
waarin zich de M cellen bevinden. Salmonella invadeert deze M cellen en afhankelijk van 
de Salmonella stam, kunnen twee ziektebeelden optreden. Bij infectie met de typhoïde 
stammen S. enterica serovar Typhi of serovar Paratyphi, stammen die alleen infectie in 
mensen veroorzaken, zullen de bacteriën zich verspreiden naar de onderliggende lymfoïde 
weefsels en zullen ze macrofagen binnen treden. De bacteriën komen in het bloed terecht, 
bereiken de lever en de milt en veroorzaken een ernstige ontstekingsreactie (inflammatoire 
respons) die typhoïde koorts of buiktyfus genoemd wordt en in 10% van de gevallen 
dodelijk is wanneer de patient niet behandeld wordt. Wanneer het echter een infectie met 
de niet-typhoïde stammen betreft zoals S. enterica serovar Typhimurium, dan blijven de 
bacteriën in de Peyerse platen en induceren daar een inflammatoire repons die 
gemediëerd wordt door cytokines, chemokines en neutrofiele granulocyten. Deze vorm van 
infectie wordt gastroenteritis genoemd en leidt tot diarrhee en gaat na een aantal dagen 
vanzelf over. In bepaalde patiënten, zoals mensen met een minder goed functionerend 
immuunsysteem, kan infectie met deze in principe ongevaarlijke stam wel leiden tot 
ernstige ziekte. Een ander probleem van S. enterica serovar Typhimurium zijn 
terugkerende infecties. Patiënten leiden dan aan steeds terugkerende infecties met 
hetzelfde isolaat. Dit is beschreven voor o.a. AIDS patienten en mensen die bestraling 
hebben ondergaan.  
Bij de meeste wetenschappelijke studies naar Salmonella wordt gebruikt gemaakt van 
een in vivo muis model. Infectie met S. enterica serovar Typhimurium, wat bij mensen 
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gastroenteritis veroorzaakt, leidt in muizen tot een ziektebeeld dat overeenkomt met 
typhoïde koorts en is daarom een goed model voor humane infectie met S. enterica 
serovar Typhi of Paratyphi. De natuurlijke infectieroute is de orale (via de mond), maar 
experimentele infecties kunnen ook intraveneus (in een ader), intraperitoneaal (in de 
buikholte), of subcutaan (onder de huid) geïnitieerd worden. Zodra de bacteriën in het 
bloed terecht komen, verlopen al deze infecties op dezelfde manier en lijken op het verloop 
van typhoïde koorts in de mens. Binnen een paar dagen verspreiden de bacteriën zich 
naar de lever en de milt waar ze verblijven en zich vermenigvuldigen in macrofagen. Dit 
leidt, samen met de influx van immuuncellen (macrofagen en neutrofiele granulocyten), tot 
een vergroting van de lever en de milt (hepatosplenomegalie). Afhankelijk van het soort 
muis en de dosis, zullen de muizen als gevolg van de infectie doodgaan, of er wordt een 
immuunrespons geïnduceerd waardoor de muizen in leven blijven en beschermd zullen 
zijn tegen een tweede infectie. Natuurlijke bescherming tegen een S. enterica serovar 
Typhimurium infectie wordt o.a. bepaald door de genen ity en lps. Ity is het gen dat codeert 
voor Nramp1, een membraan fosfoglycoproteine dat alleen tot expressie wordt gebracht 
door macrofagen van de reticulo-endotheliale organen zoals lever en milt en dat betrokken 
is bij de weerstand tegen Salmonella. Muizen die het resistente allel van Nramp1 
(Nramp1G169) tot expressie brengen kunnen de groeisnelheid van S. enterica serovar 
Typhimurium in vivo controleren zodat er een T cel-gemediëerde immuunrespons kan 
worden geïnitieerd die nodig is voor de uiteindelijke klaring van de bacteriën. Echter, 
muizen die het gevoelige allel Nramp1D169 tot expressie brengen kunnen dit niet en zullen 
aan de infectie overlijden. Expressie van Nramp1 wordt aanzienlijk vergroot na activatie 
van de macrofagen door IFNγ and LPS. Het andere gen dat bescherming biedt is lps, het 
gen dat codeert voor Toll-like receptor 4 (TLR4). TLR4 is een receptor die betrokken is bij 
de herkenning van lipopolysaccharide (LPS) wat uitbundig tot expressie wordt gebracht 
door Gram-negatieve bacteriën zoals Salmonella. Deze receptor raakt dan geactiveerd en 
geeft signalen door die de celkern instrueren om bepaalde genen af te schrijven en 
bepaalde cytokines te maken, waaronder IFNγ, Il-18 en TNFα. Deze cytokines spelen een 
belangrijke rol in het activeren van macrofagen en dus bij de afweer tegen S. enterica 
serovar Typhimurium. Muizen met een mutatie in het gen dat codeert voor TLR4, zoals in 
C3H/HeJ muizen, reageren niet op LPS als gevolg van een niet goed functionerend TLR4 
en zijn daarom extreem gevoelig voor S. enterica serovar Typhimurium infecties.  
Bij de afweer tegen S. enterica serovar Typhimurium spelen met name macrofagen 
een belangrijke rol. Macrofagen zijn fagocyterende cellen die uitgerust zijn met een heel 
scala aan mechanismen om micro-organismen te doden. Echter, S. enterica serovar 
Typhimurium heeft zich volledig aangepast en is in staat om te overleven en zelfs te delen 
in dit vijandig milieu. Een belangrijk afweermechanisme van de macrofaag tegen micro-
organismen is de productie van zuurstofradicalen. Deze radicalen zijn zeer schadelijk en 
zouden S. enterica serovar Typhimurium doden als die zich niet aangepast zou hebben. In 
het genoom van Salmonella bevinden zich twee pathogeniciteitseilanden (SPI-1 en SPI-2) 
die coderen voor type III secretie systemen (TTSS). SPI-1 is een TTSS die betrokken is bij 
de opname door de cel. Het codeert voor een soort injectiespuit waarmee bepaalde 
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eiwitten in de cel geïnjecteerd worden waardoor er allerlei veranderingen in het membraan 
van de cel optreden en de bacterie opgenomen wordt, zelfs door niet-fagocyterende cellen. 
Dit proces wordt Salmonella-geïnduceerde opname genoemd. S. enterica serovar 
Typhimurium komt dan in een fagosoom terecht waar het kan overleven doordat het 
tweede TTSS gecodeerd door SPI-2 in werking treedt. Hierbij worden weer eiwitten in het 
cytoplasma geïnjecteerd waardoor allerlei antibacteriële processen verstoord worden en S. 
enterica serovar Typhimurium kan overleven. Zo wordt via SPI-2 gecodeerde eiwitten o.a. 
voorkomen dat er superoxide geproduceerd kan worden doordat deze eiwitten de 
translocatie en vorming van het actieve NADPH oxidase complex voorkomen. Naast SPI-1 
en SPI-2 gecodeerde eiwitten spelen ook andere genen zoals soxR/S, phoP/Q een 
belangrijke rol in de afweer tegen superoxide en in overleving in de gastheer. 
Onderzoek naar de rol van superoxide-resistentiegenen in overleving van S. enterica 
serovar Typhimurium in macrofagen en muizen en onderzoek naar reactiverende 
Salmonella infecties leidt uiteindelijk tot meer inzicht in de strategieën die Salmonella 
gebruikt om te overleven.    
Hoofdstuk 1 geeft een samenvatting van wat er bekend is over Salmonella, de 
interactie met de gastheer en systemen die een rol spelen bij de afweer tegen superoxide 
en overleving in macrofagen. 
In hoofdstuk 2 wordt het opzetten van een in vivo muizenmodel voor een 
reactiverende S. enterica serovar Typhimurium infectie door middel van bestraling en 
depletie van CD4+ T cellen beschreven. Een belangrijke complicatie van S. enterica 
serovar Typhimurium infecties in sommige patiënten is het steeds terugkeren van de 
infectie. De infectie wordt opgeruimd, maar toch ziet Salmonella de kans om zich schuil te 
houden voor het immuunsysteem en te overleven en weer toe te slaan zodra het 
immuunsysteem verstoord is. Het is echter nog niet precies bekend waar Salmonella zich 
schuil houdt en welke processen een rol spelen bij de onderdrukking van groei tijdens de 
fase waarin Salmonella zich schuil houdt (persistentie/latentie fase). Reactiverende S. 
enterica serovar Typhimurium infecties betreffen met name patiënten die bestraling 
hebben ondergaan, patienten met AIDS of andere immuunstoornissen. We laten met ons 
reactivatiemodel zien dat CD4+ T cellen een rol spelen bij de onderdrukking van replicatie 
van S. enterica serovar Typhimurium tijdens de fase van persistentie.  
Sinds een aantal jaren wordt er voor de behandeling van rheumatoïde arthritis en de 
ziekte van Crohn een behandeling toegepast waarbij de patiënten behandeld worden met 
Infliximab of Ethanercept. Deze vorm van behandeling werkt voor deze patiënten erg goed, 
maar een groot nadeel van deze vorm van behandeling die in een kleine groep patiënten 
een rol speelt, is het opspelen van allerlei infecties met intracellulaire pathogenen, zoals 
Mycobacterium tuberculosis. Het kan dan gaan om nieuwe infecties, maar ook om 
reactiverende infecties. De behandeling is gebaseerd op het toedienen van antilichamen 
gericht tegen tumor necrosis factor α (TNFα). TNFα is een cytokine dat een belangrijke rol 
speelt bij de activatie van macrofagen en bij de afweer tegen allerlei pathogenen, 
waaronder Salmonella. Voor Salmonella infecties is het wel bekend dat neutralisatie van 
TNFα leidt tot verhoogd risico op ernstige Salmonella infecties, maar of deze behandeling 
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ook tot reactivatie van een latente Salmonella infectie leidt, zoals bij latente Mycobacterium 
tuberculosis infectie, is nog onduidelijk. In hoofdstuk 3 is onderzocht of TNFα ook een rol 
speelt bij de onderdrukking van S. enterica serovar Typhimurium tijdens de fase van 
persistentie in muizen. In het model dat wij gebruikt hebben, zagen we geen reactivatie 
van de S. enterica serovar Typhimurium infectie na behandeling van de muizen met een 
antilichaam gericht tegen TNFα. Verder hebben we gezien dat toevoeging van anti-TNFα 
aan IFNγ-gestimuleerde muizemacrofagen (RAW264.7 cellen) geen effect had op het IFNγ 
effect van verminderde uitgroei van S. enterica serovar typhimurium. Dit zou erop kunnen 
duiden dat TNFα een ondergeschikte rol speelt aan IFNγ bij een infectie met S. enterica 
serovar Typhimurium. Zolang IFNγ geproduceerd door CD4+ T cellen aanwezig blijft, zal de 
latent aanwezige S. enterica serovar Typhimurium onderdrukt blijven en zal geen 
reactivatie plaatsvinden.   
Hoofdstuk 4 behandelt het onderzoek naar mutanten die in staat zijn om langer te 
overleven in macrofagen. We hebben daarbij S. enterica serovar Typhimurium mutanten 
gemaakt door middel van P22 MudJ transposon insertie. MudJ transposon is een groot 
stuk DNA dat met behulp van een enzym (een transposase) at random ingebouwd kan 
worden in het genoom en hierdoor een bepaald, van tevoren niet te voorspellen, gen kan 
inactiveren. We hebben op die manier verschillende mutanten verkregen die vervolgens 
geselecteerd zijn op de mogelijkheid om langer te overleven in muizemacrofagen. 
Uiteindelijk bleven er twee mutanten over die na inverse PCR en sequentie-analyse 
dezelfde bleken te zijn, omdat het MudJ transposon op precies dezelfde plaats in het 
genoom was ingebouwd. Bij deze twee mutanten bleek het MudJ transposon ingebouwd te 
zijn in rmlC, het gen dat codeert voor het enzym dTDP-4-deoxyrhamnose 3,5-epimerase 
dat betrokken is bij de vorming van het O-antigen van het lipopolyaccharide (LPS). Analyse 
van het LPS liet ook zien dat deze mutant een verkort LPS heeft en lijkt heel veel op een 
S. enterica serovar Typhimurium stam met het ruwe Ra chemotype. Dit is een mutant die 
het O-antigen mist en alleen het lipid A deel en het core van het LPS heeft. Ook deze Ra 
mutant bleek in staat om langer te overleven in RAW264.7 cellen en was deze zelfs na 48 
uur nog in hoge aantallen aanwezig. Desondanks bleken deze mutanten toch niet in staat 
om in muizen een ernstige infectie te veroorzaken, wat niet verklaard kon worden door de 
verhoogde gevoeligheid voor complement in het bloed. 
Door random MudJ transposon insertie in wildtype S. enterica serovar Typhimurium 
14028s hebben we vele mutanten verkregen die vervolgens geselecteerd zijn op 
gevoeligheid voor het superoxide-genererende stofje menadione. Dit is gedaan door vele 
kolonies te strijken op agarplaten met en zonder menadione en die mutanten te selecteren 
die niet groeiden op de platen met menadione en wel op de controle plaat zonder 
menadione. We hebben op die manier een aantal superoxide-gevoelige mutanten 
verkregen die vervolgens getest zijn in een in vitro infectie-experiment in RAW264.7 
macrofagen zoals weergegegven in Appendix 1. Vervolgens is er met behulp van inverse 
PCR en sequentie-analyse bepaald waar het MudJ transposon was ingebouwd en welk 
gen geïnactiveerd was door dit transposon. Eén van de mutanten die op die manier 
verkregen is staat beschreven in Hoofdstuk 5 en betreft een mutant waarbij het MudJ 
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transposon was ingebouwd in de promotor regio van het gen pnp dat codeert voor 
PNPase, een enzym dat betrokken is bij de afbraak van RNA en bij de adaptate van groei 
bij lage temperaturen en wordt gezien als een regulator van virulentie en persistenie van S. 
enterica serovar Typhimurium.  Wij beschrijven een additionele rol voor PNPase in de 
resistentie tegen superoxide en in overleving in macrofagen. 
Bij  het onderzoek naar de rol van superoxide-resistentie genen beschrijven we in 
Hoofdstuk 6 de isolatie en karakterisatie van DLG294, een S. enterica serovar 
Typhimurium mutant waarbij door een MudJ transposon een tot dan toe onbekend gen 
geïnactiveerd is en dat sspJ genoemd is. Het eiwit SspJ wordt niet meer gevormd in de 
mutant en zorgt ervoor dat de mutant veel gevoeliger is geworden voor menadione, een 
redox-cycling agens dat superoxide radicalen genereert in de bacterie. DLG294 bleek 
minder virulent te zijn in vitro in macrofagen en in vivo in muizen. Door sspJ op een 
plasmide constitutief tot expressie te brengen in DLG294 is het fenotype van de mutant 
hersteld tot dat van de wildtype stam. Hieruit bleek heel duidelijk de rol van SspJ in de 
afweer tegen superoxide en in virulentie, maar de exacte rol en manier van functioneren is 
nog niet geheel duidelijk.  
DLG294 is nader onderzocht in vivo in muizen, zoals beschreven staat in Hoofdstuk 7. 
DLG294 induceert bijna geen granulomateuze lesies in de lever na subcutane infectie van 
Salmonella-resistente (Ityr) C3H/HeN muizen met 3 × 104 CFU en de aantallen bacteriën 
waren 3 log eenheden lager dan die van de wild-type stam op dag 5 na infectie. 
Daarentegen was DLG294 wel net zo virulent als wildtype en induceerde het een 
vergelijkbare leverpathologie in p47phox-/- muizen. Deze muizen missen een functioneel 
NADPH oxidase systeem door het ontbreken van de p47phox en kunnen geen superoxide 
produceren. Ook in beenmergmacrofagen van deze p47phox-/- muizen en in X-CGD PLB985 
cellen waren de  bacterie-aantallen van DLG294 net zo hoog als die van de wild-type stam 
op 24 uur na infectie. Deze resultaten suggereren dat SspJ een rol speelt bij de resistentie 
tegen oxidatieve stress en in overleving en replicatie van S. enterica serovar Typhimurium 
zowel in vitro als in vivo.   
Macrofagen spelen een belangrijke rol bij Salmonella infecties. Ze spelen hierbij een 
dubbele rol, die van gastheer- en effectorcel. DLG294 is gevoeliger voor superoxide en is 
geattenueerd in macrofagen en we weten dat superoxide hierbij een belangrijke rol speelt, 
maar wellicht dat andere processen ook een rol spelen en ervoor zorgen dat DLG94 
slechter in staat is om te overleven. Door de infectie met S. enterica serovar Typhimurium 
zal de macrofaag geactiveerd worden om de bacteriën te doden. Hierbij spelen diverse 
mechanismen een rol. Wij zijn in Hoofdstuk 8 nagegaan wat het effect is van wildtype en 
DLG249 infectie op de genexpressie in de macrofagen met behulp van een Affymetrix 
gene chip. Met deze chip kunnen 6.400 genen tegelijkertijd bestudeerd worden. Wildtype 
S. enterica serovar Typhimurium en DLG294 bleken beide de expressie van vele genen te 
beïnvloeden, maar er waren geen grote verschillen te zien. Hieruit konden we concluderen 
dat het feit dat DLG294 slechter in staat is om uit te groeien in macrofagen te wijten is aan 
de mutatie in sspJ en niet aan een veranderde activatiestatus van de macrofagen t.o.v. 
wildtype geïnfecteerde macrofagen.   
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Omdat het nog steeds onduidelijk was waarom DLG294 geattenueerd is en welke rol 
SspJ precies speelt, hebben we in Hoofdstuk 9 het fenotype van DLG294 nader 
bestudeerd met behulp van een fenotypische array waarbij tegelijkertijd vele processen 
bestudeerd kunnen worden. Het fenotype van DLG294 is vergeleken met de wildtype stam 
en liet zien dat DLG294 beter in staat was on stikstofbronnen te gebruiken voor groei, 
maar dat het daarnaast gevoeliger is voor een groot aantal antibiotica en voor hoge of lage 
pH. Daarnaast hebben we gekeken naar de genexpressie van intracellulaire DLG294 en 
hebben deze vergeleken met de genexpressie van intracellulaire wildtype S. enterica 
serovar Typhimurium. Daaruit bleek dat er slechts een paar kleine verschillen tussen 
DLG294 en de wildtype stam waren en dat er waarschijnlijk iets mis is met de 
membraanintegriteit van DLG294 waardoor er meer schadelijke stoffen worden 
opgenomen en deze stam hierdoor meer schade ondervindt. 
 
Concluderende opmerkingen 
Salmonella heeft allerlei complexe mechanismen ontwikkeld om om te kunnen gaan 
met reactive zuurstofradicalen. Salmonella bezit verschillende afweer barrières die de 
productie van zuurstofradicalen kunnen voorkomen verschillende of die de aangerichte 
schade door het beetje schadelijke stoffen dat toch nog gevormd wordt zoveel mogelijk 
beperken. Bovendien is het zo dat ieder organisme (o.a. Salmonella en E. coli) dat in de 
aanwezigheid van zuurstof groeit (aeroob) zichzelf moet kunnen beschermen tegen 
zuurstofradicalen die door het organisme zelf gemaakt worden of tegen invloeden vanuit 
de omgeving die de superoxide concentratie in de cel kunnen beïnvloeden. Uitgebreid 
onderzoek naar mutanten van E. coli en Salmonella heeft onze kennis over 
afweermechanismen tegen zuurstofradicalen al behoorlijk vergroot. Maar, zoals ook in dit 
proefschrift beschreven staat, is het op dit moment niet mogelijk om aan de hand van het 
in vitro fenotype van een mutant te voorspellen hoe deze zich in vivo zal gaan gedragen. 
Hoewel mutanten die extreem gevoelig zijn voor extracellulair superoxide waarschijnlijk wel 
geattenueerd zullen zijn in vivo, is het toch ook denkbaar dat met deze selectie criteria ook 
genen geïdentificeerd kunnen worden die niet essentieel zijn voor intracellulaire overleving 
en voor virulentie van Salmonella. Het is duidelijk dat er verschillende afweerbarrières 
tegen reactieve zuurstofradicalen zijn. Sommige van deze mechanismen zijn alleen van 
belang bij het omgaan met reactieve zuurstofradicalen in het milieu en bepalen de fitheid 
van Salmonella terwijl andere mechanismen ook van cruciaal belang zijn voor virulentie en 
bepalen daarmee de overlevingskansen van Salmonella in de gastheer. Nieuwe 
technieken, zoals microarray analyse, hebben al bijgedragen aan onze kennis over de 
verschillende genen en regulons die betrokken zijn bij afweer tegen oxidatieve stress. In de 
nabije toekomst zal uitgebreider gebruik van deze technieken een gedetailleerder beeld 
geven van de regulons die geïnduceerd worden. Zo kan de reactie van Salmonella op 
intra- of extracellulaire superoxide stress onderzocht worden en kan vervolgens de 
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